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THESIS SUMMARY 
The main objectives of this project were to adapt existing analytical 
techniques, for the examination of lipids extracted from subject-worn 
contact lenses and tear samples.  A great amount of research has been 
done in the area of meibomian gland lipid analysis; however, there has 
been little research investigating ex vivo lens deposits and more 
importantly the effect of lens wear on the lipid layer.  Since the 
development of silicone hydrogel contact lenses, lipid deposition and 
problems that relate to lipid deposition have increased.  Discontinuation of 
lens wear is often related to discomfort, particularly symptoms of dryness.  
This research was therefore based on the analysis of changes in lipid 
structure as a result of contact lens wear.  The development of an array of 
techniques enabled different aspects of lipid structure to be examined.  
Chromatographic techniques such as thin layer chromatography (TLC), 
high performance liquid chromatography (HPLC) and gas chromatography 
(GC) were utilised to separate individual lipid species and provide 
structural information.    GC analysis of ex vivo lens extracts showed 
significant differences in lipid profiles between daily wear and continuous 
wear lens extracts.  As well as assessment of lipid conformational 
changes, the presence of lipid oxidative products in the ocular 
environment were investigated.   Malondialdehyde (MDA), a secondary 
lipid oxidative end product has previously been linked with contact lens 
intolerance and discomfort.  This research showed that oxidative end 
products were building-up within the contact lens matrix.   
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1.1 Introduction 
Contact lenses are widely used throughout the world as visual aids, either 
therapeutically or cosmetically.  A large proportion of contact lens wearers 
experience discomfort (particularly at the end of the day) and in particular 
symptoms of dryness, which can sometimes lead to discontinuation of 
wear (1).  The main aim of this research was to better understand certain 
aspects of contact lens intolerance and discomfort.  The interaction 
between the lens and the ocular environment is important to understand; 
as the lens is approximately ten times thicker than the tear film it can 
cause instability and irregular function.  One of the main objectives for 
biomaterials scientists is to try to understand this complex interaction 
between a biomaterial and the host tissue.   
This research was based on the development of analytical techniques to 
enable the study of ocular lipids in contact lens wear.   Knowledge of the 
range of lipid structures involved is therefore important in order that the 
function and fate of lipids in contact lens wear can be understood. 
1.2 Lipid nomenclature 
The term lipid is given to molecules which are located in cells and tissues 
that are soluble in organic solvents but not in water (2).  Although there is 
no widely accepted definition for lipids, Christie’s description “fatty acids 
and their derivatives, and substances related biosynthetically or 
functionally to these compounds” is useful in the context of this research 
(3). It encompasses a whole array of compounds which vary in chemical 
composition, structure, polarity and function.  Lipids can be hydrophobic or 
amphipathic (i.e. can possess aspects of both hydrophilic and hydrophobic 
behaviour) and have many biological functions.  Lipids are conventionally 
separated into specific classes and each class consists of many individual 
lipids.   
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1.2.1 Hydrocarbons 
Hydrocarbons can vary in chain length and unsaturation, as seen in Figure 
1.1 to Figure 1.4.  They are non-polar lipids, which mean they are largely 
insoluble in polar solvents.   
 
Figure 1.1 – Structure of decane 
 
Figure 1.2 – Structure of dodecane 
 
Figure 1.3 – Structure of hexadecane 
 
Figure 1.4 – Structure of hexadecene 
 
1.2.2 Fatty acids 
Perhaps the most important lipid building blocks are fatty acids which are 
hydrocarbon chains of varying length and unsaturation with carboxylic 
functional groups.  The individual characteristics of the fatty acids are 
determined by the chain length and degree of unsaturation.  The longer 
the carbon chain of the fatty acid the higher the melting point and the more 
hydrophobic the fatty acid. The more double bonds the lower the melting 
point and the more fluidic the fatty acid (4).   The conventional naming of 
fatty acids is based on the number of carbons atoms in the chain and the 
number of double bonds.  The position of the double bond can also be 
used in the naming of fatty acids.  There are two ways to identify the 
position of the double bond – one way is to count from the carboxylic 
functional group end and this is the α numbering system and the other way 
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is to count from the methyl group end and this is the ω numbering system.  
There are several ways in which the same fatty acid can be named; for 
example, 18:1 can also be named octadecenoic acid or oleic acid, 16:0 
can be named hexadecanoic acid or palmitic acid.   
 
Figure 1.5 – Structure of oleic acid (18:1) 
 
Figure 1.6 – Structure of palmitic acid (16:0) 
 
Figure 1.7 – Structure of stearic acid (18:0) 
 
1.2.3 Sterols 
The second important building block is cholesterol, which is a relatively 
non-polar lipid as its structure demonstrates (Figure 1.8).  It contains a 
small polar hydroxyl group attached to a large non-polar substrate. 
Cholesterol is the major sterol found in meibomian gland secretions.   
 
Figure 1.8 – Structure of cholesterol 
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1.2.4 Cholesteryl esters 
Cholesteryl esters are simply cholesterol molecules which have been 
esterified with fatty acids of varying chain length and unsaturation.  The 
general structure of a cholesteryl ester is shown in Figure 1.9.   
 
Figure 1.9 – Structure of a cholesteryl ester 
 
1.2.5 Acyl glycerides 
Triglycerides (TGs) are glycerol molecules esterified with three fatty acids 
of varying chain length and unsaturation.  They are classed as neutral 
lipids as the polar groups are sterically hindered by the non-polar 
hydrocarbons chains.    
Monoglycerides (MGs) and diglycerides (DGs) also have glycerol 
backbones and are esterified with one and two fatty acids respectively and 
the fatty acids vary in saturation and chain length.  MGs and DGs are 
slightly more hydrophilic than TGs respectively.    
 
Figure 1.10 – General structure of a triglyceride; where R1, R2 and R3 are 
fatty acids of different chain lengths and unsaturation) 
Where R1 is a fatty acid 
of varying chain length 
and unsaturation 
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Figure 1.11 – General structure of a diglyceride; where R1 and R2 are 
fatty acids of different chain length and unsaturation 
 
Figure 1.12 – General structure of a monoglyceride; where R1 is a fatty 
acid of different chain length and unsaturation 
1.2.6 Phospholipids 
Phospholipids have similar structures to TGs but they have a phosphate 
group attached to an alcohol head-group making them polar lipids.   
 
Figure 1.13 – General structure of a phospholipid 
The polar group at the X position is usually an alcohol head group.  There 
are several alcohol head groups which can be at the X position.   
Where: R1 and R2 are fatty acids of varying 
chain length and unsaturation and X is an 
alcohol head group either ethanolamine, 
choline, serine or inositol 
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Figure 1.14 to Figure 1.17 show the structures of phospholipids with 
different alcohol head groups that are present in interfacial fluids in the 
body.   
 
 
Figure 1.14 – General structure of phosphatidyl choline (PC) 
 
Figure 1.15 – General structure of phosphatidyl ethanol amine (PE) 
 
Figure 1.16 – General structure of phosphatidyl inositol (PI) 
 
Figure 1.17 – General structure of phosphatidyl serine (PS) 
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1.2.7 Sphingolipids 
Sphingolipid is the general name given to a group of lipids that are based 
on the sphingosine structure (structure shown in Figure 1.18) and are 
polar molecules.   
 
Figure 1.18 – Sphingosine structure 
 
 
Figure 1.19 – General structure of a sphingomyelin (SM) 
1.2.8 Wax esters 
Wax esters are long chain fatty acids that have been esterified to very long 
chain fatty alcohols and are non-polar as the general structure 
demonstrates (Figure 1.20) 
 
Figure 1.20 – General structure of a wax ester 
Where R1 is a fatty 
acid, usually C14-
C26 
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1.3 The tear film 
The tear film is the thin watery layer that covers the anterior ocular 
surface.  The general and accepted model for the tear film is that it is 
made up of three layers – the inner mucous layer, middle aqueous layer 
and the outer lipid layer (5).   The three layer structure is still believed to 
be correct, however the nature of the interfaces are still uncertain (6).  The 
layers and components of each layer in the tear film help ensure the 
regular function of the ocular environment.  Each of the tear film layers will 
be discussed in detail.  Each section will describe their function and 
composition going into further in-depth description of the tear film lipid 
layer.   
 
Figure 1.21 – Cross section of the tear film (the old concept based on the 
(7, 8) model and the new concept based on (9)). 
 
1.3.1 The Aqueous layer 
The aqueous layer is reported to be ~6.5-7.5µm in thickness.   It makes up 
approximately 98% of the overall tear film and it contains a wide range of 
proteins, electrolytes and neutral metabolites (5).  Many tear proteins are 
locally produced and are mainly secreted by the lacrimal glands and to a 
lesser extent the accessory glands of Krause and Wolfring.  The number 
of identified proteins has increased following recent research.  Gachon et 
al. (10) suggested there were approximately 60 identified proteins.  
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However, more recently, De Souza et al. (11) identified 491 proteins in the 
tear film.  Over the years there have been several more proteins identified 
with the aid of newer and more sensitive analytical techniques.  Table 1.1 
shows some of the major tear proteins found in the tear film and their 
average concentrations from literature.  
Table 1.1 – An average of protein concentrations in literature (12, 13) 
Protein component Average concentration (mg/ml) 
Total protein 7.51 
Lysozyme 2.36 
Albumin 1.30 
Lipocalin 1.23 
Lactoferrin 1.84 
IgA 0.30 
IgG 0.126 
IgM 0.00086 
IgE 0.0001 
 
The general role of tear proteins is to act as a defence mechanism for the 
ocular environment.  For example, lysozyme which is one of the most 
abundant tear proteins, acts to destroy cell membranes of bacteria.  Each 
individual protein acts in different ways to protect the ocular environment 
against infection. 
1.3.2 The mucous layer 
The main function of the mucous layer is to provide a lubricious surface for 
the ocular environment.  The mucous layer coats any foreign particles that 
may have entered the eye with mucin, which ultimately protects the cornea 
and conjunctiva from damage (14).  The mucous layer composition is only 
recently starting to be understood in any detail.  It is mainly composed of 
glycoprotiens, which are proteins with a high ratio of carbohydrate to 
protein.  More and more mucins are being characterised such as 
MUC5AC and MUC5b (5).  Mucins are secreted mainly by goblet cells of 
the cornea and conjunctiva and can be soluble or insoluble (15).       
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1.3.3 Tear lipid layer  
As previously stated, the lipid layer is the outer most layer of the tear film.  
It is also the thinnest layer, with an average thickness of ~100nm 
thickness,  however this is known to vary from subject to subject (16).   
This project is mainly based on the tear lipid layer; although it is important 
to understand how this layer interacts with the other tear film layers.   
1.3.3.1 Lipid layer composition and function 
The main functions of the tear lipid layer are to prevent the evaporation of 
the underlying aqueous layer and provide a smooth surface for the eyelid 
to slide over (6, 17).  It is the unique composition of the lipid layer which 
makes its functions possible.  The lipid layer is mainly composed of lipids 
secreted by the meibomian glands.  However, it is still uncertain as to 
whether the tear lipid layer is composed solely of meibomian gland lipids 
or whether other sources contribute to the overall composition of the tear 
lipid layer (explained in further detail on Page 33).  According to Nagyova 
et al. (18) tear lipid composition is very different to meibomian gland lipids, 
however the composition of tear lipids is still under considerable debate.  
Certain publications state that the tear film lipid layer is actually two layers, 
an outer hydrophobic layer and an inner hydrophilic layer composed of 
mainly phospholipids.  Phospholipids, due to their amphipathic nature act 
as an interface between the hydrophobic lipids and the hydrophilic 
aqueous layer (19).   
1.3.3.2 Composition of meibomian gland secretions 
The majority of tear lipids are secreted by meibomian glands which are 
located in the upper and lower eyelids.  They secrete lipid and the action 
of blinking spreads the lipid across the surface of the cornea.   
The lipid composition of meibomian gland secretions has been well 
reviewed in literature and the general lipid classes are mainly agreed 
upon.  However, the percentage composition of each lipid class varies 
from researcher to researcher perhaps as a result of many advances in 
analytical methods and/or the tear sampling technique used.  The 
percentage compositions of meibomian gland lipids has been summarised 
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in the review by Wojtowicz et al. (20).  The major lipids secreted by 
meibomian glands are predominately non-polar lipids such as wax esters 
and sterol esters such as cholesteryl ester.  Other lipids are secreted as 
minor compounds such as free fatty acids, fatty alcohols, triglycerides and 
polar lipids such as phospholipids.  Figure 1.22 illustrates the mix of lipids 
secreted by the meibomian glands as an average from various authors.   
 
Figure 1.22 – Average percentage composition for meibomian gland 
secretions (from (21-24)). 
1.4 Lipid compositional differences between meibomian 
gland secretions and the tear lipid layer 
The tear lipid layer is made up of predominately lipids secreted by the 
meibomian glands, however tear lipids are believed to be more complex 
than meibomian gland secretions (25).  Other possible sources of lipid 
which contribute to the tear lipid layer are the conjunctiva, cellular debris, 
lacrimal glands and the lid margins (26).  There have been significant 
levels of research in the area of lipid composition of tears and meibomian 
glands.  There is some general agreement in literature with regards to 
meibomian gland secretion lipid composition; however the major debate is 
regarding the levels of polar lipids.  The level of phospholipids secreted by 
meibomian glands has been disputed by several authors.  Many authors 
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have reported the presence of several phospholipids from meibomian 
gland secretions, some as minor compounds and others as major 
compounds (16, 19, 23, 27-29).  However, there have been several recent 
publications which report little to undetectable levels of phospholipids 
secreted by the meibomian glands (30, 31).  Butovich (31) and Borchman 
et al. (30)  have stated that the meibomian glands do not secrete 
detectable levels of phospholipids using high performance liquid 
chromatography (HPLC) and infrared (IR) respectively.  Interestingly, 
Butovich has stated that there are phospholipids in tears, but not secreted 
by the meibomian glands which suggests there are other sources of lipid 
that contribute to the tear lipid layer.  Cellular debris, conjunctiva and 
lacrimal gland secretions are all possible sources of lipids which contribute 
to the tear lipid layer (26).   
Campbell et al. (32) have shown that phospholipids are not detected in 
tears because they are enzymatically degraded by certain 
phospholipases.  They reported the main enzyme; phospholipase C was 
responsible for the degradation of phospholipids in to by-products such as 
DGs and lysophospholipids.   
Recent publications by Saville et al. (25, 33) report the presence of several 
phospholipids in the tear film,  these include varying chain length PCs and 
SMs.  Saville et al. (33) report that the PCs detected in meibomian glands 
were also detected in tears which suggested that tear lipids originate from 
meibomian gland secretions.   
As analytical techniques have improved, a wider range of lipoidal species 
have been more accurately identified in meibomian secretions. Butovich et 
al. (34-36) have shown that very long chain fatty acids are present within 
the family of cholesteryl esters.  Although the presence of long chain fatty 
acids (C16 to C26) had previously been reported (37, 38), the lipid class 
with which they are combined had not been clearly determined because of 
the limitations of the analytical technique used.   
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1.5 Function and composition of lipids at biological 
interfaces 
To help better understand the function of tear film lipids, the composition 
and role of lipids at other body interfaces is important to review.   
Pulmonary surfactant and synovial fluid have similar functions to the tear 
film, they help reduce surface tension and do so under a load.  However, 
the composition of pulmonary surfactant and synovial fluid differ 
significantly from the composition of the tear film.  
1.5.1 Pulmonary surfactant: lipid composition and function 
Pulmonary surfactant is the fluid lining the lungs.  It is a mixture of proteins 
and lipids which coats the lungs and reduces surface tension at the 
air/water interface (39).  It was discovered that it was the role of the lipids 
which reduced the surface tension and allowed the lung to expand and 
contract without the alveolar collapsing. Phospholipids have been 
recognised for some years as the major component of pulmonary 
surfactant together with the fact that a phosphatidyl choline (PC) – 
dipalmityl phosphatidyl choline (DPPC) plays a major role in the function of 
this complex fluid (40-42).  The total lipid composition of pulmonary 
surfactant is shown in Figure 1.23.  Phosphosphatidyl cholines (PCs) 
represent approximately 80% of the total and DPPC accounts for 
approximately half of this total.  The other 40% is made up of PCs with 
fatty acids of varying chain length and unsaturation at Sn1 and Sn2 
positions on the glycerol backbone.  The fatty acids at the Sn1 and Sn2 
positions of the glycerol backbone are usually mono or di-unsaturated but 
rarely polyunsaturated.  It is interesting that lung surfactant fatty acids 
resemble those found in meibomian gland lipids in that both very small 
and polyunsaturated fatty acids are virtually absent. Cholesterol, on the 
other hand which is believed to aid in the spreading of the phospholipids 
and increase the fluidity of lung surfactant is also present in meibomian 
gland secretions (43, 44). Other non-polar lipids such as 
monoacylglycerols, diacylglycerols and triglycerides are also present in 
pulmonary surfactant at low levels (45, 46).   
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Figure 1.23 – Pulmonary surfactant phospholipid composition 
1.5.2 Synovial fluid: lipid composition and function 
The synovial fluid (SF) of joints functions as a biological lubricant, 
providing low-friction and low-wear properties to articulating cartilage 
surfaces through the combined contribution of hyaluronic acid (HA), 
lubricin and surface active phospholipids (SAPL).  These species are 
secreted by chondrocytes in articular cartilage and synoviocytes in 
synovium, and concentrated in the synovial space by the semi-permeable 
synovial lining.  The predominant contributor to fluid film lubrication is HA 
whereas SAPL play a major role in boundary layer lubrication.   
The two major functions of synovial fluid are firstly to create a smooth 
surface for the articulating joints and the second is being able to do so 
under considerable loads over a substantial time period.   HA was the first 
component found to be present in significant amounts in synovial fluid and 
was believed to be the component most responsible for lubricity in joints.  
It was later discovered that HA failed under any load and was therefore 
not the component responsible for the lubricity.  Earlier studies failed to 
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recognise the lubricating role of lipids but subsequent work established 
their key role as boundary lubricants under load (47-50).    
The important physicochemical point is that HA has no significant surface 
activity and will therefore not function effectively at interfaces.  Lubricin 
and especially phospholipid (hence SAPL) are surface active and provide 
the surface and boundary layer functionality needed to provide the 
complete lubrication capability that is essential to the functionality of 
synovial fluid. This interfacial activity of phospholipids is even more 
evident in their function in the lung (51). 
1.5.3 Comparison of lipid composition and function at biological 
interfaces 
The overall lipid compositions of synovial fluid, pulmonary surfactant and 
the tear film are different to each other.  The tear film is made up of 
predominately non-polar lipids such as cholesteryl esters and wax esters 
whereas pulmonary surfactant and synovial fluid are made up of mostly 
phospholipids.  It is clear that the tear film lipid layer is unique in its 
composition.  Although the functions of each biological fluid may be 
similar, their lipid compositions are not.  The tear film lipid layer, not only 
has to aid in the ocular surface lubrication, it has to prevent evaporation of 
the aqueous.  It is the unique mix of non-polar lipids which helps this 
function be fulfilled.   
1.5.3.1 Surfactant proteins at biological interfaces 
It is the amphipathic nature of phospholipids which promotes their ability to 
function at a range of interfaces.    Although phospholipids can function at 
interfaces, there are certain proteins present in pulmonary surfactant and 
the tear film which also act as surfactants.  Certain proteins have been 
found in pulmonary surfactant and are their presence is being researched 
in the tear film.  These surfactant proteins include surfactant protein A 
(SP-A), surfactant protein B (SP-B), surfactant protein C (SP-C) and 
surfactant protein D (SP-D).  All four of these proteins have recently been 
identified in the ocular environment, more specifically in the lacrimal 
glands (52, 53).  
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SP-B and SP-C are hydrophobic proteins and their main functions in 
pulmonary surfactant are adsorbing phospholipids to an air/liquid interface 
and the formation of surface active monolayers.  Their role in the ocular 
environment is still unknown, but is thought to be similar to that of 
pulmonary surfactant (54).   
The commonality of spreading function and boundary layer lubrication 
associated with the combination of phospholipids and the surfactant 
proteins; surfactant protein B (SP-B) and surfactant protein C (SP-C) in 
lung and articular joints is well established.  Both SP-B and SP-C have 
been identified in the ocular environment and particularly in the lacrimal 
glands (52).  The expansion and compression of the lipid layer during the 
blinking process has apparent similarities to the function of lung surfactant 
(55) and it is logical to expect that the interfacial combination of 
phospholipids and surfactant proteins plays a part in this process.   
SP-C is a very small protein approximately 4-6kDa.  The role of SP-C in 
pulmonary surfactant is to reduce surface tension between the 
phospholipid and the soluble interface (56).  The role of SP-C in the tear 
film is believed to be the same, acting as a surfactant between the 
phospholipids and the aqueous layer.  SP-B has a similar role of reducing 
the surface tension of lipids.   
Brauer et al. (53) had already reported the presence of SP-A and SP-D in 
human tear fluid and other parts of the ocular environment and later 
reported the presence of SP-B and SP-C in human tear fluid (57).  SP-A 
and SP-D are both hydrophilic and their major roles in pulmonary 
surfactant are improving the host defence and the reuse of surfactant (54). 
There is still considerable contradiction as to whether the SP-A or SP-D or 
both are present in the ocular environment.  Certain publications have 
identified SP-A and SP-D in the ocular environment (57), however others 
have only reported the presence of SP-D but not SP-A (58, 59).  Both of 
these proteins are present in lung surfactant and they have very important 
roles in aiding surface activity.   
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SP-A is 28-36kDa and its function is to aid the function of SP-B in reducing 
surface tension at an air/liquid interface (60-62)  SP-D is a 43kDa protein 
and its function in pulmonary surfactant is the interaction with bacteria and 
viruses (63).  Less is known about the function of these surfactant proteins 
in ocular environment, but they are believed to function in a similar manor 
to pulmonary surfactant.   
The tear film lipid layer is composed of mainly non-polar lipids such as 
cholesteryl and wax esters.  The lipid compositions of synovial fluid and 
pulmonary surfactant differ significantly from the tear film lipid layer as 
they are composed mainly of polar lipids such as phospholipids.   Although 
their functions are similar, their lipid compositions are very different.  The 
main focus of the research in this project was the tear film lipid layer but 
more importantly, the effects of contact lens wear on the composition of 
lipids.  Certain ocular disorders can also be a cause of or cause tear lipid 
compositional changes and these are discussed in detail in section 1.5.   
1.6 Dry eye – compositional changes to meibomian 
gland lipids 
The definition for dry eye given by the definition and classification 
subcommittee of the international dry eye workshop (DEWS) : ‘dry eye is a 
multifactorial disease of the tears and ocular surface that results in 
symptoms of discomfort, visual disturbance, and tear film instability with 
potential damage to the ocular surface.  It is accompanied by increased 
osmolarity of the tear film and inflammation of the ocular surface’ (64-73). 
Dry eye has been separated into two main classes in literature – 
deficiency of aqueous production and increased rate of evaporation.  One 
of the major causes of increased rate of evaporation is meibomian gland 
dysfunction (MGD), of which there are many types.  The causes of MGD 
include obstructive MGD, which is a physical blockage of the glands or 
non-obstructive MGD. There many types of MGD such obstruction of the 
glands, over-secretion of meibum, under-secretion of meibum.  
Obstruction of the glands can cause low levels of meibum to be secreted 
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by the glands.  However, low levels of meibum secretion may not be 
caused by obstruction.      
MGD can lead to changes in the tear film dynamics, irritation of the eye 
and disease of the ocular surface (74).  Other ocular disorders, which can 
be caused by MGD, have been previously confused with MGD and these 
include blepharitis.  Blepharitis is generally described as inflammation of 
the entire eyelid.  Because MGD can be the cause of many ocular 
symptoms such as inflammation, other disorders have been confused with 
it; however MGD can be the cause of many other ocular disorders such as 
blepharitis.   
MGD often causes changes to the tear film such as increased evaporation 
of the aqueous as a result of decreased meibum production.  Obstruction 
of the glands is the main type of MGD which often leads to decreased 
secretion of meibum.   There are many causes of obstructive MGD which 
include changes in secretion composition or an obstruction of the duct of 
the gland.  C18:1 (oleic acid) has been found to activate epidermal 
keratinocytes which could lead to blockage of the meibomian glands (75). 
Changes in lipid composition can often cause MGD.  There are reported 
differences in lipid composition between normal subjects compared to 
subjects with MGD, in particular changes in the fatty acid structure.    A 
reduction of unsaturated lipids results in a thicker secretion.  Saturated 
lipids can pack together which produces a more viscous secretion.  
Therefore, a reduction in the levels of unsaturated lipids could result in 
blockage of the meibomian glands (38).   
A recent study analysed the differences in fatty acid composition between 
subjects with MGD and aqueous deficient dry eye compared to normal 
subjects and  found differences in the fatty acid composition between 
normal subjects and subjects with MGD (38).  There was however no 
change in fatty acid composition between normal subjects compared to 
aqueous deficient dry eye subjects (38).  Significantly lower levels of 
C16:0 and C18:0 were observed for subjects suffering with MGD 
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compared to normal subjects.  Therefore, the ratio of saturated to 
unsaturated fatty acids is important for regular function of the tear film.     
There are reports that levels of phospholipase A2, an enzyme that 
degrades phospholipids (described in detail in section 1.11.2) are higher in 
dry eye patients (76).  Phospholipids in the tear lipid layer are thought to 
act as an interface between the aqueous and the non-polar lipids, 
increasing tear film stability (19).  Therefore, an increase in the levels of 
phospholipases that degrade phospholipids could lead to decreased tear 
film stability and dry eye.   
1.6.1 Contact lens wear, MGD and dry eye 
Many of the disorders discussed above can prevent the wear of contact 
lenses by certain individuals.  Certain ocular disorders can be caused by 
contact lens wear, known as contact lens induced dry eye.  There have 
been some reports that link contact lens wear to an increased risk of 
MGD.  However, the International workshop on meibomian gland 
dysfunction: report of subcommittee on epidemiology of, and associated 
risk factors for MGD have reviewed past literature and reported there was 
no significant correlation between contact lens wear and MGD (77-80), 
even though earlier studies had reported a significant correlation between 
contact lens wear and MGD (81, 82).  Arita et al. have investigated the 
morphological changes to meibomian glands in contact lens wearers vs. 
non-contact lens wearers and found significant changes to the structure of 
the glands in contact lens wearers (83).  This led to a decrease in the 
number of functioning glands which resulted in decreased meibum 
production which ultimately caused dry eye.   
1.6.1.1 MGD and dry eye therapies 
Current MGD therapies include warm compresses of the eyelids, the use 
of ocular lubricants, topical antibiotics and tetracycline derivative treatment 
(84).   
There are many therapies for contact lens induced dry eye and these 
include the use of lubricating eye drops.  Other treatments include the use 
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of contact lenses which release drugs to the eye over an extended period 
of time (85).   
Recent studies have investigated dietary essential fatty acid supplements 
to decrease the symptoms of dry eye and improve the tear lipid layer 
composition.  A review by Rosenberg et al. (86) stated that some previous 
studies using various essential fatty acids for dry eye treatment reported 
improvements in dry eye symptoms (87-89) whilst others did not show any 
significant improvements in symptoms (90, 91).  However, this was not a 
significant number of studies to conclusively state that increasing dietary 
intake of essential fatty acids decreases symptoms of dry eye disease. 
Further work by Wojtowicz et al. (92) revealed that there was no change in 
meibum lipid composition after a dietary intake of an essential omega-3 
fatty acid.  The main treatment for contact lens and non-contact lens 
induced dry eye is mainly the use of lubricating eye drops.   
1.6.1.2 Dry eye and contact lens wear strategies 
Dry eye as a result of contact lens wear is a common complaint and one of 
the most prevalent causes of discontinuation of wear (93).  There are 
many contact lens strategies for dry eye and there has been a review on 
this topic by Sindt et al. (94).   Some of these contact lens features which 
are designed to improve dryness symptoms are discussed in section 
1.7.1.   
A new daily disposable silicone hydrogel lens (Dailies Total 1 – delafilcon 
A), loaded with a phospholipid – DMPC (dimyristoyl phosphatidylcholine) 
was developed to try to improve symptoms of dryness.  The principle of 
the lens was to release the DMPC into the tear film throughout the wear 
time, increase tear film stability and therefore reduce the symptoms of 
dryness (95).  Chapter 6 investigates both in vitro and ex vivo studies of 
DMPC-containing lenses.   
1.7 Contact lenses materials 
A brief introduction to the history of contact lens materials is important to 
discuss as they will have an effect on tear film dynamics.  The interaction 
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between the lens and tear film will be effected by a change in contact lens 
properties such as the lens material, surface properties and water content 
and each of these properties are discussed below.   
1.7.1 Types of contact lenses  
To the date of writing this thesis, there had been five generations of 
contact lenses.  The first generation of contact lenses were polymethyl 
methacrylate (PMMA) based lenses.  These were very glassy in nature 
and did not allow any oxygen to pass to the cornea.   
 
Figure 1.24 – Structure of PMMA 
The second generation of contact lenses were the conventional hydrogels.  
They were based on the hydrophilic polymer, poly (hydroxyethyl 
methacrylate) (polyHEMA).  Other conventional hydrogel materials were 
developed based on copolymers of polyHEMA with other polymers.  The 
ionicity and the water content of conventional hydrogels varied according 
to the nature of the polymers.  There are four main groups of conventional 
hydrogel.  
Group I lenses = Low water content, non-ionic 
Group II lenses = High water content, non-ionic  
Group III lenses = Low water content, ionic 
Group IV lenses = High water content, ionic 
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Division between low and high water content is set at 50%.  An ionic 
material is defined as one that contains more than 0.2% ionic material (96, 
97). 
 
Figure 1.25 – Structure of HEMA (hydroxyethyl methacrylate) 
Conventional hydrogels have limited oxygen permeability and are 
therefore used predominantly as daily disposable lenses.   
The third generation of lenses were therefore developed to improve 
oxygen permeability to the cornea by the introduction of silicone to the 
lens.  Silicone has a very high Dk (oxygen permeability) value, which 
indicates high oxygen permeability.  Third generation lenses were made 
predominantly from silicone rubber which was bonded to oxygen 
(siloxane).  The lenses allowed high levels of oxygen to reach the cornea 
but they were very hydrophobic in nature which meant they adhered to the 
cornea and increased lipid deposition was a problem.    
The fourth generation of contact lenses were rigid gas permeable lenses 
that were based on copolymers of a monomer referred to as TRIS (tris 
[trimethylsiloxy] – methacryloxy – propylsilane).   
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Figure 1.26 – Structure of tris (trimethylsiloxy)-methacryloxy-propylsilane 
(TRIS monomer) 
The fifth and current generation of contact lenses were a hybrid of 
conventional hydrogels and silicone lenses.  They incorporated monomers 
such as hydroxyethyl methacrylate (HEMA) and methyl methacrylate 
(MMA) with silicone-containing monomers which produced silicone 
hydrogels.   Silicone hydrogels could be worn on an extended wear basis 
as they had greater oxygen permeability.   
There have been many developments in the area of silicone hydrogel 
materials.  One of the areas of development has been the surface 
modification of silicone hydrogel materials.  This is because the surface of 
the lens should be hydrophilic so the aqueous tear film can easily spread 
over the lens and to reduce the level of lipid deposition.   
1.7.2 Surface modification of contact lenses 
The first generation of silicone hydrogel materials such as Focus Night & 
Day (lotrafilcon A, CIBA Vision) and PureVision (balafilcon A, Bausch and 
Lomb) are surface treated in two different ways.   
Focus Night & Day lenses are coated by using plasma polymerisation 
whereas PureVision lenses are plasma oxidised.   Both of these methods 
are used to make the contact lens surface more hydrophilic to prevent 
increased attraction of lipids.  Plasma oxidation and plasma polymerisation 
have different effects on the surface of these lenses.  PureVision is 
surface treated using plasma oxidation however; this surface treatment 
does not create a uniform coating which leads to hydrophobic patches on 
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the surface of the lens.  As the lens is exposed to air (hydrophobic), the 
polymer chains rearrange themselves towards a hydrophilic nature within 
the matrix of the lens which results in hydrophobic areas being created on 
the surface of the lens.  Focus Night & Day lenses on the other hand have 
relatively uniform hydrophilic surfaces and subsequently have lower levels 
of gross lipid deposition (98).   
The next generation of silicone hydrogels such as Acuvue Advance 
(galyfilcon A, Vistakon) and Acuvue Oasys (senofilcon A, Vistakon) lenses 
are not surface modified.  They contain a molecule called polyvinyl 
pyrollidone (PVP).  PVP is a long chain hydrophobic molecule which acts 
as a wetting agent for the lens.   
Newer lens materials have been developed which are not surface modified 
or use wetting agents.  Instead they use certain polymers which are 
wettable, materials include Biofinity (comfilcon A, CooperVision) (94).   
The surface modification of the lenses effect the way in which tear film 
components interact with the lens, in particular the interaction of lipids with 
the lens.  This will affect the wettability of the lens surface.  
1.8 Factors which influence lipid deposition on contact 
lenses 
There are many factors which may influence the rate of lipid deposition on 
contact lens materials.  These include: the lens material, the surface 
characteristics of the lens, the length of wear, the wear schedule, the 
cleaning regime but ultimately the subject wearing the lens.  In many 
cases the individual is the greatest variable as lipid profiles vary from 
subject-to-subject (16), which could be as a result of individual diet and 
climate.  Variables such as age and health can significantly affect lipid 
composition (16, 99).   
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1.8.1 Contact lens material and lipid deposition  
Tear film components will readily deposit on contact lenses.  The 
interaction of lipids with contact lenses is affected by several factors that 
are discussed below.   
The lens material characteristics change the way lipids and other tear film 
components are attracted to the surface of the lens (100).  Lipid does not 
only adsorb on the surface of contact lenses but can also penetrate within 
the lens matrix, particularly with hydrogels which are semi-permeable 
(100).  Lipid adsorption has been shown to be greater on contact lenses 
that contain the monomer N-vinylpyrrolidone (NVP) (101).  The addition of 
NVP to lenses was to try and increase lens water content.  However, due 
to the hydrophobic backbone of NVP it led to the increased lipid 
deposition.   
 
 
Figure 1.27 – Structure of N-vinyl pyrrolidone (NVP) 
 
The ionicity of the lens does not greatly affect lipid deposition but has been 
shown to have a greater effect on protein deposition (102).   
Experiments performed by Bontempo et al. (103) showed that ‘group IV 
lenses (high water content, ionic matrix) are more likely to be prone to 
higher levels of protein deposition than lipid deposition.  They also showed 
that lipid deposition was more likely to occur on group II lenses (high water 
content, non-ionic matrix).  This was the case when unworn contact lenses 
had been spoiled in either a protein solution or lipid solution.  However, 
Bontempo et al. (103) demonstrate that in a lipid and protein combination 
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solution, this is not the case.  When group II lenses were spoiled in a lipid-
protein mix, they now attracted more protein than lipid.  This is because 
certain charged proteins in the solution compete with the polar lipids and 
therefore bind to the hydrophilic sites on the contact lens.   
For group I, III and IV lenses, the presence of proteins in the artificial tear 
solution caused an increase in lipid adsorption (normally non-polar lipids). 
Rigid gas permeable (RGP) contact lenses were more likely to have 
higher levels of lipid deposition than protein deposition due to their 
hydrophobic nature.  But when both protein and lipid were present in the 
artificial tear solution, the lipid made the contact lens surface more 
hydrophilic. This is because the hydrophobic sites of the contact lens 
attracted the lipid and the hydrophilic sites repelled lipids, this therefore 
created a hydrophilic surface for the proteins bind.  Lipid deposition on 
RGP contact lenses was shown to be material dependant, whereas 
protein deposition was shown to be minimal (104).   
Levels of lipid deposition are known to be greater than protein deposition 
on many silicone hydrogel materials because of the hydrophobic nature of 
tear lipids (105).  
The nature of the monomers used to make contact lenses can determine 
which individual lipids are deposited on the lens (97).  Carney et al. (97) 
have demonstrated that different lipid classes will have a greater affinity 
for different contact lens materials.  This was determined from the 
incubation of different lens materials in a non-polar lipid solution 
(cholesterol) and a polar lipid solution (PE – a phospholipid).  The lens 
materials chosen were a mix of conventional and silicone hydrogel 
materials.  Their results showed that after the 20 days incubation period, 
PureVision (balafilcon A), Acuvue Oasys (senofilcon A) had greater levels 
of cholesterol deposition.   This was most likely due to the surface 
treatments of these lenses.  Acuvue Advance (galyfilcon A) had higher 
levels of PE adsorption over the 20 day period compared with Acuvue 
Oasys and PureVision.  However, the concentration of polar lipid 
adsorption was lower for all lenses compared with non-polar lipid 
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adsorption. The monomers used to make the lens and the water content of 
the lens were determining factors for the levels of lipid deposition as well 
as the surface modification of the lens.  This study investigated lipid 
adsorption using an in vitro spoliation model but this does not mimic in 
vivo conditions.  Although in vitro lipid spoliation models are useful, they 
do not mimic in vivo conditions.  There are a limited amount of studies 
which investigate the nature of lipid deposition from ex vivo lenses.  
However, there have been recent studies which investigate the nature of 
lipid composition from ex vivo contact lenses that have been cleaned with 
various lens solutions and these publications are reviewed in section 
1.7.2.   
1.8.2 Contact lens solutions and lipid deposition 
A recent study investigated and quantified the levels of different non-polar 
lipid species deposited on ex vivo Acuvue Oasys (senofilcon A) lenses by 
using HPLC for the separation of the lens extracts (106).  Heynen et al. 
(106) found that different cleaning solutions and regimes performed 
differently, and removed varying amounts of lipid from the lens.  
Cholesteryl esters were the predominant lipid class deposited on the 
Acuvue Oasys lenses as determined by HPLC separation, with a lesser 
amount of cholesterol and free fatty acids.  The cholesterol ester used was 
cholesteryl oleate and the free fatty acid used was oleic acid.  Heynen et 
al. (106)  reported that solutions that contained particular preservatives 
such as Polyquad (Polyquarterniums) and Aldox were more effective for 
the removal of cholesteryl esters (the major lipid class deposited on the 
lens) than solutions that contained hydrogen peroxide.    This study 
focused on the cleaning efficacy of solutions for the removal of non-polar 
lipids from lenses, whereas a study by Saville et al. (25) investigated the 
propensity of various phospholipids (polar lipids) for ex vivo contact 
lenses.  The lens materials chosen were PureVision (balafilcon A) and 
Acuvue Oasys (senofilcon A).  Groups of subjects were asked to wear the 
lenses for a thirty day period and clean the lenses every night with their 
allocated solution (one of the three solutions tested).  The ex vivo contact 
lenses were spiked with a phospholipid standards, extracted and the 
50 
 
extracts were analysed by mass spectrometry.  The results showed that 
there were high levels of phospholipids and cholesterol present on Acuvue 
Oasys lenses.  PureVision lens extract analysis revealed that the levels of 
lipid deposition were not affected by the cleaning regime used which 
indicated that the cleaning solutions were not effective at the removal of 
lipids deposited on the lens throughout the wear schedule.  This accounts 
for the build-up of lipids on lenses over the wear schedule of the lens.   
1.9 Tear lipid and meibomian gland secretion collection 
techniques 
As it is still unclear whether the meibomian glands are the sole contributor 
to the tear lipid layer (18), it becomes difficult to find a suitable tear lipid 
sampling technique.  There are many techniques used for the collection of 
lipids from the ocular environment, but each technique is suited to the 
collection of lipids from a certain area.  For example, hard expression of 
meibomian glands can provide a pure meibomian gland secretion sample 
and is not contaminated by tear lipids.   Hard expression is often used to 
sample meibomian gland lipids as a large amount of lipid can be collected 
the use of this method (23).  The meibomian glands are squeezed and the 
meibum secreted is collected using platinum spatula.  This method of 
collection is used solely for meibomian gland lipids.  This method of 
collection has the advantages of being able to obtain a pure meibum 
sample and can be done on cadaver eyes as well as live patients.  The 
main disadvantage of this method is that it can be quite painful.  However, 
trying to obtain a pure tear lipid sample is much more difficult.  The many 
techniques used in literature for meibomian gland lipid collection have 
been microcapillary tube (107), Schirmer strips (26, 30) and hard 
expression of the glands (23) and each technique has its advantages and 
disadvantages.   
Microcapillary tube method is often used to collect a tear sample.  The 
microcapillary is placed in the meniscus of the eye and tears are drawn up 
the tube by capillary action.  This method has the advantages of being a 
very rapid collection method and being pain free.  However, the 
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disadvantages of this method are that there is only a small sample volume 
and that there is a great risk of contamination from tear lipids and cellular 
lipids (107). 
Schirmer Strips have also been used for tear lipid collection by Borchman 
et al. (26, 30).  The strip is placed in the lower eyelid and the sample is 
collected.  This method is a suitable method for tear lipid collection, but not 
very good for meibomian gland secretion collection.  This method is also 
more invasive compared with the microcapillary collection method.   
Ophthalmic sponges are another method used to collect tear lipids.  The 
sponge is made of cellulose and is placed in the meniscus of the eye to 
collect tear lipid sample.  The advantages of using this method for 
collecting tear lipid samples is the large sample volume obtained and it is 
a pain free method for the collection of tear lipids.  However, the 
disadvantages are the risk of contamination from cellular debris and skin 
lipids.  There are no reports in literature about the use of ophthalmic 
sponges to collect tear lipid samples. However, this technique has been 
used previously in this research group for the collection of tear lipids and 
was therefore used for the research in this thesis (108).    
The contact lens is also a method for tear lipid collection.  The analysis of 
deposits on worn contact lenses is an advantageous method for the 
collection of tear lipid samples as it can provide a ‘snapshot’ of what is 
occurring at a particular point in time.  The disadvantages of this method 
are that certain contact lenses do not adsorb that much sample volume 
and the contact lens can induce changes to the lipid composition (to be 
discussed in further detail in later chapters).   
In summary, the most advantageous methods for tear lipid sampling, 
according to literature are the Schirmer strips and the ophthalmic sponges.  
The best method for collecting a pure meibomian gland secretion sample 
is hard expression of the meibomian glands.   
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1.10 Analytical techniques for meibomian gland, tear 
lipids and lipid deposits on contact lenses analysis 
Many analytical techniques have been used by several researchers.  They 
have enabled the characterisation of lipids from meibomian gland 
secretions, tear lipid samples and contact lens extracts.    
1.10.1 Thin layer chromatography (TLC) 
TLC has been used many by many researchers for the separation 
meibomian gland secretions into their relative lipid class.  TLC separates 
the lipid classes according to their relative polarity.  TLC is often used in 
conjunction with gas chromatography (GC) as it was by Nicholaides et al. 
(37) and Harvey et al. (109).  Lipid classes were separated by TLC then 
analysed in further detail by methods such as GC (which separates 
individual fatty acids).  TLC was also used by  Zhao et al. (110) for the 
analysis of ex vivo contact lens extracts and the cholesterol band was 
analysed by mass spectrometry.   
1.10.2 Gas chromatography (GC)/gas chromatography mass 
spectrometry (GCMS) 
GC and GCMS can be used after TLC separation of lipid classes or 
independently.   GC, GCMS and TLC with GC and GCMS have been used 
by for fatty acid separation by several researchers (23, 38, 111-113).   
Joffre et al. (38) used GC with flame ionisation detection (FID) and GCMS 
to separate and identify the fatty acid moieties of lipids from meibomian 
gland samples.  They investigated the differences in the fatty acid 
composition of meibomian gland dysfunction patients and aqueous 
deficient patients compared to normal patients.   
Nicolaides et al. (23) used GCMS for fatty acid separation after TLC 
separation of lipid classes from the meibomian glands from cadavers.   
Shine et al. (111, 112) also used GCMS after lipid class separation by TLC 
to investigate the changes in fatty acids of normal patients compared to 
those with certain cases of chronic blepharitis.   
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1.10.3 High performance liquid chromatography (HPLC) 
HPLC has been used for tear lipid and meibomian lipid separation by 
various researchers.  HPLC is used for the separation of lipids into either 
lipid class or individual lipids and is used in conjunction with various 
detectors such as UV, fluorescence and different types of MS.  HPLC with 
UV detection was used by Shine et al. (19, 27) for the separation of polar 
lipids from meibomian gland secretions.  Both of the studies separated 
lipids from meibomian gland secretions by TLC and then used HPLC with 
UV detection to separate the individual lipids.  The individual lipids were 
identified by the comparison of their retention time with standards  (19, 
27).   
Butovich et al. (29, 31, 34, 35, 114) also used HPLC for the separation of 
meibomian gland lipids and a MS detector was used.  There are various 
ionisation methods in MS such as electron ionisation (EI), chemical 
ionisation (CI), atmospheric pressure chemical ionisation (APCI), and 
electrospray ionisation (ESI) (discussed in detail in section 10.3.1).  
Butovich et al. (29, 114) used different ionisation methods as they were 
each suited to the identification of different lipids.   
Jones et al. (115) and Haynen et al. (106) have also used HPLC but in 
conjunction with UV detection for the separation of ex vivo contact lens 
deposits.   
1.10.4 Types of mass spectrometry (MS) 
There are many types of ionisation which provide mass to charge data for 
unknown compounds but they each fragment the sample differently.  The 
methods described below are examples of the ionisation methods most 
suited for use in conjunction with HPLC.   
Electron ionisation (EI) applies a positively charged ion to the separated 
sample which can provide information such as the molecular weight of the 
analyte.  Chemical ionisation (CI) is similar to EI; however CI uses gases 
to produce ions of the analytes. The main advantage of CI over EI is that 
CI uses less energy than EI and therefore CI is a much softer ionisation 
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method.   Atmospheric pressure chemical ionisation (APCI) is a soft 
ionisation method and is useful for the analysis of non-polar lipids.  It is 
most often used in tandem with HPLC as it can tolerate high solvent flow 
rates.  APCI is similar to CI but the ionisation occurs at atmospheric 
pressure.  Electrospray ionisation (ESI) is particularly useful for the 
analysis of polar analytes.  ESI provides molecular weight information as 
the mass spectrum provides the positive ion of the analyte.   
1.10.5 Mass spectrometry (MS) 
Saville et al. (25, 33) used MS for the detection and quantification of 
phospholipids and cholesterol from contact lens extracts and from tear 
samples.   
1.10.6 Infrared (IR) 
Borchman et al. (26, 30, 99, 116) used fourier transform IR spectroscopy 
to investigate the conformational changes in the hydrocarbon chains of 
meibomian gland lipids which may have occurred with age, disease or 
temperature.  By using IR they were able to identify conformational 
changes in the hydrocarbon chain of meibomian gland secretions 
comparing normal subjects to subjects with MGD or older subjects.   
1.10.7 Cholesteryl esterase enzyme reaction 
This method, in simplistic terms works by the conversion of cholesteryl 
esters to cholesterol by hydrolysis and the oxidation of  free cholesterol to 
choles-4-en-3-one and this binds it to an aminopyrine, which forms a 
coloured complex (117).  This method was used by Pucker et al. (118) to 
determine the concentration of cholesterol and cholesteryl esters on ex 
vivo and in vitro spoiled silicone hydrogel contact lenses.  Lenses were 
extracted and hydrolysed, oxidised and reacted with a reaction buffer and 
the absorbance was read at 500nm.   
1.11 Lipid oxidation and degradation 
A major part of this project involved the development of existing lipid 
analytical techniques, but also the measurement of lipid oxidation products 
by the adaptation and use of commercial assays.  Lipid oxidation can be 
55 
 
an enzymatic or non-enzymatic process.  Non-enzymatic lipid oxidation is 
caused by initiators such as heat, light, metals, increased levels of oxygen 
and is referred to as autoxidation.  Enzymatic oxidation is caused by 
particular enzymes that cause degradation of the lipid species.  Therefore, 
there are two major pathways of oxidation; autoxidative and enzymatic.   
1.11.1 Autoxidation 
Autoxidation is a spontaneous reaction whereby lipids react with oxygen 
present in the atmosphere and form free radicals.  There are usually three 
stages involved: initiation, propagation and termination steps.   The 
initiation step involves the abstraction of a hydrogen atom from the carbon 
atom next to the double bond (known as the allylic hydrogen) and this 
process is promoted by one or several of the initiators mentioned above.  
This creates a radical species that can react with oxygen. This can then 
self-propagate and can repeat several times until termination.  Termination 
is achieved when two radical species react together to terminate the 
process.   
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Figure 1.28 – Autoxidation of oleic acid (119) 
Figure 1.28 demonstrates how oleic acid (C18:1) can undergo 
autoxidation which leads to the production of several hydroperoxy species.  
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Lipids with more than one double bond undergo oxidation more rapidly.  
Polyunsaturated fatty acids therefore undergo autoxidation more rapidly 
than monounsaturated fatty acid because there are more allylic hydrogens 
susceptible to abstraction (shown in Table 1.2).  
Table 1.2 – Rate of oxidation of various fatty acids (120) 
Fatty acid Number of double bonds Rate of oxidation 
Stearic acid (18:0) 0 1 
Oleic acid (18:1) 1 40 
Linoleic acid (18:2) 2 1200 
Linolenic acid (18:3) 3 2500 
 
Polyunsaturated fatty acid oxidation yields many primary and secondary 
products.  The primary products of oxidation include hydroperoxides which 
are not stable, which makes it very difficult to monitor their presence.  
However, secondary products of PUFA oxidation such as particular 
aldehydes and ketones are commonly measured as a biomarker of lipid 
oxidation.  These include aldehydes such as malondialdehyde (MDA), 
which is one of the most commonly studied lipid oxidation products.     
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Figure 1.29 – PUFA oxidation resulting in the production of MDA 
Figure 1.29 demonstrates how a PUFA such as linolenic acid (C18:3) can 
oxidise and produce MDA, as well as other shorter chain fatty acids.  The 
presence of MDA been researched in literature and has been linked with 
contact lens intolerance (121).  MDA could therefore be a potential 
biomarker for contact lens intolerance or discomfort.  Therefore, the 
occurrence of lipid oxidation in the ocular environment is important to 
monitor.   
The assessment of lipid peroxidation products can be difficult especially 
the analysis of these products in tears.  The various methods used to 
detect secondary products of lipid oxidation in tears in this project will be 
discussed in detail in Chapter 5.   
1.11.2 Enzymatic hydrolysis 
Enzymatic hydrolysis is a pathway of lipid degradation whereby lipids are 
targeted by particular enzymes which break the lipid into by-products.  
Examples include the enzymatic degradation of phospholipids by different 
phospholipases.   
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Figure 1.30 – Enzymatic hydrolytic pathways of a phospholipid with 
different phospholipases 
The presence and role of phospholipids in the tear film has been 
investigated by several researchers (21, 122-125).  As mentioned in the 
section 1.3, the presence of phospholipids in the tear film has been 
debated by several authors.  For those authors that report their presence, 
McCulley et al. (21) report that phospholipids act as the interface between 
the non-polar lipid layer and the aqueous layer of the tear film.   
59 
 
The polar layer acts a surfactant between the non-polar lipids and the 
aqueous layer.  This suggests that phospholipids are therefore vital for the 
stability of the tear film.  A lack of phospholipids has been linked to tear 
film instability and increased tear break-up (126, 127).  Phospholipids are 
susceptible to enzymatic degradation by various enzymes called 
phospholipases at various positions of the phospholipid (shown in Figure 
1.30).  There have been reports of increased levels of certain 
phospholipases that enzymatically degrade phospholipids as a result of 
contact lens wear.  The presence of phospholipids in tears is still under 
debate as certain authors suggest they are secreted by meibomian glands 
and are present in tears (21).  Others suggest they are secreted by the 
meibomian glands and are degraded by enzymes present in tears (32, 
126).  Butovich et al. report there are no phospholipids secreted by 
meibomian glands, but are detected in tear samples (29, 31).  As 
meibomian glands are holocrine glands, the entire cell is secreted and cell 
membranes are made up of phospholipids suggesting the meibomian 
glands may actually secrete phospholipids.  In the normal eye these 
phospholipids act as a surfactant, however in contact lens wear, increases 
in phospholipases can lead to phospholipid degradation.  This degradation 
in phospholipids could be the cause of an increase in dryness related 
symptoms.   
1.11.3 Cholesterol oxidation  
Cholesterol is also susceptible to oxidation due to the ease of hydrogen 
abstraction on the allylic hydrogen.  The pathway of cholesterol oxidation 
is far less complicated than fatty acid oxidation and it yields far fewer by-
products compared with fatty acid oxidation (128).  Cholesterol oxidation 
has not been fully investigated in this project but as cholesteryl esters are 
a major component of the tear film, it is a future direction of this project.   
There are three pathways of cholesterol oxidation – autoxidation, 
photoxidation and enzymatic oxidation and each pathway yield various 
forms of oxysterol.   
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1.11.3.1 Autoxidation of cholesterol 
Autoxidation of cholesterol produces various forms of oxysterol based 
around the 7- position on the cholesterol molecule and the predominant 
products are shown in Figure 1.31 and Figure 1.32.  The reaction of 
cholesterol with free radicals will most likely produce the products shown 
in Figure 1.31 and Figure 1.32 (129).   
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Figure 1.31 – Structure of a 7α-OH or 7β-OH cholesterol 
7
 
Figure 1.32 – 7-keto cholesterol 
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1.11.3.2 Photoxidation of cholesterol 
Photoxidation of cholesterol produces hydroperoxy-cholesterol molecules 
based around the 5-position on the cholesterol molecule.  The major 
product of cholesterol photoxidation is shown in Figure 1.33.   
5
 
Figure 1.33 – 5α hydroperoxy-cholesterol 
 
1.11.3.3 Enzymatic Cholesterol Oxidation 
Enzymatic oxidation is more complicated than autoxidative and 
photoxidation of cholesterol.  Enzymatic oxidation can lead to the 
production of many products such as epoxycholesterols at various 
carbons on the cholesterol molecule.  Enzymatic cholesterol oxidation 
occurs in the brain as this is where certain enzymes are produced (130).   
1.11.4 Factors influencing lipid oxidation 
There are many other factors, other than the level of fatty acid 
unsaturation which may affect the rate of oxidation.  The position of the 
fatty acid can affect the rate of oxidation.   For example, if the same fatty 
acid was attached to the SN1 and SN2 position of a glycerol backbone, 
(either a TAG or phospholipid) the fatty acid at position SN1 would have a 
higher rate of oxidation.  This is most likely because the fatty acid chain at 
the SN2 position is sterically hindered (131).   
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The lipid class can also affect the rate of oxidation. Free fatty acids have 
the fastest rate of oxidation compared with other lipid classes.  However, 
phospholipids also have a fast rate of oxidation and this may be due to the 
level of unsaturation of fatty acids attached to phospholipids.  
Phospholipids make up cell membranes and will have polyunsaturated 
fatty acids attached to keep the cell membrane fluidic.  The level of 
unsaturation ultimately affects the rate of oxidation.  
1.12 The methods used for the measurement of lipid 
oxidation 
There are several methods used in literature to measure either the extent 
of lipid oxidation or the production of lipid oxidation products.  Many of the 
currently available assays were adapted and used in this research to 
measure the presence of lipid oxidation products in tears and on contact 
lenses.  The most commonly used method to detect MDA (secondary lipid 
oxidation product) is the thiobarbituric acid reactive substances (TBARS) 
assay.  TBA binds to MDA in the sample or standard under acidic 
conditions to produce a colour complex.  This coloured complex can then 
be measured by UV or fluorescence absorbance and the concentration of 
MDA in the sample can be determined.  The TBA method was developed 
in 1957 to determine the presence of lipid oxidation in food (132).  This 
method is consistently used to determine the presence of MDA in various 
samples such as blood, urine, plasma and food products (133).  The 
TBARS assay has its limitations as TBA can bind to many other 
substances such as aldehydes.  The TBARS assay can therefore 
exaggerate the levels of MDA.  HPLC methods have therefore been 
developed as TBA – MDA complex has a characteristic retention time and 
is therefore a more accurate method for the determination of MDA 
concentration in the sample (134, 135).   
Other methods, for the measuring the concentration of MDA or other 
aldehyde in various unknown samples have been developed.  A method 
similar to the TBARS assay, works by a hydrazine complex binding to 
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MDA forming a colour complex.  The TBARS and other colorimetric 
assays were used in the work discussed in Chapter 5.   
As well as MDA analysis, there are several other methods for the 
measurement of lipid oxidative end products which include using GC or 
HPLC to assess the levels of conjugated dienes, which are primary 
products of lipid oxidation.  However, these methods were not used in this 
research because additional hardware for analytical techniques was 
required.   
1.13 Ocular antioxidants 
It is important to consider the presence and levels of antioxidants when 
lipid oxidation is discussed.  The eye is exposed to UV light, oxygen and 
environmental factors which may cause oxidation of proteins and/or lipids 
of the tear film.  The tear film is the first line of defence for the ocular 
environment.  There have been several studies which have analysed the 
levels of antioxidants in tears and have found that predominant 
antioxidants in tears are ascorbic acid and uric acid (136, 137).  Ascorbic 
acid (Vitamin C) is a dietary antioxidant and uric acid is not.  The origin of 
these antioxidants was thought to be the cornea, however, Choy et al. 
(138) state that these antioxidants are present in lacrimal gland secretions.  
Gogia et al. (139) detected several other antioxidants in human tears such 
as cysteine, glutathione and tyrosine, however the presence of these 
antioxidants has not been investigated by others.   
1.14 Consequences of lipid oxidation for contact lens 
wear 
1.14.1 Lipid degradation and discrete deposits on contact 
lenses 
The first point to make is that the autoxidation of the unsaturated fatty acid 
moieties, whether present as free acids or esters can lead to 
oligomerisation, cross-linking and consequent immobilisation.  In this state 
the lipid is not extractable without destroying the lens matrix in which it is 
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immobilised.  This leads to two clinically undesirable problems.  The first is 
the formation of hydrophobic domains driven, for example, by the 
oligomerisation of unsaturated cholesteryl esters.  These domains attract 
the more hydrophobic components which lead to regions of severe 
dewetting which are anchored into the lens matrix.  The second problem 
arises from autoxidation and immobilisation of lipids in the formation of 
discrete elevated deposits which are white in colour because of 
sequestered calcium.  Several authors have previously identified the 
presence of ‘white spots’ or ‘jelly bumps’ on hydrogel contact lenses (140, 
141).  Bowers et al. (141) described their formation as a combination of 
the oligomerisation of the unsaturated fatty acids which then complex with 
tear – borne calcium ions resulting in the formation of insoluble deposits 
that are both on and in the lens matrix.  These deposits are readily seen 
with the naked eye but can be more effectively examined using 
microscopy.  Confocol microscopy is especially useful in that it enables the 
visualisation of the deposit structure not only at the surface but also within 
the lens matrix.  The technique has the ability to scan across sections of 
the lens allowing the images to be stacked providing a three – dimensional 
image.  Figure 1.34 shows ‘slices’ taken through a white spot deposit 
(142-144).  The images show sections through deposits and illustrate that 
the structure continues to grow through the matrix.  It is important to 
recognise that there would be no white spot deposit formation without lipid 
degradation (autoxidation) and that, additionally the level of calcium ions in 
the tear of individual subjects plays an important part in driving the rate of 
deposit formation.  
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Figure 1.34 – Scanning confocol microscopy images of white spots on a 
conventional hydrogel, showing: 
Optical “slices” though a white spot in the X-Y (horizontal) plane (A and B); 
an X-Y white spot image (C ) indicating (transverse white line) the section 
reconstructed in the Z direction (D) by stacking optical images at that 
point. The horizontal line in D results from the fact that the lens was placed 
anterior surface down on a microscope slide to collect the images. 
1.14.2 Lipid oxidation products and ocular discomfort 
One possible contribution to the ‘end of day’ discomfort phenomenon may 
be found in the lipid oxidation and degradation processes that arise due to 
exposure of immobilised lipids on the anterior surface of the lens for long 
periods.  Lipid turnover in general is much slower than aqueous tear flow 
and turnover in contact lens wear (145). The lipid profile of individual 
subjects and ocular dynamics affecting tear break-up and inter-blink period 
will ultimately determine the rate of oxidation.  For example, if the subject 
has an unusual fatty acid profile containing more unsaturated fatty acids, 
or a significant level of unsaturated fatty acids from plasma leakage, these 
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will increase the level of oxidative degradation.  Similarly, longer inter-blink 
periods and greater exposure of the lipid layer to light and atmospheric 
oxygen will accelerate oxidative processes. It is important therefore to 
assess the potential contribution of these processes to environmental 
changes brought about by contact lens wear.   
Build-up of polyunsaturated fatty acids leads to oxidation which can 
ultimately result in the production of oxidative end products such as MDA 
(malondialdehyde, Figure 1.29).  Although there are few studies of this 
molecule in tears (assays are not straight forward), MDA has been 
detected in the tears of intolerant contact lens wearers (121).  In this 
study, Glasson et al. (121) analysed tears for MDA of two separate groups 
of subjects known to be either contact lens intolerant or contact lens 
tolerant.  They observed a statistically significant difference in MDA levels 
for the two subject groups and identified the intolerant subjects as having 
higher levels of MDA in their tears.  One important feature of MDA is the 
ability to react with proteins or DNA disrupting their regular function.  Thus 
MDA (and other aldehydes) can be toxic in tissues because of reactivity 
with thiol and amino groups of proteins which can therefore cause tissue 
damage (133).   
In addition to increased levels of oxidised lipid products in contact lens 
intolerant subjects, there have been several reports of increased levels of 
enzymes which specifically degrade phospholipids.  Glasson et al. for 
example reported increased levels of phospholipase A2 (PLA2) in the 
tears of contact lens intolerant patients (121).  Phospholipids are believed 
to be responsible for the stability of the tear film and increased levels of 
enzymes which degrade phospholipids may decrease tear film stability.  
Additionally, there have been several reports of PLA2 in tears of contact 
lens wearers and in the tears of subjects with ocular disorders (76, 126, 
146-148).  Campbell et al. also reported the presence of phospholipase C 
and identified DGs as the end product of the cleavage reaction.  This is 
potentially important because the degradation of phospholipids by different 
phospholipases yields different end products.   All of which have 
significant polarity, which suggests that phospholipases may have a 
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significant role in modulating aspects of lipid composition that influence 
spreading and tear film integrity (32).   
These various factors, taken together, indicate considerable scope for the 
range of subject specificity encountered in reports and studies of contact 
lens induced discomfort.  It is clear that the lipid layer, although regarded 
as relatively inert for many years, is now seen as a potentially important 
and reactive family of compounds in the search for improvements in 
contact lens comfort.    
This literature survey has helped identify what is already known about 
ocular lipids and what areas still require a significant amount of research.  
There have been several publications which have investigated meibomian 
gland secretions and differences between meibomian gland secretions 
compared to tear lipids.  There have also been a significant number of 
publications which have investigated in vitro lipid spoliation models on 
contact lenses and methods for analysing the extracts.  There have been 
far fewer publications which investigate the nature of lipid deposition on ex 
vivo contact lenses.    
It is apparent from the literature review that there has not been much 
research investigating the fate of lipids on lenses and in particular what 
effect lens material, wear schedule and subject-to-subject variability have 
on the nature and fate of lipids.   
The work in this project was therefore based on firstly the development of 
an array of analytical techniques and a process of ex vivo lens analysis 
and secondly using the results generated to better understand lipids on 
contact lenses.   
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2. Chapter 2 – Materials and Methodology 
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2.1 Introduction 
The work in this project involved the modification of existing analytical 
techniques to investigate lipid composition of lipids from ex vivo contact 
lenses and tear samples.  These techniques were then used to investigate 
changes in lipid structure as a result of contact lens wear.   
2.2 Contact lens materials used 
Table 2.1 – General information about the contact lenses used in this 
project 
Commercial name (abbreviation) 
/USAN name/manufacturer 
SiHy/CoHy Principle components 
of the lens 
PureVision (PV)/balafilcon A/Bausch & 
Lomb 
SiHy N-vinyl pyrrolidine, 
tris-vinyl carbamate, 
N-carboxyvinyl ester 
Focus Night & Day (F.N&D)/lotrafilcon A 
/CIBA vision 
SiHy Dimethyl acrylamide, 
TRIS, siloxane 
Air Optix (AO)/lotrafilcon B/CIBA vision SiHy Dimethyl acrylamide, 
TRIS, siloxane 
Air Optix Aqua (AOA)/lotrafilcon B/CIBA 
vision 
SiHy Dimethyl acrylamide, 
TRIS, siloxane 
Acuvue/ etafilcon A/ Johnson & Jonhson CoHy Hydroxyethyl 
methacrylate, 
methacrylic acid 
Acuvue Oasys (AcuOas) /senofilcon A/ 
Johnson & Johnson 
SiHy Polydimethylsiloxane, 
dimethyl acrylamide, 
hydroxyethyl 
methacrylate 
Soflens 66 (S66)/ alphafilcon A/ Bausch 
& Lomb 
CoHy Hydroxyethyl 
methacrylate, vinyl 
pyrrolidone 
Focus Dailies/  nelfilcon A/ CIBA vision CoHy Polyvinyl alcohol 
Acuvue TruEye/ narafilcon A/B/ Johnson 
& Johnson 
SiHy Polydimethylsiloxane, 
dimethyl acrylamide, 
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hydroxyethyl 
methyacrylate, 
polyvinyl pyrrolidone 
Dailies Total 1/ delafilcon A/ CIBA vision SiHy Contains dimethyl 
phosphatidylcholine 
The commercial names will be referred to throughout the thesis.   
2.3 Contact lenses and tear samples 
The ex vivo contact lenses used throughout this thesis were all harvested 
from clinically controlled trials.  Individual lenses were extracted using the 
extraction protocols described in section 2.6 and the extracts were 
subjected to an array of analyses (discussed in Chapter 3).   
The two methods used for tear collection throughout this thesis were both 
the microcapillary tube method and the Visispear ophthalmic sponge 
technique.  The Visispear ophthalmic sponge tip is made from cellulose, 
which is an absorbent material.   It was therefore suitable for the collection 
of lipids in tears.  Tears were collected by placing the tip of the sponge in 
the lower meniscus of the eye, taking care to minimise contact with the 
conjunctiva.  Tears were collected by the sponge; the tip of the sponge 
was then cut off and placed in a glass vial for extraction.  The sponge was 
then extracted using the extraction protocol described in section 2.9.  The 
volume of tears collected from individuals varied from subject-to-subject. 
The microcapillary method is used for the collection aqueous tears.    This 
method of tear collection was suitable for the work in Chapter 5 
(investigating lipid peroxidative products in the ocular environment).  The 
microcapillary tube is placed in the lower meniscus of the eye and tears 
are drawn into the tube by capillary action.  Varying volumes of tears are 
collected from individuals depending on individual subjects tear flow.  In 
certain cases, no tears were collected because of reduced to no tear flow, 
which was related to dry eye in certain individuals.   
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2.4 Tear envelope 
A tear envelope is a tear film sample which has been in direct contact with 
the anterior and posterior surfaces of a contact lens.  A tear envelope 
sample is collected by placing a freshly worn contact lens into a 0.7ml 
eppendorf that has a small hole at the base. Various volumes of water (or 
other solvents, the choice of which depended on how the sample was to 
be analysed) are added to either side of the lens. The smaller eppendorf, 
containing the lens, is then placed inside a larger eppendorf (2ml).  The 
eppendorfs are centrifuged for 5 minutes at 3300rpm which draws the tear 
envelope sample into the large eppendorf.  Tear envelope samples were 
analysed by various techniques (used mainly for the work discussed in 
Chapter 5).     
2.5 Lipid analysis: Preparation of FAMEs 
Samples must be volatile for GCMS analysis; therefore fatty acids (not 
volatile) are converted to fatty acid methyl esters (FAMEs) which are 
volatile.  This reaction is known as a tranesterification or transmethylation.  
Lens extracts and tear samples were transmethylated for GCMS analysis.  
The transmethylation process is described below.  
950μl methanol and 5μl concentrated sulphuric acid were added to amber 
vials that contained lens extracts or tear sample extracts.  The vials were 
then placed in a heating block for 90mins at 70°C.  The vials were then 
allowed to cool for 5mins.  400μl isohexane followed by 100μl water were 
added to the vials.  The vials were shaken and the solutions were allowed 
to stand to phase separate.  The fatty acid methyl esters (FAMEs) partition 
into the upper layer (isohexane layer).  The upper layer was collected 
using a Pasteur pipette and transferred to 2ml amber vials.  Another 400μl 
isohexane was added to the first vial and it was shaken.  The upper layer, 
which contained the FAMEs was collected.  The process was repeated 
another two times until the final volume of FAMEs collected was 1.6ml.  
The solvent containing the FAMEs was evaporated to dryness under 
nitrogen and resuspended in 100μl isohexane.  The solution was 
transferred to a glass insert (100μl glass insert designed to sit inside a 2ml 
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amber vial), evaporated to dryness under nitrogen and resuspended in 
25μl isohexane for GCMS analysis.     
2.6 Protocols used for the extraction of lipids from 
subject-worn contact lenses  
HPLC grade solvents were used for extraction and for mobile phase 
preparation.   
There are several protocols used by different researchers in the literature 
for the extraction of lipids from lenses. They are mainly based on 
extraction using different ratios of chloroform: methanol for various 
amounts of time (25, 102, 110, 118, 126, 149, 150).  Some of the 
protocols are used for the extraction of lipids from lenses which have been 
spoiled in vitro and some are used on ex vivo lenses. The extraction of 
lipids from lenses which have been spoiled in vitro would be very different 
to the extractability of lipid from subject-worn contact lenses.  In vitro 
spoliation does not mimic the blink action of the eyelid over the contact 
lens.  There are also other components in the tear film which have an 
effect on lipid deposition on lenses.  Whilst the use of in vitro models 
provides useful information, they do not mimic the extractability of lipids 
from ex vivo lenses.   
2.6.1 Extraction protocol 1:  
Extraction protocol 1 was the main protocol used for lipid extraction from 
ex vivo lenses because it was an effective lipid extraction procedure.  
Single lenses were placed in glass vials that contained 1:1 chloroform: 
methanol (1.5ml).  The glass vials were covered with aluminium foil and 
then parafilm and placed on a flat bed shaker for at least 30mins.    The 
extract medium was transferred to an amber vial and evaporated to 
dryness.  The extract was resuspended in a solvent, the selection of which 
depended on the technique to be used for analysis.  Sample preparations 
for each technique are detailed under the appropriate headings (section 
2.10).     
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2.6.2 Extraction protocol 2: 
Single lenses were placed in 2ml amber vials.  1:1 chloroform: methanol 
(600µl) was added to the vials and they were then placed on a flat-bed 
shaker for 30mins.  The vials were also vortexed for 30 seconds at 0mins, 
15mins and 30mins time points in the extraction.  The lens was removed 
and discarded and the solvent extract was evaporated to dryness under 
nitrogen.  The extract was then resuspended in a solvent, the choice of 
which depended on the technique to be used for analysis.  
2.6.3 Extraction protocol 3 (double extraction): 
Lenses were extracted using extraction protocol 1.  Fresh 1:1 chloroform: 
methanol (1.5ml) was added to the vials that contained the already 
extracted lens.  The vials were placed on a flat-bed shaker for at least 
another 30mins.  The extracts were either pooled or kept separate 
depending on the nature of investigation.  The extract medium was 
evaporated to dryness and resuspended in a solvent, the choice of which 
depended on the technique to be used for analysis.   
2.6.4 Extraction protocol 4 (double extraction): 
Lenses were extracted using extraction protocol 2.  Fresh 1:1 chloroform: 
methanol (600µl) was added to the vial containing the already extracted 
lens.  The vial was placed on a flat-bed shaker for another 30mins.  In 
addition, the vial and lens were vortexed for 30 seconds at 0mins, 15mins 
and 30mins time points in the extraction.  The extracts were either pooled 
or kept separate depending on the nature of investigation.  The solvent 
extract was evaporated to dryness under nitrogen and resuspended in a 
solvent, the choice of which depended on the technique to be used for 
analysis.   
2.6.5 Extraction protocol 5: 
A single lens was added to a 20ml stopperred measuring cylinder that 
contained 10ml methanol, 5ml chloroform and 3.75ml 0.15M acetic acid.  
The cylinder was shaken by hand for 5mins.  2.5ml chloroform and 2.5ml 
water were added to the cylinder.  The solution was allowed to stand to 
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phase separate for 40mins and the lower organic phase was collected 
using a Pasteur pipette and transferred to 2ml amber vial.  The solvent 
extract was evaporated to dryness under nitrogen whilst the extraction 
procedure was repeated another two times.  The extracts were pooled 
together and the extract medium was evaporated to dryness.  The extract 
was resuspended in a solvent, the choice of which depended on the 
technique to be used for analysis.   
2.7 Extraction of dimyristoyl phosphatidylcholine 
(DMPC) from phospholipid-containing contact lenses  
In order to try and mimic in vivo extraction of DMPC from phospholipid-
containing lenses, several extraction procedures were tested.  The results 
are shown in Chapter 6 and the extraction procedure details are described 
below.   
2.7.1 100% methanol 
A lens was taken straight from the blister pack and placed in a glass vial 
that contained 1.5ml methanol.  The vial was covered with aluminium foil 
and then parafilm and then placed on a flat-bed shaker for 40mins.  The 
solvent extract was transferred to an amber vial.  The solvent was 
evaporated to dryness under a steady stream of nitrogen.  The extract was 
then transmethylated (described in section 2.5) and analysed by GCMS.  
2.7.2 Hexane: methanol extraction 
A lens was taken straight from the blister pack and placed in a glass vial 
that contained 1.5ml 1:1 hexane: methanol (not miscible).  The lens was 
extracted for 40mins.  The solvent extract was evaporated to dryness 
under nitrogen and transmethylated as described in section 2.5.    
2.7.3 Ethyl acetate extraction  
A lens was removed from the blister pack and placed in a glass vial that 
contained 1.5ml ethyl acetate.  The vial was placed on a flat-bed shaker 
for 40mins.  The extract was transmethylated as described in section 2.5 
of this chapter.   
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2.7.4 Butanol extraction 
A lens was removed from the blister pack and transferred to an amber vial 
that contained 100µl butanol.  The vial was placed on a flat-bed shaker for 
1hr and vortexed for 30 seconds at 0mins, 30mins and 60mins time 
intervals.  The extraction solvent was evaporated to dryness under 
nitrogen and transmethylated as described in section 2.5.  
2.7.5 Octanol extraction  
A lens was removed from the blister pack and transferred to a glass vial 
that contained 750μl octanol.  The lens was extracted for 2 hours on a flat-
bed shaker.  200μl of the extract medium was transferred to an amber vial 
and transmethylated as described in section 2.5 of this chapter.  The 
FAMEs were resuspended in 100μl isohexane and analysed by GCMS. 
2.7.6 Isopropyl palmitate (IPP) extraction 
10µl IPP was transmethylated in order to validate the volume of IPP the 
lenses should be extracted in.  The C16 peak (which was the main peak 
for IPP) was very strong; therefore no more than 10μl was 
transmethylated.  A lens was removed from the blister pack and placed in 
a glass vial that contained 2ml IPP.  The vial was placed on a flat-bed 
shaker and 10µl aliquots were taken at 30mins, 60mins, 4 days, 5 days 
and 6 days.  The 10µl aliquots of the solvent extracts were 
transmethylated directly (without evaporation under nitrogen).  The FAMEs 
were resuspended in 100μl isohexane.  Samples were injected using a 
split injection (where only part of the sample is transferred to the column).   
The second IPP extraction method used involved placing a lens in a 1.5ml 
eppendorf that contained 200µl IPP.  The eppendorf was vortexed for 30 
seconds and placed on a flat-bed shaker for 1 hour.  After 1 hour on a flat-
bed shaker, the eppendorf was vortexed for 30 seconds.  10µl IPP was 
transferred to an amber vial and transmethylated as previously described 
(section 2.5).  The FAMEs were resuspended in 100µl isohexane.  The 
samples were injected using a split injection.   
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2.7.7 IPP extraction of glass slides 
This extraction method involved dipping a lens in IPP.  This lens was then 
placed between two glass slides and the glass sides were rubbed at 
periodic intervals.  The glass slides were then extracted in 1:1 chloroform: 
methanol (1.5ml) for 40mins, transmethylated and analysed by GCMS.    
The lenses were also kept and extracted in 1:1 chloroform: methanol 
(1.5ml) for 40mins, transmethylated and analysed by GCMS to evaluate 
how much DMPC remained in the lens.   
2.7.8 Glycerol extraction 
A lens was removed from the blister pack and placed in an amber vial that 
contained 100µl glycerol.  The lens was extracted for 30mins on a flat-bed 
shaker and vortexed for 30 seconds at 0mins, 15mins and 30mins time 
intervals.  The lens was removed and the extract was transmethylated as 
described in section 2.5.     
2.8 MDA extraction from ex vivo lenses: extraction 
protocols (used in Chapter 5) 
2.8.1 Extraction procedure 1 
Acetonitrile: 0.2% trifluoroacetic acid (1ml) was added to single lenses 
(daily wear and continuous wear PV and F.N&D) in glass vials covered 
entirely with foil.  The vials were kept in a dark cupboard overnight and the 
lens removed.  10μl of each extract was added to 1ml 0.2% TBA buffer 
(preparation of TBA buffer is described in section 2.11.5.1.1) in individual 
eppendorfs.  The eppendorfs were placed in the oven for 1hr at 90°C.  The 
solutions were cooled in a water bath for 5mins.  200μl of each solution 
was transferred to 96 well plate and the UV absorbance measured at 
532nm.   
2.8.2 Extraction procedure 2 
1ml PBS was added to single lenses (daily wear and continuous wear PV 
and F.N&D lenses) and placed on a flat-bed shaker overnight.  The lenses 
were removed and the extracts were prepared for analyses.  10μl of each 
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extract was added to 1ml 0.2% TBA buffer (preparation of TBA buffer 
described in section 2.11.5.1.1) in individual eppendorfs.  The eppendorfs 
were placed in the oven for 1hr at 90°C.  The solutions were cooled in a 
water bath for 5mins.  200μl of each solution was transferred to 96 well 
plate and the UV absorbance measured at 532nm.   
2.8.3 Extraction procedure 3 
1:1 chloroform: methanol (1ml) was added to individual lenses (daily wear 
and continuous wear PV and F.N&D lenses) in glass vials and the vials 
were placed on a flat-bed shaker for 2 hours.  The lenses were removed 
and the solvent evaporated to dryness under a steady stream of nitrogen.  
The extracts were resuspended in 1ml PBS.  10μl of each extract was 
added to 1ml 0.2% TBA buffer (preparation of TBA buffer described in 
section 2.11.5.1.1) in individual eppendorfs.  The eppendorfs were placed 
in the oven for 1hr at 90°C.  The solutions were cooled in a water bath for 
5mins.  200μl of each solution was transferred to a 96 well plate and the 
UV absorbance measured at 532nm. 
2.9 Extraction of tear samples taken using Visispear 
ophthalmic sponges 
As described in section 2.3, tears were collected using the Visispear 
sponge by another researcher. The tips of the sponges that had collected 
tears were cut and placed in glass vials that contained 1.5ml chloroform.  
The vials were covered with aluminium foil and then parafilm and placed 
on a flat-bed shaker for at least 2 hours.  The extraction solvent was 
transferred to an amber vial and evaporated to dryness under nitrogen.  
The extract was then either transmethylated for GC analysis (as described 
in section 2.5 of this chapter) or resuspended in mobile phase for HPLC 
analysis (as described in section 2.10.4.1 of this chapter).   
2.10 Analytical techniques methodology 
The techniques used for lipid detection and analysis throughout this thesis 
were fluorescence spectrophotometry (FS), thin layer chromatography 
(TLC), high performance liquid chromatography (HPLC) with UV and 
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fluorescence detection and gas chromatography mass spectrometry 
(GCMS).  FS was used for the measurement of the levels of gross lipid 
deposition on contact lenses.  TLC and HPLC were useful for general lipid 
class separation and GCMS was used for fatty acid separation.   
2.10.1 Fluorescence spectrophotometry (FS) 
Certain molecules possess natural fluorescence.  These molecules are 
usually aromatic or have conjugated double bonds.  Lipids such as 
cholesteryl esters are fluorescent molecules.  The fluorescence of lipids is 
visible when excited at 360nm and a peak is observed in the emission 
spectra at approximately 440nm.    
For the work in this thesis, fluorescence spectrophotometry was used to 
provide a measure of the gross levels of lipid on the anterior and posterior 
surfaces of worn contact lenses.   FS was an effective method to non-
destructively measure the levels of gross lipid on lenses.  The model used 
in this research project was a modified Hitachi F4500 spectrophotometer.  
The contact lens was placed in a cylindrical cuvette and the cuvette was 
filled with distilled water.  The cuvette was placed in the holder with the 
convex side of the lens facing the beam of light.  The wavelength was set 
at 360nm excitation and the emission spectra was analysed 440nm 
(representing the lipid peak).  The intensity of the peak at 440nm provided 
a measure of the gross levels of lipid on the lens.   
2.10.2 Thin layer chromatography (TLC) 
The principle of this technique is to separate lipids according to their 
relative polarity.  TLC was used to separate lipids extracted from lenses or 
tear samples.   
The TLC plates used for this research were made of silica gel, they were 
20cm x 20cm and the silica layer was 250µm in thickness.   
Single lens extracts (protocol 1, section 2.6.1 was used for extraction) and 
tear samples extracts (extraction protocol described in section 2.9) were 
resuspended in 100µl chloroform.  The samples were spotted on a line 
drawn 2cm from the bottom of the TLC plate.  3 x 10µl aliquots of each 
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sample were spotted on the plate.  The plate was placed in a TLC tank 
that contained the mobile phase consisting of hexane: diethyl ether: acetic 
acid (70:30:1 v/v).  These conditions allowed for general lipid class 
separation where non-polar lipids eluted to the top of the plate with the 
non-polar solvent and polar lipids eluted quickly, nearer the bottom of the 
plate.  The plate was taken from the tank when the solvent line was 
approximately 2cm from the top of the plate.    
The plate was allowed to dry for approximately one minute and it was 
placed in an iodine tank to stain the separated spots.  The separated 
species were identified from the comparison of their retentions times 
compared to lipid standards.   
2.10.3 High performance liquid chromatography (HPLC) 
HPLC is used for the separation, identification and quantification of 
individual species in unknown samples.  In this project, both reverse 
phase and normal phase HPLC columns were used for the separation of 
lipids collected from tears samples and contact lens extracts.    
An Agilent 1100 HPLC system, connected to a diode array detector (DAD) 
and fluorescence detector was used in this project.    
2.10.4 Normal phase chromatography 
The column used for general lipid class separation was a LiChrospher 100 
diol 250mm length x 4mm (inner diameter ID) with 5µm packing.  The 
mobile phase consisted of hexane: propan-2-ol: acetic acid (1000: 5: 1 
v/v).  This combination of non-polar solvents and polar column allowed for 
the separation of lipids according to their relative polarities.  Non-polar 
lipids would elute quicker than polar lipids because of their interaction with 
the polar column.       
8µl of each sample was injected using the autosampler and the flow rate 
was set to 1ml/min.  The wavelengths selected on the DAD were 205nm, 
254nm, 280nm, 360nm.  An excitation wavelength of 360nm and emission 
wavelength of 440nm were set on the fluorescence detector.   
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2.10.4.1 Sample preparation for normal phase HPLC 
Both, tear samples and lens extracts were analysed by HPLC.  Lenses 
were extracted using mainly extraction protocol 1 (1:1 chloroform: 
methanol as described in section 2.6.1) and tear samples were extracted 
using the protocol described in section 2.9.  The extracts were evaporated 
to dryness under nitrogen and resuspended in 100µl mobile phase and 
transferred to a glass insert.  The solution was evaporated to dryness 
under nitrogen and resuspended in 25µl mobile phase.   
2.10.4.2 Normal phase HPLC calibration curve preparation  
The column and mobile phase details are outlined in Chapter 2 section   
2.10.4.  Both UV and fluorescence detectors were used in conjunction with 
HPLC.  In contrast to mass spectroscopy, UV and fluorescence detectors 
do not provide any structural information for separated species but are 
extremely useful for the detection of individual species.  Unknown peaks 
were identified by the comparison of their retention times to lipid 
standards. Calibration curves were prepared with known concentrations of 
lipid standards to assist with quantification.  Lipid classes known to be 
secreted by meibomian glands, including cholesteryl esters, cholesterol, 
free fatty acids and triglycerides were used as standards.       
The calibration curve data and calibration curve for a cholesteryl ester 
(cholesteryl myristate) are shown in Table 2.2 and Figure 2.1 respectively.  
The calibration curves for other lipid standards (cholesterol, free fatty acid 
and TAG) are shown in Appendix 1. 
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Table 2.2 – Calibration curve data for cholesteryl myristate 
 
 
Figure 2.1 – Calibration curve of cholesterol myristate (cholesteryl ester) 
 
2.10.4.3 Retention times of lipid standards measured by normal phase 
HPLC 
Using the normal phase column and conditions described in section 
2.10.4, the following retention times were observed for lipid standards 
(Table 2.3).  
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Table 2.3 – Relative retention time of lipid classes 
Lipid class Retention time (minutes) 
Cholesteryl ester 1.5-1.8 
Cholesterol 8.6-8.9 
Fatty acids 6.0-6.3 
Phospholipids Too polar to detect in reasonable run time 
Triglycerides 1.9-3.0 
Diglycerides 3.4-3.8 
Wax ester 1.5-1.7 
 
It was difficult to distinguish between a wax ester and a cholesteryl ester 
using normal phase HPLC because they both had the same retention 
time.  Cholesteryl esters and wax esters have similar polarity which made 
it difficult to separately identify them using a normal phase column.  An 
equal mix of cholesteryl ester (cholesteryl myristate) and a wax ester 
(behenyl oleate) standard was analysed by HPLC and it produced a single 
peak that centred at 1.533mins.  
Contact lens extracts and tear samples could now be analysed by HPLC.  
The concentration of lipid classes in unknown samples were determined 
from the relative calibration curves (Appendix 1).     
2.10.5 Reverse phase chromatography 
A reverse phase column was used for the separation of lipid species that 
had similar retention times when separated by a normal phase column 
(wax esters and cholesteryl esters).  Normal phase columns are generally 
used for the separation of non-polar compounds because non-polar 
compounds will be soluble in non-polar solvents, which are compatible 
with the polar column.  One particular problem encountered with normal 
phase separation was that the separated species all had similar retention 
times because they all had similar polarities.  Therefore a reverse phase 
column was used to try and separate lipid species with similar polarities.   
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The reverse phase column used was a Zorbax Eclipse XDB C18 2.1(ID) x 
150mm, 3.5μm particle size from Agilent.  The mobile phase used for this 
work was 700: 300(v/v) acetonitrile: water.  The flow rate was set at 
300μl/min and sample injection volume set at 8μl.  The same wavelengths 
that were used in normal phase separation were used in reverse phase 
separation (205nm, 254nm, 280nm and 360nm.  Fluorescence detection 
wavelengths were - excitation at 360nm and emission at 440nm).  The 
analysis time was initially set at 35mins (same as the normal phase 
analysis time), however the standards were non-polar and were expected 
to have a very long retention time, therefore and the analysis time was 
increased to 60mins.   
2.10.5.1 Reverse phase chromatography sample and standard 
preparation 
Lenses were extracted using mainly extraction protocol 1 (described in 
section 2.6.1) and extracts were resuspended in hexane because hexane 
does not have a UV absorbance at the wavelengths chosen for lipid 
analysis.  For polar lipid analysis (fatty acids and phospholipids), lipids 
(standards and lens extracts) were resuspended in reverse phase mobile 
phase (ACN: H2O).  For non-polar lipid analysis, lipids (standards and lens 
extracts) were resuspended in hexane.  However, after initial investigation, 
reverse phase C18 column was not used for non-polar lipid separation 
because standards did not elute after 60mins of analysis time.  Reverse 
phase separation was therefore used for polar lipid class (fatty acids) 
separation.  Shorter chain fatty acids eluted quicker as they were more 
hydrophilic than longer chain fatty acids.    
Fatty acid standard separation by reverse phase HPLC column showed 
lipids eluted in the order of ascending molecular weight: C16:0, C16:1, 
C18:0, C18:1, C20:0 and C20:4.  Although reverse phase chromatography 
achieved separation of fatty acids, lens extracts were not analysed.  
GCMS was the preferred technique for separation and identification of 
individual fatty acids from contact lens extracts.  
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2.10.6 Gas chromatography mass spectrometry (GCMS) 
GCMS can both separate and identify individual species within an 
unknown sample.  In this project, GCMS was used to separate and identify 
individual fatty acid species from worn lens extracts and tear samples.  A 
Varian Saturn 2000 GCMS with an 8400 autosampler was used in this 
project for analysis.   
Chromatography is the term for a range of techniques used for separation.  
Each chromatographic technique works by mobile phase passing the 
unknown sample through a stationary phase.  The mobile phase in GC is 
a gas, which in this research was helium and the stationary phase was the 
column.  A VF-5ms column with dimensions of 30m x 0.25mm (inner 
diameter ID) and DF of 0.25 was used for all GCMS analyses carried out 
throughout this thesis.  The packing in the column consisted of 5% phenyl 
and 95% dimethyl polysiloxane.  This was a slightly polar column which 
allowed the separation of fatty acid methyl esters.  The injector 
temperature was set at 250°C.  The GC column oven temperature 
sequence was 100°C hold for 2mins.  Increased temperature to 180°C at 
10°C/min, temperature was held for 5mins.  The temperature was 
increased to 240°C at 5°C/min, with no temperature hold, which made a 
total analysis time of 35mins.   
The mass spectrometer was set on electron ionisation (EI) mode.  The 
helium flow rate was set at 1ml/min.  The ionisation range was set at 
40m/z to 650m/z.    
2.10.6.1 GCMS calibration curve preparation and method development 
The GCMS conditions chosen for this research are described in section 
2.10.6.  An isocratic temperature at the beginning of the run provided good 
peak shape and resolution.  The temperature was raised to ensure 
separation of all species over a range of melting points. The column oven 
temperature was set as described in Chapter 2 section 2.10.6, which 
enabled efficient separation of peaks. 
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A calibration curve was constructed of known concentrations of 
heptadecanoic acid (C17:0) to assist with quantification.   
Table 2.4, Figure 2.2 and Figure 2.3 show the data, calibration curve and 
gas chromatograms of heptadecanoic acid at different concentrations 
respectively.  
Table 2.4 – Heptadecanoic acid (17:0) calibration curve data 
Heptadecanoic acid concentration 
(mg/ml) 
Area under peak at 13.949 
0.00012 178760 
0.0009765 432594 
0.001953125 562284 
0.00390625 14580000 
0.0078125 21560000 
0.015625 38970000 
0.03125 62190000 
 
 
Figure 2.2 – Calibration curve for heptadecanoic acid (C17:0) 
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Figure 2.3 – GC traces of C17:0 calibration curve 
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Very long chain fatty acids (C20:0 and C20:1) could also be analysed by 
GCMS.  C20:0 produced a peak which centred at 17.090mins and C20:1 
produced a peak which centred at 17.11mins.  The identity of individual 
lipid species was determined from the retention times of lipid standards.  
The identity of individual peaks was also determined by comparing the 
individual mass spectra against a library of standards. 
2.10.7 Mass spectra for standard fatty acid methyl esters 
Each peak was identified by its retention time on the gas chromatogram 
and their mass spectra.   Mass spectra for representative unsaturated 
(C18:1) and saturated (C18:0) fatty acids are shown in Figure 2.4 and 
Figure 2.5 respectively.  These fatty acids are predominant fatty acids 
known to be secreted by the meibomian glands (as well as C16:1 and 
C16:0).  The mass spectra for other fatty acid standards are shown in 
Appendix 2.   
 
Figure 2.4 – MS of stearic acid (C18:0) methyl ester 
100 200 300 400 500 600
m/z
0%
25%
50%
75%
100%
 41.1
 34254
 43.0
 53207
 55.0
 44992
 75.0
 17616
 87.0
 62453
 88.0
 5481
 97.0
 10502
 143.1
 40882
 171.0
 7735
 199.1
 29631
 213.2
 13468
 298.0
 15280
 299.2
 9406
Spectrum 1A
15.013 min, Scan: 938, 40:650, Ion: 576 us, RIC: 751249, BCBP: 87.0
- Molecular weight = 298m/z 
- Fragment at 267 = Loss of 
methyl ester (molecular 
weight – 32) 
- Fragment at 74m/z = the most common 
fragment for saturated fatty acids  
- Fragment at 87m/z = loss 
of [(CH2)nCOOH3]
+ 
88 
 
 
Figure 2.5 – MS of oleic acid (C18:1) methyl ester 
The mass spectral fragmentation patterns of saturated fatty acids differ 
from those obtained from unsaturated fatty acids.  Mass spectroscopy can 
also provide molecular weight information for each separated species.  
The combination of gas chromatography with mass spectroscopy makes 
the identification of separated species more accurate than GC alone.   
The analysis of standards and the preparation of calibration curves 
enabled separated species from unknown samples to be identified and 
their concentrations determined.  Both normal phase HPLC and GCMS 
are used for the analysis of lens extracts and tear samples, this is 
discussed in Chapter 3.   
2.11 Oxidative assays methodology  
Several oxidative assays kits were used in this research for the analysis of 
lipid peroxidative products in the ocular environment.   Many of the assay 
kits available were not designed for the analysis of tears so were therefore 
adapted.  For example, many of the assays required 100μl or more sample 
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individuals in one go, therefore tears were either pooled or made-up to the 
required volume with water or PBS.  The sample preparation details for 
each assay are discussed in Chapter 5.   
The assays and analytical techniques used were the thiobarbituric acid 
reactive substances (TBARS) assay, N-methyl-2-phenylindole (NMPI) 
assay, capillary electrophoresis, high performance liquid chromatography 
(HPLC) with fluorescence detection and enzyme linked immunosorbant 
assay (ELISA).  The TBARS, NMPI and ELISA assays were commercially 
available assays, currently used for malondialdehyde (MDA – an end 
product of lipid oxidation, discussed in Chapter 1, section 1.11) detection 
from blood, urine and plasma samples.   
2.11.1 TBARS assay protocol (Oxi Select TBARS assay kit 
MDA quantitation from Cell Biolabs Inc.)  
This is a commercially available assay kit and all reagents required for 
sample preparation are supplied in the kit.  The general assay theory is 
that MDA, in unknown samples (tear samples, lens extracts and tear 
envelope samples) or standards binds to thiobarbituric acid (TBA) to form 
an MDA-TBA adduct which has UV absorbance at 523nm and 
fluorescence absorbance at 590nm emission wavelength when an 
excitation at 540nm is applied.  The reaction scheme is shown in Figure 
2.6.  The sample volume required for this assay was 100μl.   
thiobarbituric acid (TBA) malondialdehyde (MDA) TBA-MDA adduct  
Figure 2.6 – TBA reaction with MDA forming an MDA - TBA adduct under 
acidic conditions 
2.11.1.1 TBARS method: 
The supplied assay protocol was followed.  The reagents supplied with the 
assay kit were prepared as described below.     
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The 1xTBA acid diluent was prepared from the dilution of 2xTBA acid 
diluent (supplied) with distilled water.  For 10 assays, 6ml 2xTBA acid 
diluent was diluted with 6ml distilled water.  For more assays, more 1xTBA 
acid diluent was prepared.    
SDS lysis (supplied) was prepared by placing the SDS lysis bottle in a 
warm water bath until the crystals had dissolved.    
5.2mg/ml TBA reagent was prepared from the addition of the appropriate 
amount of TBA (appropriate weight for 10 samples was 13mg) to the 
1xTBA acid diluent (2.5ml for 10 samples).  The pH of the TBA reagent 
was adjusted to pH3.5 by the addition of sodium hydroxide to the solution 
and the use of the pH meter.   
Once all of the above reagents were prepared, MDA standards over a 
range of concentrations (for the calibration curve) were prepared.   
A 1mM MDA standard is supplied with the assay.  From this standard, 
125µM to 0.98µM MDA standards were prepared by double dilution in 
water.  100µl of each MDA standard was transferred to individual 2ml 
eppendorfs, 100µl SDS lysis (supplied) and 250µl TBA reagent (previously 
prepared, as described above) were added to each standard and unknown 
sample.  The eppendorfs were placed in the oven at 95°C for 60mins.  The 
eppendorfs were then placed in an ice bath for 5mins and then centrifuged 
for 15mins at 3300rpm to collect any unwanted debris at the bottom of the 
eppendorf.  The upper 200µl of each standard or unknown sample was 
transferred to a 96 well plate for spectroscopic analysis at 532nm UV 
absorbance or fluorescence absorbance with an excitation wavelength of 
540nm and emission wavelength of 590nm.  The concentration of MDA in 
unknown samples was determined from the calibration curve of MDA 
standard. The calibration curves obtained by using this assay are shown in 
Chapter 5 (Figure 5.1).   
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2.11.2 MDA – Specific assay protocol (ALDetect Lipid 
Peroxidation assay kit from Enzo Life Sciences) 
The principle of this assay is similar to the TBARS assay.   MDA binds to 
N-methyl-2-phenylindole (NMPI) to produce a coloured complex that can 
be detected by UV absorption (Figure 2.7).  The maximum absorbance for 
the adduct was found to be at 572nm, although the assay protocol 
suggested it was at 586nm.   The sample volume required for this assay 
was 200μl.  The advantage of this assay over the TBARS assay is that it 
gives a more accurate measure of MDA levels.  TBA can bind to other 
aldehydes and can exaggerate the true level of MDA.    
N-methyl-2-phenylindole (NMPI) Malondialdehyde (MDA) MDA-NMPI adduct  
Figure 2.7 – MDA reaction with NMPI forming a MDA – NMPI adduct 
2.11.2.1 NMPI method: 
The protocol supplied with this assay was followed.  Briefly, the supplied 
reagents were prepared in the following ways.  R1 reagent (supplied) was 
prepared from the addition of 18ml R1 reagent to 6ml methanol.  
Tetramethoxypropane (TMOP) was used as an MDA substitute, TMOP 
was supplied as a 10mM stock solution.  TMOP was diluted 1/500 with 
water to prepare a 20µM stock solution.  The preparation of TMOP 
standards over a range of concentrations is shown in Table 2.5.   
Once the TMOP standards (over a range of concentrations) were 
prepared, 200μl of each TMOP standard or test sample was transferred to 
a 15ml centrifuge tube.  10µl probucol (supplied) was added to the 
centrifuge tube.  640µl of the diluted R1 reagent (previously prepared) was 
then added. 150µl R2 reagent (supplied) was also added and the 
centrifuge tubes were vortexed to mix the solution.  The centrifuge tubes 
were then incubated in the oven for 60mins at 45°C.   They were then 
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centrifuged (1.1rpm for 10mins) until a clear solution was obtained.  Each 
solution was added to a cuvette and UV wavelength scans were taken to 
determine the maximum absorbance.  The maximum UV absorbance was 
found to be at 572nm.  Therefore, all subsequent standards and unknowns 
were analysed at 572nm.  The calibration curve is shown in Chapter 5. 
Table 2.5 – Preparation of TMOP standards for MDA-NMPI calibration 
curve 
Volume of 20µM 
stock (µl) 
Volume of water (µl) Concentration of 
TMOP (µM) 
0 200 0 
25 175 0.5 
50 150 1.0 
100 100 2.0 
150 50 3.0 
200 0 4.0 
 
2.11.3 ELISA-MDA assay protocol (from Cell Biolabs Inc.) 
MDA and 4-hydroxynonenal have the ability to bind to proteins and form 
stable MDA-protein adducts.  An enzyme immunoassay was used to 
quantitatively detect this MDA-protein adduct.  The sample volume 
required for this assay was 100μl.   
2.11.3.1 Method: 
MDA-BSA standards were prepared at the concentrations shown in Table 
2.6.  (The 1µg/ml standard is diluted by half to prepare a stock solution of 
0.5µg/ml MDA-BSA standard for the calibration curve).  100µl standards or 
unknowns were added to the 96-well plate provided in the assay kit and 
incubated overnight at 4°C.  The plate was then washed with a non-
reacting blocking buffer (supplied) which prevented non-specific binding of 
primary antibody.  The plate was washed with several buffers supplied in 
the assay kit and the plate was then patted dry on tissue paper.  100µl of 
the secondary horseradish peroxidise conjugated antibody (supplied) was 
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added the plate and it was incubated for 1hr at room temperature.  The 
plate was washed with the wash buffer provided with the assay.  100µl 
substrate solution (supplied) was added to the wells of the plate and a 
colour change was observed (from clear to blue).  The reaction was 
stopped by the addition of the stop solution (which was supplied) and a 
change of colour from blue to yellow was observed.  The absorbencies of 
the samples and standards were analysed at 450nm and a calibration 
curve of standards was obtained.  The concentration of MDA in unknown 
samples was determined from the calibration curve (shown in Chapter 5).  
Table 2.6 – Preparation of standards for MDA-ELISA assay 
Tube Number Volume of MDA-
BSA (µl) 
Volume of 
reduced BSA 
(µl) 
MDA adduct 
concentration 
(pmol/mg) 
1 1000 0 120 
2 500µl of no.1  500 60 
3 500µl of no.2 500 30 
4 500µl of no.3 500 15 
5 500µl of no.4 500 7.5 
6 500µl of no.5 500 3.75 
7 500µl of no.6 500 1.875 
8 0 500 0 
 
2.11.4 Capillary Electrophoresis with UV detection  
Capillary electrophoresis was used to detect MDA as it had previously 
been used for MDA detection in tears by Georgakopoulosa et al. (151).  
Capillary electrophoresis is a combination of electrophoresis and HPLC, it 
can therefore separate components based on polarity and charge.   
The following conditions were used for the detection of MDA – Capillary: 
bared fused-silica capillary with 50μm ID, 56cm effective length and 65cm 
total length. Separation: 25mM borate buffer, pH10.0 which contained 
100mM sodium dodecyl sulfate (SDS) at the temperature of 25°C and 
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voltage at 20kV.  Detection: 266nm and 290nm wavelengths using a 
diode-array detector. Samples were pressure injected at 50mbars at the 
anode (normal polarity).  The conditions used in this research were similar 
to those used in the literature. 
To determine a lower limit of detection, MDA standards were analysed by 
capillary electrophoresis.  A 2.5µM MDA solution was analysed and it 
produced a peak at approximately 20mins, however the peak had a very 
low intensity.  Tear samples, tear envelope samples and lens extracts 
were subsequently analysed however, MDA was not detected in any 
sample.   
2.11.5 High Performance Liquid Chromatography (HPLC) with 
fluorescence detection 
HPLC with fluorescence detection had been used for MDA separation and 
identification in blood plasma samples by Fukunaga et al.  (134).  The 
methodology used by Fukunaga et al. was followed in this research.  The 
method is based on an MDA-TBA reaction.  The MDA-TBA adduct is then 
separated by HPLC with fluorescence detection.  TBA can bind with other 
aldehydes; however only TBA bound to MDA will have a characteristic 
retention time.  MDA-TBA adduct has a characteristic retention time which 
makes this method more accurate than the TBARS assay alone.   
An MDA substitute was used because MDA is not stable and was 
therefore not commercially available.  1,1,3,3 tetraethoxypropane (TEP) 
was used as the substitute (Figure 2.8).  The theory is that TEP changes 
to MDA in a hydrolysis reaction when the TBA buffer and TEP are heated.  
A Hypersil ODS column with 5µm packing, 150mm x 4.6mm ID (Kinesis 
UK) was used for the separation of MDA-TBA.  The column was also fitted 
with a guard column with 5µm packing and 10mmx4.6mm ID.  The mobile 
phase was 700/300 (v/v) acetonitrile: water with a flow rate of 0.5ml/min.  
The MDA-TBA adduct had a fluorescence absorbance at the following 
wavelengths - excitation of 515nm and the emissions were analysed at 
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553nm.  The sample volume required for this assay, as described in the 
literature was 5μl (134).   
 
Figure 2.8 – Structure of 1,1,3,3 tetraethoxypropane (TEP) 
 
2.11.5.1 MDA-TBA separation and detection by HPLC with fluorescence 
detection method: 
2.11.5.1.1 Preparation of TBA buffer 
0.1M sodium acetate buffer was prepared by firstly, dissolving 1.36g 
sodium acetate in 100ml HPLC grade water.  Secondly, 8.5ml was 
transferred to a 100ml volumetric flask, 0.1M acetic acid was added until 
the final volume was 100ml.  The pH of the sodium acetate buffer was 
adjusted to pH3.5 by adding sodium hydroxide.   
0.2g TBA was then added to the 0.1M sodium acetate buffer solution, 
which made a 0.2% (w/v) TBA solution in 0.1M sodium acetate buffer.   
2.11.5.1.2 Preparation of standards 
10µmol/ml TEP stock solution was prepared by addition of 24µl TEP to 
10ml HPLC grade ethanol.  Other concentrations of TEP were prepared by 
serial dilution of the 10μmol/ml stock solution with dilution in HPLC grade 
water. 
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Table 2.7 – Preparation of TEP standards for HPLC separation 
Standard 
tubes 
TEP standard Amount of 
water 
Concentration of TEP 
Stock 24μl 10ml 10μmol/ml 
1 200μl of stock 9800μl 200nmol/ml 
2 100μl of stock 9900μl 100nmol/ml 
3 50μl of stock 9950μl 50nmol/ml 
4 40μl of stock 9960μl 40nmol/ml 
5 30μl of stock 9970μl 30nmol/ml 
6 20μl of stock 9980μl 20nmol/ml 
7 10μl of stock 9990μl 10nmol/ml 
8 1ml of tube 7 9ml  1nmol/ml 
9 1ml of tube 8 1ml 0.5nmol/ml 
10 1ml of tube 8 9ml  0.1nmol/ml 
11 1ml of tube 10 9ml 0.01nmol/ml 
 
2.11.5.1.3 Preparation of samples for HPLC analysis 
5µl TEP standard or 5µl unknown sample was added to 1ml of 0.2% (w/v) 
TBA buffer in 0.1M sodium acetate buffer in 2ml eppendorfs.  These 
eppendorfs were then placed in an oven for 60 minutes at 90°C.  The 
solutions in the eppendorfs were then cooled by placing them in a cold 
water bath for 5mins.  The eppendorfs were centrifuged for 15mins at 
6600rpm.  The upper 750µl were transferred to amber vials for analysis by 
HPLC.   
2.12 Method used for inducing lipid oxidation 
100μl linolenic acid standard was transferred to a glass vial and left 
exposed to atmospheric oxygen on a shaker for 24hrs to promote 
oxidation.   
5ml chloroform was added to the remaining unused linolenic acid standard 
and stored at -20°C.   
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10μl of each standard (the oxygen exposed linolenic acid and the fresh 
linolenic acid standard from the freezer) was added to 500μl TBA buffer 
and placed in an oven for 1hr at 90°C.   
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3. Chapter 3 – Technique development        
and analysis of lenses, lens extracts and tears 
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3.1 Introduction  
After the insertion of a contact lens, tear film components begin to adsorb 
on to its surface and in some cases begin to absorb into the lens matrix.  
To monitor the progression of lipid build-up, a range of analytical 
techniques were used.  A process of analysis (shown in Figure 3.1) was 
developed and followed in order to, firstly, measure gross lipid non-
destructively and, secondly, analyse lipids by destructive techniques.  
Fluorescence spectrophotometry is a non-destructive technique and it was 
used to measure gross lipid on the both anterior and posterior surfaces of 
single worn lenses.  To gain structural information about the lipids, lenses 
were extracted and analysed by an array of chromatographic techniques.  
The results generated by each technique provide information about 
different aspects of the lipid structure.   
Thin layer chromatography (TLC) and high performance liquid 
chromatography (HPLC) were used to separate lipid classes in 
accordance to their relative polarities.  Gas chromatography (GC) was 
used for the separation of individual fatty acids (in the form of their methyl 
esters) from lens extracts and it also provided information about the state 
of oxidation of each fatty acid.  To determine the extent of oxidation, 
various assays were used to quantify the levels of oxidative end products 
in tears, or on contact lenses (details of each analytical technique are 
explained in detail in Chapter 2 and results are discussed in Chapter 5).   
The work discussed in this chapter will show that a single lens extract can 
be analysed by various techniques, each technique providing information 
about lipid structure.  Unworn lenses will be analysed by GCMS and HPLC 
to provide a baseline for ex vivo lens extracts.  Tear samples, taken using 
Visispear ophthalmic sponges were also analysed by HPLC and GCMS.   
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3.2 Analytical technique development 
 
Figure 3.1 – Analytical technique flow diagram 
The process of analysis for a single subject-worn lens is shown in Figure 
3.1.  This process shows how a single lens extract, subjected to an array 
of techniques can provide a vast amount of information about lipid 
structure.   
3.3 Non-destructive analysis: ex vivo lens analysis by 
fluorescence spectrophotometry  
Fluorescence spectrophotometry (FS) was used to non-destructively 
analyse the levels of gross lipid deposition on lens surfaces.  FS enables 
differences in lipid deposition between anterior and posterior surfaces of 
lenses to be analysed.  It also provides data for lipid deposition on 
different lens materials.  The details for this technique are explained in 
Chapter 2, section 2.10.1.     
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Figure 3.2 – Lipid subject-to-subject variability on two contact lens 
materials over a range of subjects measured by fluorescence 
spectrophotometry 
Figure 3.2 compares lipid deposition across a range of subjects wearing 
either Proclear (a conventional hydrogel) or Air Optix lenses (a coated 
silicone hydrogel).  Over the range of subjects, it is clear that the level of 
lipid deposition on Air Optix lenses is greater than on the Proclear lenses.  
Additionally, it can be seen that there is marked subject-to-subject 
variation in the level of deposited lipid.  For a small subset of subjects, lipid 
deposition can be described as abnormally high.  This technique shows 
that lipid deposition on lenses is to an extent material dependant, but it is 
ultimately subject dependant.   
Once lenses had been analysed by fluorescence spectrophotometry for 
gross lipid levels, individual lenses were subjected to destructive analysis.  
Single lenses were extracted (using various extraction protocols described 
in section 2.6) and subjected to an array of techniques.  
3.4 Destructive analysis: lens extraction and process of 
analysis  
Although the fluorescence absorbance results for worn PureVision (PV) 
lenses are not shown, they usually have an absorbance above 500 
fluorescence units, which is considerably higher than the Air Optix lenses 
analysed in Figure 3.2.  This was the reason a PV lens extract was 
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separated by an array of techniques.  In order to show that a single lens 
could be extracted and analysed by several techniques, a single PV lens 
was extracted using extraction protocol 1 (described in section 2.6.1) and 
was separated by TLC, HPLC and GCMS.  The results generated by each 
technique showed different aspects of lipid structure.  TLC separation 
provided a general lipid class separation based on polarity.  HPLC also 
provided a general lipid class separation; the ratios of non-polar to polar 
lipids could also be determined by this method.  GCMS enabled the 
separation and identification of individual fatty acids.  Subjecting a lens 
extract to this process of analysis validated both the choice of extraction 
protocol and the technique conditions chosen.   
3.4.1 TLC separation of an ex vivo PureVision lens extract 
A single PureVision (PV) lens (known for high levels of lipid deposition) 
was extracted using extraction protocol 1 (described in section 2.6.1) and 
resuspended in chloroform for TLC analysis.   TLC separation of this PV 
lens extract is shown in Figure 3.3.  Using the conditions described in 
section 2.10.2, individual lipid classes, extracted from a single lens were 
separated.  Polar lipids eluted quickly, nearer the bottom of the plate and 
non-polar lipids eluted more slowly, nearer the top of the plate.  The 
separated bands were identified by the comparison of separated species 
against lipid standards.  The spots on the line near the bottom of the plate 
were identified as phospholipids, however, analysis of worn lens extracts 
by HPLC showed no peaks for phospholipids.  The non-polar lipids, such 
as the sterol esters and TGs ran to the top of the plate with the non-polar 
mobile phase.   
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Figure 3.3 – TLC separation of a single worn PureVision lens extract 
3.4.2 Normal phase separation of an ex vivo PureVision lens 
extract 
The remainder of the extract medium (from TLC analysis) was evaporated 
to dryness under nitrogen and resuspended in mobile phase for normal 
phase HPLC analysis.  An analysis time of 35mins was chosen to ensure 
that no other polar lipids eluted (Figure 3.4).   
 
Figure 3.4 – HPLC trace of a single ex vivo PureVision lens extract 
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The HPLC trace of a single ex vivo PV lens extract shown in Figure 3.4 
demonstrates how powerful normal phase chromatography is for the 
separation of lipids.  This HPLC trace shows the separation of the major 
lipid classes adsorbed on the contact lens.  The trace for this particular 
lens extract showed peaks corresponding to CEs, TGs, DGs, FFA and 
cholesterol.  The concentration of individual lipids was determined from 
the calibration curves shown in Appendix 1.   
Table 3.1 – Analysis of the HPLC trace shown in Figure 3.4 
Lipid class Concentration of lipid class 
Cholesteryl esters (CEs) 1.67x10-3moldm-3 
Triglycerides (TGs) 1.40x10-3moldm-3 
Diglycerides (DGs) 0.8x10-3moldm-3 
Free fatty acids (FFAs) 4.0x10-3moldm-3 
Cholesterol 9.5x10-4moldm-3 
3.4.3 GCMS separation of an ex vivo PureVision lens extract 
Although normal phase HPLC separation provided information about the 
general lipid classes deposited on and in the lens, GCMS was able to 
separate and identify the fatty acid groups from single lens extracts.  The 
analysis of lens extracts by GCMS is important to investigate because the 
levels of unsaturated fatty acids and the ratio of unsaturated to saturated 
fatty acids can be determined.  GCMS is used in Chapter 4 to investigate 
changes in individual fatty acid profiles between lenses worn on a daily 
wear schedule compared to a continuous wear schedule.   
The remainder of the contact lens extract (from Figure 3.4) was 
evaporated to dryness under nitrogen and then transmethylated (as 
described in Chapter 2 section 2.5). The individual fatty acids were 
separated and the GC trace is shown in Figure 3.5.   
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Figure 3.5 – Gas chromatogram of a single ex vivo PV lens extract 
The GC trace shown in Figure 3.5 represents a worn PV lens extract.  The 
major peaks observed correspond to the major tear film fatty acids as 
reported in literature (23).  C14:0, C16:1, C16:0, C18:1 and C18:0 are 
observed for this PV lens extract (as shown in Table 3.2).  GCMS has not 
previously been used for the analysis of fatty acids from contact lens 
extracts.  These results show that single lenses can be extracted and 
analysed by GCMS.  The concentrations of individual fatty acids could be 
determined from the calibration curve (shown in Figure 2.3). 
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Table 3.2 – Fatty acid retention times, separated by GCMS 
Peak retention time (mins) Fatty acid Saturated/unsaturated 
10.3 C14:0 saturated 
12.5 C16:1 unsaturated (1 double bond) 
12.8 C16:0 saturated  
14.8 C18:1 unsaturated (1 double bond) 
15.0 C18:0 saturated 
     
Unworn PureVision and other unworn lens materials were also analysed 
by GCMS (shown in section 3.5.1).  This allowed the differentiation 
between extractable material from lenses and tear lipids to be made.  
Although the peaks for unworn lenses were at the same retention times as 
certain fatty acids (mainly C16:0 and C18:0), the peaks were less intense 
for unworn lens materials compared to worn extracts.  Tear samples were 
also analysed to show both C16:0 and C18:0 are common tear lipids and 
do deposit on lenses (shown in Figure 3.16).   
3.5 Unworn lens extraction results 
In addition to the extraction of worn lenses and the analysis of the 
deposits, unworn (fresh lenses) were extracted (using extraction protocol 
1) and analysed by both GCMS and normal phase HPLC.  Several ex vivo 
lens materials including PureVision and Focus Night & Day were extracted 
and the deposits analysed throughout this thesis.  It was therefore 
necessary to extract and analyse unworn (blank) lenses to provide a 
baseline.  Several unworn lens materials were extracted and analysed by 
both GCMS and HPLC (Figure 3.6 to Figure 3.11).  Unworn lenses were 
extracted and treated in the same way ex vivo lenses were, to provide a 
direct comparison between worn and unworn lenses.   
Prior to the extraction of unworn lenses, empty vials were extracted (with 
no lens) using extraction protocol 1 (section 2.6.1).   The empty vial 
extracts were also analysed by GCMS to ensure the vials were clean.   
Unworn lenses were then extracted in these vials to ensure the vials were 
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not contaminated. The gas chromatograms for empty vial extracts are 
shown in Appendix 3.   
3.5.1 Gas chromatograms of unworn lens extracts 
The gas chromatograms in Figure 3.6 represent various unworn lens 
extracts.  Unworn PureVision, Focus Night & Day, Air Optix, Air Optix 
Aqua and Soflens 66 lenses were analysed by GCMS.   These particular 
lenses were chosen because they represented a range of both silicone 
and conventional hydrogels from the major contact lens manufacturers 
(Ciba Vision and Bausch & Lomb).   Also, because ex vivo PureVision and 
worn Focus Night & Day lens extracts are analysed by GCMS and HPLC 
(in Chapter 4), baseline chromatograms were required.   
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Figure 3.6 – Gas chromatograms representing unworn lens extracts, 
where: Chromatogram 1 – unworn PV extract, Chromatogram 2 – unworn 
F.N&D extract, Chromatogram 3 – unworn AO extract, Chromatogram 4 – 
unworn AOA extract and Chromatogram 5 – unworn Soflens 66 extract. 
The peaks observed for all unworn contact lenses analysed corresponded 
to C16:0 and C18:0 (at 12.8 and 15.0mins respectively).  These peaks 
were identified from their retention times and their mass spectra.  The 
peak intensities for the silicone hydrogel materials did not differ 
significantly from one another.  The C16:0 peak height for the silicone 
hydrogel materials was ~700kcounts (equivalent to approximately    
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3.5x10-4mg/ml, determined from the calibration curve shown in Figure 2.2).  
The peak intensities for the unworn Soflens 66 lens extract (chromatogram 
5) were very low in comparison to all other silicone hydrogel materials 
analysed.   The C16:0 peak height was ~200kcounts (equivalent to 
approximately 1.1x10-4mg/ml).   
The C16:0 peak height for a worn PureVision lens extract (Figure 3.5) is 
approximately 2.5Mcounts (approximately 8.0x10-4mg/ml), which is 
considerably higher compared to an unworn PureVision lens extract.   
Chromatogram 1 and 2 represent unworn PV and F.N&D lens extracts 
respectively.  Both of the chromatograms for each lens extracts look 
similar, there are peaks at 10.3mins, 12.8mins and 15.04mins.  The C16:0 
peak intensities are also similar (approximately 700kcounts for both lens 
materials).  The C18:0 (15.04mins) peak intensities differed, 400kcounts 
(2.7x10-4mg/ml) for the F.N&D lens extract and 200kcounts (1.4x10-
4mg/ml) for the PV lens extract.     
Chromatograms 3 and 4 represent unworn Air Optix and Air Optix Aqua 
lens extracts.  Both of the chromatograms showed peaks at 8.1mins, 
10.3mins, 12.8mins and 15.04mins.  The peak intensities differed between 
these two lenses.  The peak intensities were higher for the Air Optix Aqua 
lens extract compared to the Air Optix extract.   
Chromatogram 5 represents an unworn Soflens 66 lens extract.  The 
chromatogram showed peaks at 12.8mins (peak height of ~200kcounts, 
equivalent to 1.1x10-4mg/ml) and 15.04mins (peak height of ~100kcounts 
equivalent to 0.75x10-4mg/ml).   
Although the peak intensities differed significantly between the 
conventional and silicone hydrogel materials tested, there was no 
difference in the retention times of the extractable components.    
The mass spectra for each of the peaks were analysed and compared to 
the NIST (National Institute of Standards and Technology) database.  The 
peak at 12.8mins corresponded to C16:0, which was identified by its 
retention time and its mass spectrum.  The peak at 15.04mins 
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corresponded to C18:0 by the retention time and the mass spectrum.  The 
peaks at 8.1mins and 10.3mins were identified as benzoic acid, 4-
ethoxyethyl ester and tridecanoic acid methyl ester respectively.  These 
were identified by the use of the NIST database which gave a 97% match 
to the spectrum for the peak at 8.1mins and a 59% match to the peak at 
10.3mins.  Both C16:0 and C18:0 peaks are present on gas 
chromatograms of worn lens extracts and are common tear fatty acids.  
The analysis of ex vivo lens extracts by gas chromatography also shows 
peaks which corresponded to C16:0 and C18:0.  These fatty acids are 
believed to be from tear lipids as they are present in tear sample analysis.   
The peaks observed for unworn lens extracts were thought to be from un-
reacted monomers used in the manufacturing process of lenses.   
3.5.1.1 GCMS separation of unworn lenses: Summary 
- GCMS analysis of unworn lenses showed that there was extractable 
material from the particular lenses analysed 
- The peaks on GC traces for all unworn lenses tested corresponded 
to C16:0 and C18:0 
- C16:0 and C18:0 peaks are observed for worn lens extracts but the 
peaks are more intense (3.5x10-4mg/ml for unworn lenses and 
1.0x10-3mg/ml for worn lenses) 
- C16:0 and C18:0 were also observed for tear samples, therefore they 
correspond to fatty acids from tears not from the lens itself 
3.5.2 Normal phase HPLC separation of unworn lens extracts 
The same lens materials as those analysed by GCMS (Figure 3.6) were 
extracted and analysed by HPLC.  Whilst GCMS analysis of unworn 
lenses showed there was extractable material from unworn lenses, the 
samples had to be transmethylated prior to analysis.  Therefore, HPLC 
was used for unworn lens extract analysis because the extract could be 
analysed directly without any sample preparation.  Also, only volatile 
species can be separated by GCMS, therefore, HPLC was used for 
analysis because the entire extract can be separated.   
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Figure 3.7 to Figure 3.11 represent chromatograms of unworn lens 
extracts.  The same wavelengths used for worn lens analysis were chosen 
for unworn lens analysis.   
 
Figure 3.7 – HPLC traces at 205nm and 234nm of an unworn PV lens 
extract 
 
Figure 3.8 – HPLC traces at 205nm and 234nm of an unworn F.N&D lens 
extract 
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Figure 3.9 – HPLC traces at 205nm and 234nm of an unworn Air Optix 
lens extract 
 
Figure 3.10 – HPLC traces at 205nm and 234nm of an unworn Air Optix 
Aqua lens extract 
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Figure 3.11 – HPLC traces at 205nm and 234nm of an unworn Soflens 66 
lens extract 
As well as GCMS analysis of unworn lenses, HPLC with UV and 
fluorescence detection were used to separate and detect the extractable 
material from unworn lenses.  The results are shown in Figure 3.7 to 
Figure 3.11.   
The HPLC traces in Figure 3.7 represent an unworn PV lens extract.  A 
predominant peak at 16.5mins (205nm absorbance) was observed.  This 
peak had an intensity of ~20mAU which is considerably lower than the 
intensity of the peak observed for ex vivo PureVision lens extracts 
(120mAU for CE peak, Figure 3.4).  The peaks were not identified, but the 
peak at 1.9mins was very hydrophobic as it has a short retention time.   
The HPLC trace for AO lens extract (Figure 3.9) at 205nm showed a 
strong peak at 2.881mins with a peak intensity of 180mAU.   The HPLC 
trace for an AOA lens extract showed a similar trace to the AO extract.  
There was a strong absorption at 2.881mins of over 200mAU at 205nm 
(Figure 3.10).   
The HPLC trace for an unworn S66 lens extract shown in Figure 3.11 
showed very small peaks not more than 20mAU.   
The separation of unworn contact lens extracts by HPLC produced many 
peaks.  The retention times of the peaks on HPLC traces of unworn lens 
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extracts differed to worn lens extracts.  The retention times of the peaks 
for unworn lens extracts did not correspond to lipids.  This meant that 
peaks observed for worn lens extracts corresponded to lipids and not 
extractable components of the lens itself.   
The GC and HPLC traces both showed the most extractable material was 
from AO and AOA lenses.  Both of these lens extracts showed high 
absorbencies on both the GC and the HPLC traces.  The peaks were not 
identified but they were very hydrophobic as they had a short retention 
time.  When both AO and AOA lenses had been extracted and evaporated 
to dryness there was a white solid that coated the vial observed for both 
lens extracts.   
Zhao et al. (110) used TLC to separate lipids extracted from lenses and 
also analysed unworn lens extracts.  They found that there were 
separated species observed for unworn lens extracts.  However, these 
bands did not correspond to any lipid standards and were therefore 
extractable components of the lens itself.   
3.5.2.1 Unworn lens extraction: Summary 
The HPLC results showed that there was extractable material from the 
unworn contact lenses that were tested.  Tear samples and ex vivo 
contact lens extracts were analysed by HPLC to distinguish between tear 
lipids and extractable components of the lens.   
- The HPLC traces for single unworn lens extracts showed that there 
are extractable components from unworn lenses 
- The HPLC traces for the materials tested differed from one another 
- Air Optix and Air Optix aqua lenses had similar traces as they are 
essentially the same lens material (Figure 3.9 and Figure 3.10) 
- There was less extractable material from Soflens 66 lenses 
compared to all the silicone hydrogel materials analysed (Figure 
3.11) 
- Although the GC traces for the unworn lens materials analysed had 
similar profiles to one another (Figure 3.6), the HPLC traces for the 
same set of materials differed from one another 
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- GC separation only allowed volatile species to be separated, 
however HPLC allowed the separation of all extracted species 
- The HPLC profile for unworn and worn lenses differed  
o Peaks were more intense for worn lens extracts compared with 
unworn extracts (for PV lenses, 25mAU for unworn lens 
extracts compared to 125mAU) 
o The retention times of peaks for unworn lenses were different to 
the retention times of lipids 
- Components from unworn lenses are believed to be extracted by the 
tear film during wear, however the effect on the tear film is yet 
unknown   
3.6 HPLC and GCMS analysis of tear samples 
HPLC and GCMS were both used for lens extract analysis. However, 
these techniques were very useful for the analysis of tear samples.  This 
would enable the differences in lipid profiles between tear samples and 
lens extracts to be analysed.   
3.6.1 Normal phase separation of tear samples 
HPLC was used for the separation of tear samples which were collected 
using the Visispear sponge method (as described in section 2.3).  Tear 
samples were analysed to establish whether there were any differences in 
lipid profiles between tear samples and lens extracts.   
The HPLC traces of tear samples are shown in Figure 3.12 and Figure 
3.13. 
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Figure 3.12 – HPLC trace of subject (AM) tear sample taken with a 
Visispear ophthalmic sponge 
 
 
Figure 3.13 – HPLC trace of subject (AM2) tear sample taken with a 
Visispear ophthalmic sponge 
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Figure 3.12 and Figure 3.13 represent Visispear tear samples collected 
from two different subjects.  The traces for both subjects tear samples are 
very similar as they both show predominant peaks at 1.6mins which 
correspond to CEs.  However, the HPLC trace of the worn lens extract 
(Figure 3.4) differed significantly from the traces of tear sample extracts 
(Figure 3.12 and Figure 3.13).   
The HPLC trace for the worn lens extract showed significantly higher 
levels of TGs, free fatty acids and cholesterol compared to both HPLC 
traces for tear samples (Figure 3.12 and Figure 3.13).  The major lipid 
class extracted from tear samples was cholesteryl esters.  This clearly 
demonstrates that lipids build up on the contact lens throughout the wear-
time of the lens.  The PV lens extract in Figure 3.3, Figure 3.4 and Figure 
3.5  was worn on a daily wear basis for a period of 30 days.  The lens was 
cleaned with contact lens solution every night and re-inserted every 
morning.  The results also show that this particular contact lens solution is 
not effective at removing lipid deposits from the lens.  Whilst it is known 
that lipids deposit on lenses, these HPLC traces clearly show the extent of 
lipid build-up.  Lipids deposited on and in the contact lens are left 
immobilised within the lens matrix and are susceptible to oxidative attack.  
This forms the basis for our proposition that tear film lipids are susceptible 
to degradation and structural change as a result of contact lens wear.    
3.6.1.1 Normal phase HPLC separation: Summary 
Normal phase HPLC separation of contact lens extracts and tear samples 
showed:  
- lipid class separation of tear samples and single lens extracts 
- extent of lipid build-up on contact lenses (Figure 3.4) 
- differences in lipid classes from lens extracts compared with tear 
samples (Figure 3.4 compared with Figure 3.12) 
- the Visispear ophthalmic sponge is an effective tear lipid sampling 
tool 
- ratios of non-polar to polar lipids can be determined 
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- lipids are immobilised within the lens and are susceptible to 
degradation 
Although the HPLC traces for tear samples and lens extracts differed 
(shown in Figure 3.12 and Figure 3.5 respectively), the peaks observed for 
worn lens extracts corresponded to known tear lipids and not extractable 
components of the lens.  Certain lipids such as cholesterol, TGs and free 
fatty acids are known tear lipids but they were not observed for certain 
subjects tear samples (Figure 3.12 and Figure 3.13), however they were 
observed for the contact lens extract shown in Figure 3.5.  This is because 
particular lipids will build up on certain lenses.  Therefore, lipids that are 
present in the tear film at low levels will build up on lenses and will be 
present at higher levels when analysed. 
3.6.2 Normal phase HPLC analysis of lipid samples from the 
lens-wearing eye 
A Visispear ophthalmic sponge was gently wiped over the anterior surface 
of an in vivo contact lens and care was taken not to move the lens.  The 
tip of the sponge was cut off, placed in a vial and extracted as described in 
Chapter 2, section 2.9.  The sponge lipid sample and the contact lenses 
were extracted and analysed by HPLC.  This experiment was undertaken 
to determine whether the Visispear sponge would collect lipids from the 
anterior superficial lipid layer.  By extracting the lens and the Visispear 
sponge, would indicate the level of lipid build-up on and in this lens.   
The chromatograms representing the Visispear sponge sample and lens 
extracts are shown in Figure 3.14.   
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Figure 3.14 – HPLC traces of a lipid sample of the lens-wearing eye. A 
Visispear sponge was wiped over the anterior surface of two Acuvue 
Oasys lenses in vivo.  Trace 1: UV absorbance at 205nm, Trace 2: UV 
absorbance at 280nm.  Trace 3: Fluorescence absorbance, excitation 
360nm and emission 440nm.  Peak at 1.5mins = cholesteryl esters 
Figure 3.14 shows that the sponge had adsorbed lipids, mainly CEs from 
the anterior superficial lipid layer.  Peaks corresponding to CEs and TGs 
were observed.  The circled peak on Figure 3.14 (trace 1: 205nm) 
corresponds to cholesteryl esters and its intensity was ~120mAU.  This 
shows that significant levels of CEs were absorbed by the sponge from the 
superficial lipid layer.   
The contact lenses that had been wiped by a Visispear sponge were also 
extracted and analysed by normal phase HPLC.  The chromatograms are 
shown in Figure 3.15.  To ensure the sponge did not have any extractable 
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components that would interfere, a blank sponge was extracted and 
analysed by HPLC and no peaks were observed.   
 
Figure 3.15 – HPLC traces of ex vivo contact lens extract (Acuvue Oasys 
left lens) after the lens was wiped with ophthalmic sponge.  Trace 1: UV 
absorbance at 205nm, Trace 2: UV absorbance at 280nm, Trace 3: UV 
absorbance at 254nm, Trace 4: Fluorescence absorbance, excitation 
360nm, emission 440nm.  Peaks at 1.5mins = cholesteryl esters, peaks at 
2.1mins = triglycerides 
 
 
-10 
40 
90 
140 
190 
0 5 10 15 20 25 30 35 40 
m
A
U
 
Retention time (mins) 
-5 
45 
95 
145 
195 
245 
0 5 10 15 20 25 30 35 40 
m
A
U
 
Retention time (mins) 
-20 
0 
20 
40 
0 5 10 15 20 25 30 35 40 
m
A
U
 
Retention time (mins) 
0 
10 
20 
30 
0 5 10 15 20 25 30 35 40 
m
A
U
 
Retention time (mins) 
205nm 
280nm 
254nm 
Fluorescence 
121 
 
Although the sponge absorbed lipids (Figure 3.14), in particular CEs from 
the anterior superficial lipid layer, there were still significant levels of CEs 
extracted from the lens (Figure 3.15).  This is shown in the chromatograms 
in Figure 3.15, which represent the lens extracts.   The height of the peak 
that correspond to CEs (~1.6mins) was much more intense for the lens 
extracts compared to the tear sample.     
This suggested that these lipids were not easily removed from the lens 
surface because they were absorbed into the lens matrix.  Although wiping 
a sponge over the surface of the lens did remove some lipid, there was 
still a considerable amount still left on and in the lens.  It is these non-polar 
lipids which penetrate into the lens matrix and are difficult to be removed 
by contact lens cleaning solutions (as discussed in the literature overview 
– section 1.8.2).  Again, it is these immobilised lipids that are susceptible 
to oxidative attack and have been shown in literature to produce ‘jelly 
bumps’ or ‘white spots’ (140, 141).   These highly non-polar lipids also 
make the surface of the contact lens less wettable, leading to contact lens 
discomfort.   
3.6.2.1 Lipid samples from the lens-wearing eye: Summary 
HPLC analysis of tear samples taken from the lens-wearing eye 
demonstrated that: 
- lipids were absorbed by the sponge from the superficial lipid layer 
from the lens-wearing eye 
- high levels of lipids were still extracted from lenses even though they 
had been wiped by an ophthalmic sponge  
- lipids become immobilised in the lens and they are therefore not 
absorbed by the ophthalmic sponge 
- immobilised lipids make the surface of the lens less wettable and are 
susceptible to oxidative attack, which has links to contact lens 
discomfort.   
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3.6.3 GCMS analysis of tear samples  
GCMS was also used for the analysis of tear samples taken with Visispear 
ophthalmic sponges.  The GC trace of a sponge tear sample extract is 
shown in Figure 3.16.  A blank Visispear ophthalmic sponge was also 
extracted to ensure there was no contamination.  No peaks were observed 
on the GC trace for a blank Visispear extract. 
 
Figure 3.16 – Gas chromatogram of a Visispear ophthalmic sponge tear 
sample 
The GC traces for worn lens extracts (Figure 3.5) and tear samples 
(Figure 3.16) showed a similar profile, but the intensity of the peaks 
differed significantly.  The peak heights were more intense on the gas 
chromatogram representing the PureVision lens extract (Figure 3.5) 
compared to the tear sample trace (Figure 3.16).  This again shows that 
lipids accumulate on, and in the contact lens.  It is these immobilised lipids 
that are susceptible to oxidative attack.  Therefore, certain lens extracts 
were analysed by various oxidative assays to investigate the presence of 
lipid oxidative products such as MDA (assay details explained in further 
detail in Chapter 2 and results discussed in Chapter 6).   
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3.6.3.1 GCMS separation of lens extracts and tear samples: Summary 
GCMS analysis of worn lens extracts showed: 
- single lenses extracts can be analysed by GCMS and compared to 
tear samples 
- results in Figure 3.5 and Figure 3.16 show lipids build-up on and in 
the contact lens (peak intensity lower for tear samples compared 
with lens extracts) 
- lipids become immobilised in the lens result in decreased wettability 
of the lens, which leads to decreased comfort 
3.7 Conclusions 
Overall, the work discussed in this chapter was important because it 
demonstrated that a single lens could be extracted and subjected to 
various chromatographic analyses.  Each technique provided different 
information about lipid structure.   
Normal phase HPLC was extremely useful for general lipid class 
separation and was able to separate individual lipid classes from a single 
lens extract.  It was also useful for the separation of tear lipids.   HPLC 
separation of lens extracts and tear lipids demonstrated that various lipid 
classes accumulate on and in the lens throughout the wear schedule.   
GCMS was able to separate and identify individual fatty acid species from 
single lens extracts and from tear samples.  GCMS has not been 
previously used for fatty acid analysis from lens extracts.  The work in this 
chapter showed that single lens extracts could be analysed using this 
technique.    
Both GCMS and HPLC have been shown to be very useful techniques for 
the analysis of tear lipid chemistry.  Each of these techniques is used 
throughout this research to investigate various aspects of lipid structure.    
 
 
124 
 
 
 
 
 
 
 
 
 
 
4. Chapter 4 – Changes in lipid composition 
during overnight contact lens wear 
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4.1 Introduction  
The aim of the work discussed in this chapter was to investigate the 
changes in lipid structure during overnight contact lens wear.  GCMS was 
used for the separation of individual fatty acids and HPLC was used for 
individual lipid class separation.   
PureVision (PV) and Focus Night & Day (F.N&D) lenses were harvested 
from a clinically controlled study.  The clinical study involved 43 subjects 
wearing either PV or F.N&D lenses for 30 days on a daily wear or 
continuous wear schedule.  Those subjects wearing lenses on a daily 
wear schedule wore the lenses throughout the day and used OptiFree 
Express for disinfection of the lens.  The subjects wearing lenses on a 
continuous wear schedule wore the lenses for 30 days and nights.  The 
study details are outlined in Appendix 4.   
GCMS and HPLC were used to investigate the changes in the structure of 
lipids deposited on lenses as a function of wear schedule.  GCMS was 
chosen for the analysis of lens extracts because of its ability to separate 
and identify individual fatty acid profiles for single lens extracts (shown in 
Chapter 3).  The length and unsaturation of the fatty acid moieties for 
individual lipid classes can dictate the susceptibility to oxidation (Table 
1.2).  The analysis of single lens extracts was important because 
individual subject variability in lipid deposition could be monitored.  It has 
been demonstrated in Chapter 3 that a single lens can be extracted, 
transmethylated and the individual fatty acids separated and identified by 
GCMS.   
During initial method development stages, the analysis of certain lens 
extracts revealed differences in fatty acid profiles relating to wear 
schedule.  The work presented in this chapter, therefore, elaborates on 
these initial findings and provides further evidence that there are changes 
in fatty acid profiles for lenses that are worn for different wear schedules.   
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HPLC separation was used to investigate whether there were any 
differences in individual lipid classes between lenses worn for different 
wear schedules, different lens materials and subject-subject variability.    
 
Figure 4.1 – The variable factors discussed throughout Chapter 4 
 
Figure 4.1 shows the many variables that were investigated throughout 
this chapter such as wear schedule, lens material, extraction protocol and 
length of wear.   
4.1.1 Lens material – PureVision and Focus Night and Day 
The two lens materials harvested from a clinically controlled study were 
PureVision (PV) and Focus Night & Day (F.N&D).   They are both 
approved by the FDA to be worn on a daily wear and continuous 
(overnight) wear schedule.  The properties of both of these lenses are 
discussed in Chapter 1 (section 1.7.2).  Briefly, they are both surface-
treated silicone hydrogel materials.  PV lenses are known for high levels of 
lipid deposition because not only are they silicone hydrogels but they also 
contain the monomer NVP.    
4.1.2 Wear schedule – Daily wear or continuous wear  
Lenses were worn by subjects on a continuous wear (overnight) or daily 
wear schedule.  Those subjects wearing lenses on a daily wear schedule 
used OptiFree Express for disinfection of their lenses.  The lenses were 
collected from individuals after wear and stored at 4°C until required for 
analysis in vials that contained saline.   
4.1.3 Length of wear – 7 days or 30 days 
The study involved subjects wearing lenses for a 30 days period.   
However, a smaller study involving two subjects wearing lenses for 7days 
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was carried out (section 4.2.6).  Only two subjects were recruited for this 
part of the work because it was difficult finding subjects to wear lenses on 
a continuous wear schedule.   
4.1.4 Extraction protocol – single extraction or double extraction 
To investigate whether a change in extraction protocol affected the levels 
or composition of lipids extracted, lenses were extracted using either:  
- extraction protocol 1: single extraction in 1.5ml 1:1 chloroform: 
methanol),  
- extraction protocol 2: single extraction in 600µl 1:1 chloroform: 
methanol) 
- extraction protocol 3: double extraction in 1.5ml 1:1 chloroform: 
methanol) 
- extraction protocol 4: double extraction in 600µl 1:1 chloroform: 
methanol) 
4.1.5 Subject-to-subject variability  
To investigate subject-to-subject variation in lipid profiles several subjects 
lenses were analysed.   
4.1.6 Analytical technique – GCMS and HPLC 
Lens extracts were analysed by GCMS for fatty acid separation and HPLC 
for general lipid class separation.   
4.2 Results and analysis 
Representative gas chromatograms of both daily wear and continuous 
wear PV lens extracts are shown in Figure 4.2.  Although many subjects 
lenses were extracted and analysed, the gas chromatograms were similar 
for all; however, ratios of saturated to unsaturated lipids differed from 
subject-to-subject.  Therefore, representative gas chromatograms for both 
daily wear and continuous wear PV and F.N&D lenses are displayed in 
this chapter (Figure 4.2 and Figure 4.3 respectively) and all other 
additional gas chromatograms are shown in Appendix 5 and 6. The gas 
chromatograms shown in Appendix 5 represent additional traces for 
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continuous wear and daily wear PV lens extracts that had been worn by 
various subjects.  The gas chromatograms shown in Appendix 6 represent 
additional traces for continuous and daily wear F.N&D lenses extract that 
had been worn by various subjects.   
To ensure complete separation of individual fatty acid species by GC, 
35mins elution time was chosen.  However the peaks of interest were 
observed between the retention times of 10mins to 20mins.  The retention 
times for the peaks of interest and corresponding fatty acids are shown in 
Table 3.2.   
4.2.1 Gas chromatograms of daily wear and continuous wear 
PV lens extracts-30 days wear 
Figure 4.2 shows gas chromatograms of continuous wear and daily wear 
PV lens extracts worn by two subjects.    Gas chromatograms of daily 
wear lens extracts clearly show both saturated and unsaturated lipids 
whereas continuous wear lens extracts do not.  These traces are 
representative of almost all of the PV lenses analysed, however ratios of 
unsaturated (for example C18:1) to saturated (for example C18:0) differed 
from subject-to- subject.  Additional gas chromatograms for the all other 
PV lens extracts are shown in Appendix 5.   
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Figure 4.2 – Gas chromatograms of PV lens extracts: 
Chromatogram 1 – Continuous wear PV lens extract (extraction protocol 
1) 
Chromatogram 2 – Continuous wear PV lens extract (extraction protocol 
3) 
Chromatogram 3 – Daily wear PV lens extract (extraction protocol 1) 
Chromatogram 4 – Daily wear PV lens extract (extraction protocol 3) 
 
The gas chromatograms in Figure 4.2 show: 
- A single extraction was efficient for lipid extraction as the fatty acid 
profiles for single vs. double extraction were the same 
- No unsaturated fatty acids were observed on GC traces representing 
continuous wear PV lens extracts (Chromatograms 1 and 2)  
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4.2.2 Gas chromatograms of daily wear and continuous wear 
F.N&D lens extracts-30days wear 
Figure 4.3 shows gas chromatograms of continuous wear and daily wear 
F.N&D lens extracts for two subjects.  These traces are representative of 
almost all of the F.N&D lenses analysed.  The gas chromatograms for the 
other F.N&D lenses analysed are shown in Appendix 6.     
 
Figure 4.3 – Gas chromatograms of F.N&D lens extracts where: 
Chromatogram 1 – Continuous wear F.N&D lens extract (extraction 
protocol 1) 
Chromatogram 2 – Continuous wear F.N&D lens extract (extraction 
protocol 3) 
Chromatogram 3 – Daily wear F.N&D lens extract (extraction protocol 1) 
Chromatogram 4 – Daily wear F.N&D lens extract (extraction protocol 3) 
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The gas chromatograms in Figure 4.3 show: 
- A single extraction was efficient for the extraction of lipids from 
F.N&D lenses as the fatty acid profiles for single and double 
extraction were the same 
- There were no unsaturated lipids observed on the GC traces 
representing continuous wear lenses (Chromatograms 1 and 2) 
- There was less gross lipid, therefore lower levels of C16:1 observed 
for F.N&D lens extracts compared with PV lens extracts 
4.2.3 GC results analysis – lenses worn for 30 days (Figure 4.2 
and Figure 4.3) 
4.2.3.1 Differences in fatty acid profiles relating to wear schedule 
One of the major variables in this chapter was the wear schedule of the 
lenses (Figure 4.1).  As previously stated, lenses were either worn on a 
continuous wear basis or a daily wear basis.  There were obvious 
differences in fatty acid profiles observed between lenses worn on a daily 
wear schedule compared to a continuous wear schedule.   
The gas chromatograms in Figure 4.2 (PV lens extracts) and Figure 4.3 
(F.N&D lens extracts) show clear differences in fatty acid profiles between 
lenses which were worn on daily wear schedule compared to those worn 
on a continuous wear schedule.   
In general, the chromatograms representing lens extracts worn on a 
continuous wear schedule (Figure 4.2 chromatograms 1 and 2; Figure 4.3 
chromatograms 1 and 2) showed no detectable levels of unsaturated fatty 
acids (no C16:1 and C18:1).  However, those lenses worn on a daily wear 
schedule (Figure 4.2 chromatograms 3 and 4; Figure 4.3 chromatograms 
3 and 4) showed both unsaturated and saturated fatty acids.  The 
differences in fatty acid profiles relating to wear schedule were also 
observed for the majority of lenses analysed (additional chromatograms 
shown in Appendix 5 and Appendix 6).   
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4.2.3.2 Differences in fatty acid profiles related to contact lens material 
The major difference observed between PV and F.N&D GC traces were 
the levels of lipid deposition.  The intensities of the peaks for PV lens 
extracts were higher than F.N&D lens extracts.   
Table 4.1 – Comparison in C16:0 concentration between ex vivo PV and 
F.N&D lenses 
Lens material Peak identity Peak intensity 
Concentration of 
fatty acid 
PureVision (PV) C16:0 (12.8mins) 2.5MCounts 1.0x10-3mg/ml 
Focus Night & Day 
(F.N&D) 
C16:0 (12.8mins) 150kCounts 0.9x10-4mg/ml 
 
The peak height for the C16:0 (12.8mins) in Figure 4.2, chromatogram 3 
(daily wear PV lens extract) is approximately 2.5MCounts, equivalent to 
1.0x10-3mg/ml.  However, the peak height for the C16:0 (12.8mins) in 
Figure 4.3, chromatogram 3 (daily wear F.N&D) is 150kCounts equivalent 
to 0.9x10-4mg/ml.  Because of the difference in overall lipid deposition 
between PV and F.N&D lenses, the levels of individual lipids was also 
lower.  The C16:1 peak (usually observed at 12.6mins) was not observed 
for daily wear F.N&D.   
4.2.3.3 Extraction procedure variable 
Figure 4.2, chromatograms 1 and 2 represent continuous wear PV lens 
extracts for one subject.  One lens was extracted using extraction protocol 
1 (single 1:1 chloroform: methanol extraction) and the other lens was 
extracted using extraction protocol 3 (double 1:1 chloroform: methanol 
extraction).  To ensure the majority of lipids were extracted, a double 
extraction was used.  Both chromatograms 1 and 2 showed two 
predominant peaks at 12.8mins and 15.0mins.  They were identified as 
C16:0 and C18:0 respectively by their retention time and mass spectra.      
Figure 4.2, chromatograms 3 and 4 represent daily wear PV lens extracts 
for one subject.  Again, one lens was extracted using extraction protocol 1 
(single extraction) and the other was extracted using extraction protocol 3 
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(double extraction).  Both chromatograms looked identical, which again 
proved that a single extraction was effective for the removal of the majority 
of the lipid.   Both chromatograms 3 and 4 showed peaks at 10mins, 
11.5mins, 12.5, 12.8mins, 14.8mins and 15.0mins.  These peaks were 
identified as C14:0 (at 10.33mins), C16:1 (at 12.5mins), C16:0 (at 
12.8mins), C18:1 (at 14.8mins) and C18:0 (at 15.0mins) from their 
retention times and their mass spectra (shown in Chapter 3, section 
2.10.7).   
There was no difference in fatty acid profile relating to extraction protocol 
for the both the PV or the F.N&D lenses analysed (Figure 4.3 and 
Appendix 6).   
4.2.4 Daily wear and continuous wear PV and F.N&D, 30days 
wear:  Summary 
The fatty acid profiles for continuous wear and daily wear lens extracts 
were very different from each other (as seen in Figure 4.2 and Figure 4.3).  
This was regardless of contact lens material or extraction protocol used.  
PV and F.N&D lenses have very different properties.  The two lenses differ 
in equilibrium water content (EWC); PV lenses have an EWC of 35% and 
F.N&D of 24%.  They are both silicone hydrogel lenses that have been 
surface treated in two different ways.  Both lenses have different surface 
properties to one another because of the method of surface treatment.  PV 
lenses are known for higher levels of lipid deposition compared with 
F.N&D lenses.  Although PV and F.N&D lenses have different 
characteristics, the variations in fatty acid profile between continuous wear 
and daily wear lens extracts were still observed.  There were no 
unsaturated lipids observed on the gas chromatograms representing 
lenses worn on a continuous wear schedule.  
From the gas chromatogram shown in Figure 4.2 and Figure 4.3, it was 
concluded that the lenses worn on a continuous wear schedule had little to 
no unsaturated lipids on the lens compared to the lenses worn on a daily 
wear schedule.  Further analysis of other subjects lens extracts was 
carried out in order to prove that the differences in fatty acid profiles 
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between daily wear and continuous wear lipid deposits were as result of 
wear schedule and not material or extraction procedure.  Even with a 
double extraction, there were no detectable levels of unsaturated lipid 
observed.    
The gas chromatograms representing PV and F.N&D lens extracts from 
various subjects are shown in Appendix 5 and Appendix 6.  For the 
majority of lens extracts analysed, unsaturated lipids were not present on 
lenses that were worn on a continuous wear basis.  The lenses worn on a 
continuous wear schedule had been worn overnight.  The composition of 
tear components in the overnight tear film is very much different in the 
open eye.     However, this has never previously been studied because it 
is difficult to obtain a ‘true’ overnight tear sample.  The work discussed in 
this chapter used the contact lens as a tear sampling tool and it provided a 
snapshot of the overnight tear film.   
4.2.4.1 PV and F.N&D continuous and daily wear results: Key 
observations 
The main observations from GC analysis of 30 days continuous and daily 
wear PV and F.N&D lens extracts (Figure 4.2 and Figure 4.3) are listed 
below:  
- The most significant finding was that there were no unsaturated lipids 
observed on the GC traces of continuous wear lens extracts  
- the differences in fatty acid profile relating to wear schedule was 
seen for both lens materials even though they have such different 
properties 
- the difference in fatty acid profile relating to wear schedule was 
observed even when the lens was extracted for a second time (i.e. 
using extraction protocol 3 – double extraction)  
- there was less gross lipid extracted from F.N&D lenses which 
resulted in less C16:1 extracted from daily wear lenses 
- a single extraction was efficient for the extraction of lipids from daily 
wear and continuous wear PV and F.N&D lenses 
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All of the evidence collected for lenses worn for 30 days shows that 
unsaturated lipids degrade during overnight wear of lenses.  However, 
these lenses were worn for 30 days and nights.  Would this degradation 
occur on lenses worn for a shorter time period?  To try to answer this 
question, subject were recruited and they wore PV and F.N&D lenses for 7 
days, again either on a daily wear schedule or a continuous wear 
schedule.  The results are discussed in the next section. 
4.2.5 Gas chromatograms of PV lens and F.N&D lens extracts 
worn for 7 days 
To establish whether degradation of unsaturated lipids occurs after a 
shorter wear period than 30 days, subjects wore lenses for 7days.  Again 
PV and F.N&D lenses were worn on both a daily and continuous wear 
schedule.  However, only two subjects were recruited for this study and 
Subject 1 was only able to wear the PV lens material.   
The gas chromatograms in Figure 4.4 to Figure 4.6 represent both PV and 
F.N&D lens extracts worn for 7 days on a continuous and daily wear basis. 
All of the lenses collected were extracted using extraction protocol 1 
(single extraction) as previous work had established it was an effective 
extraction procedure.  Due to the small number of subjects recruited to 
wear lenses for 7days, lenses were analysed by only GCMS and not 
HPLC.   
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Figure 4.4 – Gas chromatograms of 7 days wear PV lens extracts 
(SUBJECT 1) where: Chromatogram 1 – Continuous wear PV lens extract 
(extraction protocol 1) and Chromatogram 2 – Daily wear PV lens extract 
(extraction protocol 1) 
 
 
Figure 4.5 – Gas chromatograms of 7 day wear F.N&D lens extracts 
(SUBJECT 2) where: Chromatogram 1 – Continuous wear F.N&D lens 
extract and Chromatogram 2 – Daily wear F.N&D lens extract 
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Figure 4.6 – Gas chromatograms of 7 day wear PV lens extracts 
(SUBJECT 2) where: Chromatogram 1 – Continuous wear PV lens extract 
(extraction protocol 1) and Chromatogram 2 – Daily wear PV lens extract 
(extraction protocol 1) 
 
4.2.6 GC results analysis – lenses worn for 7 days 
The gas chromatograms representing Subject 1, daily wear and 
continuous wear PV lens extracts are shown in Figure 4.4.  There were 
low levels of unsaturated fatty acids (18:1 in particular) extracted from 
Subject 1 continuous wear PV lenses.  The intensity of the C18:1 is 
60kCounts which is equivalent to 5.71x10-5mg/ml (for continuous wear PV 
extract).  The concentration of the C18:1 peak for Subject 1, daily wear PV 
lens extract (Figure 4.4, chromatogram 2) was determined to be     
5.75x10-5mg/ml.   Therefore, a similar concentration of C18:1 was 
extracted from both the continuous and daily wear lenses for Subject 1 
(shown in Table 4.2).    
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Table 4.2 – Analysis of subject 1, PV, daily wear vs. continuous wear GC 
traces (shown in Figure 4.4) 
Wear schedule Peak identity 
Peak 
intensity 
Concentration of fatty 
acid 
Continuous 
wear 
C18:1 
(15.0mins) 
~60kCounts 5.71x10-5mg/ml 
Daily wear 
C18:1 
(15.0mins) 
~60kCounts 5.75x10-5mg/ml 
 
However, the gas chromatograms for Subject 2 continuous wear PV lens 
extract showed no detectable levels of unsaturated lipid (Figure 4.6, 
chromatogram 1).  However, the concentration of C18:1 extracted from 
Subject 2, daily wear PV lens extract (Figure 4.6, chromatogram 2) was 
approximately 1.89x10-4mg/ml.  The amount of C18:1 extracted from 
Subject 2 daily wear PV lens was higher than the amount extracted from 
Subject 1 daily wear PV lens.  This showed subject-to-subject variability in 
the levels of lipid deposition.   
The gas chromatograms for Subject 2 continuous wear and daily wear 
F.N&D lens extracts are shown in Figure 4.5.  The gas chromatogram of 
Subject 2 continuous wear F.N&D lens extract did not show peaks 
corresponding to unsaturated fatty acids (i.e. no peaks corresponding to 
C18:1 and C16:1).  However, the concentration of C18:1 extracted from 
the daily wear F.N&D lens (Figure 4.5, chromatogram 2) was determined 
to be 1.06x10-4mg/ml (shown in Table 4.3).    
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Table 4.3 – Analysis of subject 2, PV and F.N&D, daily wear vs. 
continuous wear GC traces (shown in Figure 4.5 and Figure 4.6) 
Wear 
schedule 
Lens 
material 
Peak 
identity 
Peak intensity 
Concentration 
of fatty acid 
Continuous 
wear 
PureVision 
(PV) 
C18:1 
(15.0mins) 
Below lower 
limit of 
detection 
Below lower 
limit of 
detection 
Daily wear 
PureVision 
(PV) 
C18:1 
(15.0mins) 
~200kCounts 1.89x10-4mg/ml 
Continuous 
wear 
Focus Night 
& Day 
(F.N&D) 
C18:1 
(15.0mins) 
Below lower 
limit of 
detection 
Below lower 
limit of 
detection 
Daily wear 
Focus Night 
& Day 
(F.N&D) 
C18:1 
(15.0mins) 
~130kCounts 1.06x10-4mg/ml 
 
4.2.6.1 Summary 
- the results in Figure 4.4 to Figure 4.6 suggested that degradation of 
unsaturated fatty acids was subject-dependent in this first week of 
wear  
- the unsaturated fatty acids had fully degraded on one subjects 
continuous wear lens extracts (Figure 4.5), but not for the other 
subject 
- degradation had occurred for the majority of 30 days wear lens 
extracts analysed (see Figure 4.2 and Figure 4.3).  Degradation 
during the first week of wear seemed subject-dependent 
- ratios of lipids classes differ from subject-to-subject; therefore rate of 
lipid deposition on lenses will also vary   
- the extent of degradation after 7 days continuous wear will therefore 
depend on the rate of lipid deposition, this is ultimately subject 
dependant 
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Overall, GCMS proved to be a very useful technique for the analysis of 
changes in fatty acid profiles from contact lens extracts.  It clearly showed 
changes in fatty acid profiles from those lenses worn on different wear 
schedules.  GCMS was very useful as it provided information about the 
fatty acid moiety.   
4.3 Normal phase HPLC results: daily and continuous 
wear PureVision and Focus Night and Day lens extracts 
HPLC was used to provide information about the lipid classes.  GCMS 
analysis of daily wear and continuous wear lens extracts had shown 
significant differences in fatty acid profiles relating to wear schedule.  
Therefore, normal phase separation was used to investigate whether there 
were any differences observed in lipid class profiles between daily wear 
and continuous wear lens extracts.  To examine whether a second 
extraction would remove more lipid, extraction protocol 3 (double 
extraction in 1:1 chloroform: methanol 1.5ml) was used for certain lenses.   
The HPLC column, mobile phase and flow rate details were described in 
section 2.10.4.  In brief; a normal phase column was used, the mobile 
phase consisted of hexane: isopropanol: acetic acid (1000: 5: 1 v/v) and 
the flow rate was set at 1ml/min.  The UV wavelengths selected were at 
205nm, 254nm, 280nm and 360nm.  An excitation wavelength of 360nm 
and emission wavelength of 440nm were set on the fluorescence detector.   
4.3.1 Normal phase HPLC separation results: continuous wear 
and daily wear PureVision lens extracts (extraction protocol 1) 
The HPLC traces, shown in Figure 4.7 and Figure 4.8 represent 
continuous wear and daily wear PV lens extracts respectively.  These 
lenses were extracted using extraction protocol 1 (1.5ml 1:1 chloroform: 
methanol for at least 30mins).   
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Figure 4.7 – HPLC trace of a daily wear PV lens extract (Subject 61) 
 
 
Figure 4.8 – HPLC trace of a continuous wear PV lens extract (Subject 56) 
The HPLC trace in Figure 4.7 represents a daily wear PV lens extract.  
The peaks observed for this particular subject’s daily wear lens extract 
correspond to CEs, TGs, DGs, FFAs and cholesterol.   
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The HPLC traces in and Figure 4.8 represent a continuous wear PV lens 
extract.  The peaks observed for this particular subject’s continuous wear 
PV lens extract correspond to CEs, TGs, DGs, FFAs and cholesterol.  
Particular lipids classes such as cholesterol and cholesteryl esters have 
natural fluorescence, therefore fluorescence spectra are shown.  The 
fluorescence spectra for the continuous wear lens extract (Figure 4.8) 
shows strong peak at 6.5mins.  The retention time of this peak did not 
correspond to retention time of cholesteryl esters or cholesterol.  Also due 
to the intensity of the peak, it suppressed all other peaks.  This peak was 
not observed for all lens extracts analysed by HPLC, but it was observed 
for certain subjects lens extracts.  It was therefore concluded that this 
peak corresponded to an unknown extractable component from particular 
subject’s lenses.  This peak did not correspond to extractable material 
from the lens as unworn PV and F.N&D lens extracts did not produce a 
fluorescence signal. 
There were clear observable differences in lipid profile between the two 
lens extracts analysed in Figure 4.7 and Figure 4.8.  The differences did 
not correspond to differences in wear schedule.  The peaks representing 
the major lipid classes (CE, TGs, DGs, FFAs, cholesterol) were all 
present, although the ratios of each differed which is due to subject-to-
subject variability in lipid deposition.   
HPLC was used for the analysis of various subjects PV lens extracts and 
the traces are shown in Appendix 7.  It can be seen from the HPLC traces 
displayed in Appendix 7 that there are no clear differences in lipid class 
profiles for lens extracts relating to wear schedule (daily wear vs. 
continuous wear).  The majority of the lenses analysed showed peaks that 
corresponded to the major tear lipid classes such as cholesteryl esters, 
TGs, FFAs and cholesterol.  However, the ratios of lipid classes differed 
from subject-to-subject.   
The HPLC traces shown in Appendix 7 were obtained using the same 
column and column conditions as the results shown in Figure 4.7 to Figure 
4.12 .  However, the column was removed and the same column replaced.  
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The HPLC traces in Appendix 7 were all obtained after the column had 
been replaced.  Fresh lipid standards were used to re-calibrate the column 
to ensure all peaks were correctly identified.  The peak that corresponds to 
cholesterol eluted at approximately 16-18mins in Figure 4.7 to Figure 4.12 
(before the column change), but eluted at 7-9mins in the HPLC traces 
shown in Appendix 7 (after the column change).  Again, there were no 
significant differences in lipid profiles for relating to a change in wear 
schedule, although there were subject-to-subject differences.   
4.3.1.1 Figure 4.7 and Figure 4.8: Summary 
- There were no observable differences in lipid profiles relating to   
wear schedule (daily wear vs. continuous wear) for the PV lens 
extracts 
- However, the differences in the ratios of lipid profiles was subject-
dependent 
- The peak at 6.5mins (Figure 4.8, fluorescence signal) did not 
correspond to lipids or extractable material from the lens, it was 
subject-dependent.     
4.3.2 Normal phase HPLC separation results: continuous wear 
and daily wear extracts (extraction protocol 4) 
Extraction protocol 4, 1:1 chloroform: methanol (600μl) was used to 
investigate whether extracting in a smaller volume of solvent would 
improve the extractability of lipids from lenses.   The vials were also 
vortexed to try and improve the extraction of lipids which were absorbed 
within the lens matrix.  The HPLC traces shown in Figure 4.9 to Figure 
4.12 represent PV lens extracts which were extracted using extraction 
protocol 4.  Extraction protocol 4 was either a single or double extraction in 
1:1 chloroform: methanol (600μl), as outlined in sections 2.6.2 and 2.6.3.    
The first and second extracts were analysed separately to investigate 
whether: a) lipids were extracted by a second extraction and b) whether 
there was a difference in lipid classes extracted by a first extraction 
compared to a second extraction.   
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Figure 4.9 – HPLC trace of a continuous wear PV lens extract (extraction 
protocol 4, 1st extract) (subject 24) 
 
 
Figure 4.10 – HPLC trace of a continuous wear PV lens extract (extraction 
protocol 4, 2nd extract) (subject 24) 
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4.3.2.1 Analysis of HPLC traces in Figure 4.9 and Figure 4.10 (continuous 
wear PV, single vs. double extraction) 
The HPLC traces shown in Figure 4.9 represent the first extraction of a 
continuous wear PV lens.  The peaks corresponded to CEs, FFAs and 
free cholesterol (at 2.1, 12.01 and 17.0mins respectively).  The peak which 
corresponds to FFAs (at 12.01mins) is the predominant peak, with an 
intensity of ~100mAU which is equivalent to approximately              
3.67x10-3moldm-3.  The predominant peak seen for most lens extracts 
corresponds to cholesteryl esters.  However, for this particular subject, the 
peak corresponding to FFAs was the most predominant.  This again 
demonstrates that the ratios of individual lipid classes vary from subject-to- 
subject.   
The traces shown in Figure 4.10 represent the second extraction of the 
same continuous wear PV lens (as in Figure 4.9).  The trace at 205nm 
shows peaks that correspond to CEs, TGs, DGs and FFAs (at 2.1, 3.5, 4.5 
and 11.9mins respectively).  However, all peaks had lower intensities than 
the peaks on the HPLC traces of the first extract (100mAU first extract 
compared to 17.5mAU from the second).  This showed that the first extract 
was successful for the extraction of the majority of the lipid in this case.  
The concentration of cholesteryl esters extracted in the second extract 
was 1.32x10-4moldm-3. This was significantly lower than in the first extract.  
For this particular lens, the first extract was effective for the removal of the 
majority of the lipid; however a second extract did still extract a lower 
amount of lipid. 
 
 
 
 
146 
 
Table 4.4 – Analysis of HPLC traces in Figure 4.9 and Figure 4.10 
(continuous wear PV, single vs. double extraction) 
Extract 
Peak 
retention 
time (mins) 
Peak identity 
Peak 
height 
Concentration 
1st extract 12.0 FFAs ~100mAU 3.67x10-3moldm-3 
2nd extract 2.1 CEs ~16mAU 1.32x10-4moldm-3 
 
 
Figure 4.11 – HPLC trace of a daily wear PV lens extract (extraction 
protocol 4, 1st extract) (subject 51) 
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Figure 4.12 – HPLC trace of a daily wear PV lens extract (extraction 
protocol 4, 2st extract) (subject 51) 
   
4.3.2.2 Analysis of HPLC traces in Figure 4.11 and Figure 4.12 (daily wear 
PV, single vs. double extraction) 
The HPLC traces shown in Figure 4.11 represent the first extraction of a 
daily wear PV lens.  The peaks at 2.1, 3.7, 10.1, 17.3mins (at 205nm) 
correspond to CEs, TGs, FFAs and cholesterol respectively.  The peak 
that corresponds to CEs had a very strong absorbance of ~400mAU, 
which is equivalent to 8.49x10-3moldm-3.  CEs also had a fluorescence 
absorbance at 3.1mins.   
The HPLC trace of the second extraction of the same lens showed peaks 
representing CEs, TGs and cholesterol (Figure 4.12).  The peak that 
corresponds to CEs (at ~2.1mins) had a strong absorbance of ~100mAU, 
which is equivalent to 1.08x10-3moldm-3.  This showed that a single 
extraction was not effective for the removal of the majority of the lipids in 
this case.  This particular subject deposited high levels of non-polar lipids 
on the lens after 30 days daily wear.   
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Table 4.5 – Analysis of HPLC traces in Figure 4.11 and Figure 4.12 (daily 
wear PV, single vs. double extraction) 
Extract 
Peak 
retention 
time (mins) 
Peak identity 
Peak 
height 
Concentration 
1st extract 2.1 CEs ~400mAU 8.49x10-3moldm-3 
2nd extract 2.1 CEs ~100mAU 1.08x10-3moldm-3 
 
4.3.2.3  Figure 4.9 to Figure 4.12: Summary 
- A single extraction using extraction protocol 4 was not efficient at 
removing most of the lipid in the first extract 
- There was a considerable amount of CEs extracted in the second 
extract (shown in Figure 4.11 and Figure 4.12) 
- There was still no observable difference in lipid profiles relating to  
wear schedule for PV lenses using different extraction protocols 
- Extraction protocol 1 was used for all future extractions 
4.3.3 HPLC results of daily wear and continuous wear F.N&D 
lens extracts for various subjects 
Daily wear and continuous wear F.N&D lenses were analysed by GCMS, 
they were therefore also analysed by normal phase HPLC.  Daily wear 
and continuous wear PV lenses were analysed by normal phase HPLC 
and no differences in lipid profiles relating to wear schedule were 
observed.   Figure 4.13 to Figure 4.14 represent HPLC traces of both 
continuous and daily wear F.N&D lens extracts worn by two different 
subjects.   
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Figure 4.13 – HPLC traces of a daily wear F.N&D lens extract (extraction 
protocol 1) (subject 33) 
 
 
 
Figure 4.14 – HPLC traces of a continuous wear F.N&D lens extract 
(extraction protocol 1) (subject 38) 
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The HPLC separation of daily wear and continuous wear F.N&D lenses 
did not show any significant differences in lipid profile between relating to 
wear schedule.  However, there was definite subject-to-subject variability 
observed.  
The HPLC traces in Figure 4.13 represent a daily wear F.N&D lens 
extracts for worn by one particular subject.  The predominant peaks 
observed on the chromatogram correspond to CEs and FFAs (at 1.7mins 
and 6.6mins).  The concentration of CEs extracted from this particular 
daily wear F.N&D lens was 1.15x10-3moldm-3.  The concentration of FFAs 
extracted was 5.07x10-3moldm-3.  CEs were the most predominant lipid 
class extracted from the majority of lenses analysed.   Many other F.N&D 
lens extracts that had been worn by various subjects were analysed by 
HPLC, the results are shown in Appendix 8.   
The HPLC traces in Figure 4.14 represent a continuous wear F.N&D lens 
extract worn by one particular subject.  The predominant peak at 1.7mins 
corresponds to CEs (equivalent to 9.64x10-4moldm-3).  Various other 
subjects continuous wear F.N&D lens extracts were analysed by HPLC 
and the traces are shown in Appendix 8.  There were no differences in 
lipid class profiles between relating to wear schedule.  The same general 
lipid classes were observed for all F.N&D lens extracts, such as CEs, TGs, 
FFAs and cholesterol.  However, subject-to-subject variability in the ratios 
of individual lipid classes were observed.   
Table 4.6 – Analysis of HPLC traces in Figure 4.12 and Figure 4.13 
Wear 
schedule 
Peak 
retention 
time (mins) 
Peak identity 
Peak 
height 
Concentration 
Daily wear 1.7 CEs ~70mAU 1.15x10-3moldm-3 
Continuous 
wear 
1.7 CEs ~50mAU 9.64x10-4moldm-3 
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4.3.3.1 Figure 4.13 and Figure 4.14: Summary 
- There were no observable differences in lipid profile between daily 
wear and continuous wear F.N&D lens extracts relating to wear 
schedule 
- Subject-to-subject variability in individual lipid profiles were observed 
- For the majority of F.N&D lens extracts analysed, the predominant 
peak for both daily wear and continuous wear F.N&D lenses 
corresponded to CEs 
4.4 Discussion and overall observations 
The overall observations from the GCMS results of various lens extracts 
were: 
- there were no unsaturated fatty acids in the extracts of the majority of 
continuous wear lens extracts, regardless of lens material, subject-to-
subject variability in lipid deposition and extraction procedure 
- ratios of unsaturated to saturated lipids did vary from subject-to- 
subject (for daily wear lens extracts only) 
- a single extraction was effective for the removal of the majority of 
lipids deposited on and in the lens matrix (above 90%) 
- initial results for lenses worn for a 7day period showed degradation 
of unsaturated lipids for one subject and not the other, suggesting 
degradation is dependent on the individual wearing the lens 
The overall observations from HPLC results of various lens extracts 
showed: 
- subject-to-subject variation in ratios of individual lipid classes, 
however, these changes did not have any correlation with wear 
schedule 
- for certain lenses, a single extraction did not remove all lipid 
deposited on and within the lens matrix (Figure 4.10 and Figure 4.12) 
although the majority of GCMS traces suggested a single extraction 
was effective for lipid extraction 
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The GCMS results revealed that there were significant differences in fatty 
acid profile for lenses worn on a daily wear schedule compared to those 
worn on a continuous wear schedule for 30 days.  This could be seen in 
Figure 4.2 and Figure 4.3 which represent PV and F.N&D lens extracts 
respectively.  There were no peaks that corresponded to the major 
unsaturated tear fatty acids, C16:1 (at 12.5mins) and C18:1 (at 14.8mins) 
observed on gas chromatograms of continuous wear PV and F.N&D lens 
extracts (Figure 4.2, chromatograms 1 and 2; Figure 4.3, chromatograms 
1 and 2).  However, both unsaturated and saturated lipids were extracted 
from both lens materials that were worn on a daily wear schedule for 30 
days (observed in Figure 4.2, chromatograms 3 and 4; Figure 4.3, 
chromatograms 3 and 4). 
Additional gas chromatograms which represent daily wear and continuous 
wear PV lens extracts for various subjects are shown in Appendix 5. 
Additional gas chromatograms which represent daily wear and continuous 
wear F.N&D lens extracts for various subjects are shown in Appendix 6.  
For the majority of the lenses analysed, there were no unsaturated lipids 
on the lenses worn on a continuous wear schedule. This indicated that the 
unsaturated lipids had been degraded during overnight contact lens wear.    
This was the most significant finding of the research discussed in this 
chapter.  Changes in lipid structure during sleep have never been 
previously studied.  This work was therefore novel in showing that there 
are significant changes occurring in the overnight tear film to lipids.   
As mentioned in the introduction, the overnight tear film is stagnant which 
leads to increase in levels of certain tear components due to reduced tear 
flow.  Certain enzymes are believed to be responsible for the degradation 
of unsaturated lipids during eye closure.     
The preliminary results for the lenses worn for 7 days on either a daily 
wear schedule or a continuous wear schedule indicated that the 
degradation of unsaturated lipids on continuous wear lenses was subject- 
dependent.  Certain subjects gas chromatograms showed no detectable 
levels of unsaturated lipids after 7 days continuous wear.   However, other 
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subjects lens extracts showed there were still detectable levels of 
unsaturated lipid on the continuous wear lenses analysed (Figure 4.4 to 
Figure 4.6).  This was believed to be as a result of subject-to-subject 
variation in lipid deposition.  This work therefore clearly showed that 
unsaturated lipids degrade during overnight contact lens wear and that this 
degradation occurs at different rates.   
As well as using GCMS to investigate any possible differences in fatty acid 
profile, HPLC was used for individual lipid class separation.   
Many of the HPLC traces for the lens extracts analysed (daily wear and 
continuous wear) were similar to one another.  The use of GC enabled the 
analysis of individual fatty acid composition and the results showed 
significant differences between lenses worn daily to those worn 
continuously.  HPLC identified differences in ratio of different lipid classes, 
however, the differences observed had no correlation to wear schedule.  
The differences in lipid profiles observed varied from subject-to-subject.   
This chapter showed that there are significant differences in lipid profiles 
from contact lens extracts worn on two different wear schedules.  This 
chapter also showed that GCMS is a powerful technique which provided 
results that allowed these changes to be observed.  
The work discussed in this chapter showed the degradation of unsaturated 
lipids during overnight wear of contact lenses.   
The work discussed in Chapter 5 is therefore based on investigating the 
presence of lipid oxidative end products in tears and contact lens extracts.   
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5. Chapter 5 – Lipid oxidation and biomarkers 
of lipid oxidation 
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5.1 Introduction 
The presence of MDA in tears has previously been linked with contact lens 
intolerance (121).  The purpose of the work discussed in this chapter was 
to adapt existing methods, currently used for malondialdehyde (MDA) 
quantification in blood, urine and plasma samples to enable the 
measurement of MDA in the ocular environment.  As discussed in Chapter 
1 (section 1.11), MDA is a secondary product of lipid oxidation and is also 
a biomarker for lipid oxidation.  MDA is only produced from the oxidation of 
polyunsaturated fatty acids (e.g. C18:3); the scheme is shown in Figure 
1.29 (Chapter 1, section 1.11.1).  Although the most predominant fatty 
acid found in tears is C18:1 and polyunsaturated fatty acids (such as 
C18:3) are found at very low levels, MDA was chosen for analysis 
because it provides a measure of oxidation.  It is important to note that 
MDA can be produced from other sources such as carbohydrate oxidation.  
5.2 Assays and techniques 
Several commercially available assay test kits were adapted to enable the 
measurement of MDA in tear samples and contact lens extracts.   The 
assays used for MDA measurement were the thiobarbituric acid reactive 
substances assay (TBARS), MDA-specific assay (using N-methyl-2-
phenylindole) and ELISA-MDA assay (enzyme linked immunosorbant 
assay).  All of the assay kits were used in accordance to the individually 
supplied protocols.  Each of the assay protocols are described in Chapter 
2. 
Analytical techniques such as HPLC and capillary electrophoresis have 
been used for MDA analysis and have been discussed in the literature.  
Capillary electrophoresis has been used previously by Georgakopoulos et 
al.(151) for the measurement of MDA in tears, therefore a similar 
methodology was followed in this research.   
High performance liquid chromatography (HPLC) with fluorescence 
detection was used by Fukunaga et al. (134) to separate and quantify 
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levels of MDA in plasma samples.  The HPLC and capillary 
electrophoresis conditions are described in detail in Chapters 2.   
5.3 Sample acquirement 
Various samples were analysed by an array of assays and techniques in 
order to determine the location of MDA in the ocular environment.  Tear 
samples were collected from individual subjects using the microcapillary 
tear collection method.  Tear envelope samples (method described in 
section 2.4) were collected from stored lenses which were obtained from 
clinically controlled studies.  Tear envelope samples were also collected 
from freshly worn contact lenses.  Contact lens extracts that were 
extracted using various extraction protocols were also analysed.   
5.4 TBARS: method development, sample preparation 
and results 
5.4.1 Tear sample (TS) preparation 
Microcapillaries were used for the collection of tear samples from 
individuals throughout a day.  The tear samples were pooled together until 
the required volume of 100µl was obtained.  Certain subjects tear samples 
were up to 100µl with PBS.   
5.4.2 Tear envelope (TE) preparation 
Tear envelope samples were taken by the addition of 100µl of either water 
or PBS to the lens, centrifuging and the collection of the tear envelope 
sample (as described in Chapter 2, section 2.4).   
5.4.3 Contact lens preparation 
Worn contact lenses were extracted (for 2hrs) by using the standard 1:1 
chloroform: methanol protocol 1.  The extracts were then resuspended in 
200µl PBS for ready for analysis.   
The method was developed by the preparation of a calibration curve as 
described in the assay protocol (Chapter 2, section 2.11.1.1) and all 
unknowns were compared to this calibration curve.   
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5.4.4 TBARS assay preparation 
Briefly, MDA standards were prepared from the reaction of MDA (at 
different concentrations) with the TBA diluent at 95°C for 60 minutes.  The 
absorbencies of these standards were read at 532nm and a calibration 
curve was prepared.   All unknown samples were treated in the same way 
as MDA standard, and the absorbance values were compared to the 
standard curve.   
The concentrations of the standards are shown in Table 5.1 and the 
calibration curve is shown in Figure 5.1.   
5.4.5 TBARS calibration preparation data 
The standards for the calibration curve were prepared as described in 
Chapter 2, section 2.11.1.1.  The calibration curve data and standard 
curves are shown in Table 5.1, Figure 5.1 and Figure 5.2 respectively.   
Table 5.1 – Calibration curve data for MDA TBARS assay 
Concentration of MDA (µM) Absorbance of MDA at 532nm 
250 2.693 
125 1.413 
62.5 0.745 
31.25 0.383 
15.63 0.195 
7.81 0.095 
3.91 0.050 
1.95 0.027 
0.98 0.012 
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Figure 5.1 – Standard curve of MDA standard using the TBARS assay at 
532nm UV absorbance 
 
 
Figure 5.2 – Standard curve of MDA using TBARS measured by 
fluorescence.  Excitation of 540nm and emission at 590nm 
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A linear standard curve of MDA standard measured at 532nm UV 
absorbance was achieved.  Known concentrations of MDA standard were 
also measured by fluorescence absorbance.  The calibration curve (Figure 
5.2) was as shown in the assay protocol.  All unknown samples were 
measured by UV absorbance at 532nm.    
5.4.6 TBARS results 
The values displayed in Table 5.2 are the preliminary results obtained by 
the TBARS assay.  The concentration of MDA in unknown samples was 
determined by using the calibration curve shown in Figure 5.1.  The 
samples analysed all showed low concentrations of MDA.  Tear samples 
were collected from individual subjects throughout a day and pooled 
together to achieve the volume required for this particular assay (100µl).  
Ex vivo PureVision lenses were extracted using extraction protocol 1 (1:1 
chloroform: methanol) and resuspended in 200μl PBS.   
Table 5.2 – Preliminary TBARS results 
Sample Values Results (µM) 
Tear sample (TS) subject 1 0.019 1.05 
Tear sample (TS) subject 2 0.029 1.91 
Tear envelope (TE) subject 3 0.024 1.50 
Tear sample (TS) subject 3 0.036 2.53 
(10x) worn PV lens extracts 1 0.241 19.81 
(10x) worn PV lens extracts 2 0.218 17.90 
Where: 100µl TS were collected and then pooled, TE from 2x ex vivo 
Focus Dailies lenses, 10xPV lenses extracted in 1:1 chloroform: methanol 
and resuspended in 200µl PBS 
The preliminary results obtained from the TBARS assay showed positive 
results for tear samples, TE samples and lens extracts. These results 
revealed that tear samples collected from certain subjects had higher 
levels of MDA than others.  As only three subjects tears were analysed by 
the TBARS assay, further work was required to determine the validity of 
this assay.  Therefore, more samples were collected including tear 
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samples, tear envelope samples and contact lens extracts.  They were all 
analysed by the TBARS assay and the results are shown Table 5.3 and 
Table 5.4.  The sample details are given below Table 5.3.   
Table 5.3 – TBARS results measured by UV absorbance at 532nm 
Sample Value Result (µM) 
Subject 1 TS LE -0.008 -1.21 
Subject 1 TS RE 0.021 1.25 
Subject 1 TS RE (repeat) 0.01 0.37 
Subject 2 TS LE 0.032 2.19 
Subject 2 TS RE 0.003 -0.28 
Subject 2 TS RE (repeat) 0.009 0.26 
Subject 3 TS LE 0.008 0.13 
Subject 3 TS RE 0.002 -0.31 
Subject 3 TS RE (repeat) 0.038 2.67 
Unworn Focus Dailies soaked in MDA, extracted in 
PBS (1) 
0.487 40.54 
Unworn Focus Dailies lens soaked in MDA with 
addition of BHT, extracted in PBS (1) 
0.485 40.37 
Unworn Focus Dailies lens soaked in MDA, 
extracted in PBS (2) 
0.564 46.99 
Unworn Focus Dailies lens soaked in MDA with 
addition of BHT, extracted in PBS (2) 
0.491 40.88 
Unworn Focus Dailies lens soaked in MDA, 
extracted in Renu (1) 
0.109 8.68 
Unworn Focus Dailies lens soaked in MDA with 
the addition of BHT, extracted in Renu (1) 
0.065 4.96 
Unworn Focus Dailies lens soaked in MDA, 
extracted in Renu (2) 
0.061 4.64 
Unworn Focus Dailies lens soaked in MDA with 
the addition of BHT, extracted in Renu (2) 
0.1 7.95 
MDA standard saline (1) 0.505 42.07 
MDA standard saline (2) 0.484 40.25 
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MDA standard saline BHT (1) 0.47 39.11 
MDA standard saline BHT(2) 0.61 50.90 
Where: TS LE/RE= pooled tear samples from right/left eye of subjects 1,2 
and 3.  Unworn Focus Dailies lens soaked in MDA standard overnight, 
extracted in PBS for 2hrs (with and without the addition of antioxidant 
butylated hydroxytoluene - BHT) and assayed.  MDA standard saline= 
2mg/ml MDA in PBS with/without BHT.  Unworn Focus Dailies lens 
soaked in MDA standard (2mg/ml) overnight, with or without BHT and 
extracted with multipurpose solution – Renu.   
The concentrations of the unknown samples in Table 5.3 were determined 
by using the calibration curve in Figure 5.1.  The concentration of MDA in 
tear samples showed variable results.  Some subjects showed positive 
values, however some subjects showed negative results.   
Focus Dailies lenses were soaked in MDA standard overnight and 
extracted in either PBS or Renu (contact lens multipurpose solution).  The 
extraction of MDA from contact lenses had not previously been studied in 
literature.  This work was therefore based on trying to find an effective 
extraction procedure and to establish the reproducibility of this assay.  The 
PBS and Renu extracts of lenses soaked in MDA standard showed 
positive results.  This means that both PBS and Renu were efficient for the 
extraction of MDA from lenses.  Renu was less efficient for the extraction 
of MDA from lenses because the concentration of MDA in Renu extracts 
was considerably lower than the PBS extracts.   
The results shown in Table 5.4 are the same samples as those shown in 
Table 5.3.  The fluorescence absorbance of the unknown samples was 
measured and the concentration of MDA determined from the calibration 
curve shown in Figure 5.2. 
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Table 5.4 – MDA TBARS results measured by fluorescence 
Sample Value Result (µM) 
Subject 1 TS LE 1.856 0.43 
Subject 1 TS RE 1.133 0.37 
Subject 1 TS RE (repeat) 0.95 0.36 
Subject 2 TS LE 1.68 0.42 
Subject 2 TS RE 1.855 0.43 
Subject 2 TS RE (repeat) 1.205 0.38 
Subject 3 TS LE 1.165 0.38 
Subject 3 TS RE 1.075 0.37 
Subject 3 TS RE (repeat) 1.418 0.40 
Unworn Focus Dailies lens soaked in MDA, 
extracted in PBS (1) 
128.60 14.48 
Unworn Focus Dailies lens soaked in MDA with 
the addition of BHT, extracted in PBS (1) 
127.00 14.32 
Unworn Focus Dailies lens soaked in MDA, 
extracted in PBS (2) 
150.56 18.04 
Unworn Focus Dailies lens soaked in MDA with 
the addition of BHT, extracted in PBS (2) 
128.40 14.46 
Unworn Focus Dailies lens soaked in MDA, 
extracted in Renu (1) 
29.12 3.05 
Unworn Focus Dailies lens, soaked in MDA with 
the addition of BHT, extracted in Renu (1) 
20.54 1.80 
Unworn Focus Dailies lens soaked in MDA, 
extracted in Renu (2) 
17.80 1.60 
Unworn Focus Dailies lens soaked in MDA with 
the addition of BHT, extracted in Renu (2) 
28.74 3.00 
MDA standard saline (1) 126.60 14.28 
MDA standard saline (2) 128.67 14.48 
MDA standard saline BHT (1) 135.80 15.19 
MDA  standard saline BHT (2) 133.38 14.95 
These samples were the same as those tested in Table 5.3 
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The tear samples all showed positive results for MDA as measured by 
fluorescence absorbance.  However, the concentration of MDA in the tear 
samples measured by fluorescence absorbance was higher than the same 
tear samples measured by UV absorbance.   The concentration of MDA 
from in vitro spoiled lenses was lower when measured by fluorescence 
absorbance compared with UV absorbance.  For example, the unworn 
Focus Dailies lens soaked in MDA, extracted in Renu showed an 
absorbance of 29.12 which was equivalent to 3.047μM MDA when 
measured by fluorescence absorbance.  However, the same sample 
measured by UV absorbance showed an absorbance of 0.109, equivalent 
to 8.675μM MDA.  As the results varied depending on the calibration curve 
used, the TBARS assay was not very accurate for the measure of MDA in 
the ocular environment.   
Also, according to the assay protocol a new calibration curve had to be 
prepared each time the assay was used.  The absorbance values for 
known concentrations of MDA standard varied each time they were 
measured, therefore the calibration curve varied.  This meant that the true 
concentration of MDA in unknown samples varied depending on the 
calibration curve used.  All unknown samples were therefore compared to 
one calibration curve (shown in Figure 5.1).  This assay was therefore not 
very accurate for the purposes of this research. 
5.4.7 TBARS assay results: Summary 
- the results obtained using the TBARS assay showed that MDA was 
present in some tear samples, however, this was not very accurate 
because the results depended on the calibration curve used 
- the assay protocol recommended a new calibration curve be 
prepared each time the assay was used, which altered the results 
- fluorescence absorbance of samples showed lower levels of MDA 
compared with UV absorbance 
- PBS was efficient at extracting MDA from lenses that had been 
soaked in an MDA solution in vitro 
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5.5 MDA – specific N-methyl-2-phenylindole (NMPI) 
assay results 
The assay methodology described in Chapter 2, section 2.11.2.1 was 
followed.   Briefly, a dilution series of tetramethoxypropane (TMOP, a MDA 
substitute), in the concentration range 0-4μM was prepared from the 
dilution of TMOP in water.  The concentration of MDA in unknown samples 
was determined from the calibration curve of TMOP standard.  The 
calibration curve is shown in Figure 5.3.   
5.5.1 Tear sample preparation 
Tear samples were taken using microcapillaries (described in chapter 2 
section 2.3) and either pooled together to obtain a final volume of 200µl 
required for the assay or made up to the final volume using PBS. 
5.5.2 Tear envelope sample preparation 
100µl PBS was placed on either side of the lens and the tear envelope 
collected.  This was made up the final volume of 200µl for analysis. 
5.5.3 Contact lens extracts preparation 
Single lenses were extracted in 500µl PBS for a minimum of 2 hours on a 
slow shaker and the extract was used directly for analysis. 
 
165 
 
 
Figure 5.3 – Calibration curve of TMOP standard using the MDA – specific 
assay UV absorbance at 572nm 
5.5.4 MDA-specific NMPI: Summary 
The assay protocol recommended reading the samples at a wavelength of 
586nm (maximum absorbance), however the calibration curve was not 
very linear.  Therefore, the standards were analysed at 572nm as this 
produced a linear calibration curve.  All of the samples were below the 
calibration range and this assay was not used for this research.   
5.6 MDA – ELISA 
This assay methodology was followed as described in Chapter 2, section 
2.11.3.  The sample volume required was 100µl.  The concentration of 
MDA in unknown samples was compared to the standard calibration curve 
(full assay details are described in Chapter 2).   
5.6.1 Tear sample preparation 
Tears that were collected using microcapillaries from individuals were 
pooled and analysed by the assay. 
5.6.2 Tear envelope sample preparation  
100µl PBS was added to the lens and centrifuged to collect the volume 
required for the assay (as described in section 2.4).    
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5.6.3 Contact lens extracts preparation 
Single contact lenses were extracted in 1:1 chloroform: methanol and 
resuspended in 100µl PBS for analysis by the assay.   
The results for various contact lens extracts, TE samples and TS are 
shown in Table 5.5.  The concentration of MDA in unknown samples was 
established from the calibration curve shown in Figure 5.4. 
 
 
Figure 5.4 – MDA-BSA ELISA standard curve, absorbance read at 450nm 
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Table 5.5 – The concentration of MDA in various samples (lens extracts, 
TS and TE samples) measured by the MDA – ELISA assay 
Sample Amount of MDA 
(pmol/ml) 
Stored Air Optix lens extract (using extraction protocol 
1, resuspended in PBS) 
21.0 
Fresh Air Optix lens extract (using extraction protocol 
1, resuspended in PBS) 
4.0 
Unworn Air Optix lens extract (using extraction 
protocol 1, resuspended in PBS) 
0.5 
Fresh Focus Dailies lens extract (using extraction 
protocol 1, resuspended in PBS) 
3.0 
Unworn Focus Dailies lens extract (using extraction 
protocol 1, resuspended in PBS) 
0.5 
Fresh PV lens extract (using extraction protocol 1, 
resuspended in PBS) 
1.0 
Unworn PV lens extract (using extraction protocol 1, 
resuspended in PBS) 
0.5 
Fresh Air Optix TE (pooled LE and RE using PBS) 1.0 
Focus Dailies TE (pooled LE and RE using PBS) 2.5 
PV TE (pooled LE and RE-using PBS) 0.7 
Pooled TS (using capillary collection method) 0.5 
 
The results shown in Table 5.5 represent various samples that were 
assayed using the MDA-ELISA technique.  Various samples including lens 
extracts, tear samples and tear envelope samples were analysed.   
The concentration of MDA in the TS analysed was very low (0.5ρmol/ml).  
MDA was extracted from worn lenses, with ex vivo stored Air Optix lens 
extracts showing higher levels of MDA than fresh lens extracts.  Unworn 
lens extracts were also analysed and these did not show significant levels 
of MDA.  Therefore, extractable material from the lens did not interfere 
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with the results.  The lenses were extracted using 1:1 chloroform: 
methanol extraction and the extracts were resuspended in PBS.   
MDA was also present in tear envelope samples.  PBS was used to obtain 
tear envelope samples from worn Air Optix, Focus Dailies and PureVision 
lenses.  The Focus Dailies TE sample showed the highest levels of MDA 
compared with the TEs of the other lenses.   
5.6.4 MDA-ELISA results: Summary  
- the highest levels of MDA were observed for stored Air Optix lens 
extracts 
- fresh lens extracts also showed significant levels of MDA 
- tear samples showed very low levels of MDA  
- this assay was the most sensitive assay of those tested 
- future work is required to validate this assay, however these initial 
findings were very interesting and unique 
5.7 Capillary electrophoresis with UV detection 
Capillary electrophoresis was used for MDA detection and the method 
conditions and parameters are described in Chapter 2, section 2.11.4.  A 
calibration curve was not obtained using capillary electrophoresis because 
a high concentration of MDA standard was required to produce a peak 
with a low intensity.  The capillary electrophoresis trace for MDA standard 
is shown in Figure 5.5.  Samples were not analysed using this method 
because a high concentration of MDA was required to produce a peak with 
low intensity.  Therefore this method was not sensitive enough for the 
purposes of this research.   
Georgokopoulos et al. (151) used capillary electrophoresis to separate 
and identify MDA in tear samples. A very similar method followed in this 
research; however the same results were not achieved.  Georgokopoulos 
et al. state their method has a lower limit of detection of 2.5μM MDA.  In 
this research, a 250μM MDA standard was separated by capillary 
electrophoresis and this produced a peak with very low intensity, as seen 
in Figure 5.5.  Georgokopoulos et al. were able to detect MDA in the tears 
169 
 
of 7 out of 11 healthy subjects; however the levels of MDA were below the 
lower limit of quantitation for all tear samples.   
Tear samples, tear envelope samples and contact lens extracts were not 
analysed using this method because it was not considered to be sensitive 
enough. 
 
Figure 5.5 – Capillary electrophoresis trace of MDA standard (250µM) 
5.7.1 Capillary electrophoresis results: Summary 
- although this method had been used for the detection of MDA in 
tears in the literature, similar results were not achieved in this 
research 
- MDA standards were separated by capillary electrophoresis but a 
high concentration of standard produced a peak of low intensity 
- this method was therefore not used for the analysis of MDA in 
unknown samples 
5.8 MDA-TBA HPLC with fluorescence detection results 
For this assay, 5µl of standard MDA or unknown samples were reacted 
with 100µl TBA buffer for 60 minutes at 95°C in eppendorfs.  These were 
then placed under cold water for 5 minutes and centrifuged for 15 minutes 
at 6600rpm.  The upper 750µl were transferred to amber vials for analysis 
by HPLC.  The column and mobile phase details were used as described 
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in Chapter 2, section 2.11.5.  Briefly, TEP (tetraethoxypropane), a MDA 
substitute, was reacted with 0.2% TBA buffer (prepared as described in 
2.11.5.1.1).  Dilution series of TEP over a range of concentrations was 
prepared by serial dilution of TEP in water (concentration range shown in 
Table 2.7).   All standards were separated by HPLC with fluorescence 
detection and the area under the peak that corresponded to TEP-TBA was 
measured (at approximately 2.4mins as shown in Figure 5.8 to Figure 
5.10).   Calibration curves of TEP (at various concentrations) were plotted 
(Table 5.6, Table 5.7, Figure 5.6 and Figure 5.7).  The concentration of 
MDA in unknown samples was determined from the calibration curves.  
Throughout this section both TEP and MDA are interchangeable. 
Table 5.6 – Calibration curve data for MDA measured by HPLC 
Concentration of MDA (µmol/ml) Area under peak at ~2.4 minutes 
0.625 21.97 
1.25 61.13 
2.5 111.92 
5.0 208.62 
10.0 412.12 
 
  
Figure 5.6 – Calibration curve for MDA measured by HPLC 
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Calibration curve of MDA at lower concentrations was also prepared and 
the curve is shown in Figure 5.7. 
Table 5.7 – Calibration curve data for MDA measured by HPLC at lower 
concentrations 
Concentration of MDA (nmol/ml) Area under peak at ~2.4mins 
0 0 
20 2.16 
30 2.18 
40 2.55 
50 2.98 
100 5.89 
200 10.09 
   
 
Figure 5.7 – Calibration curve for MDA measured by HPLC at lower 
concentrations 
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MDA-TBA peak (shown in Figure 5.11).  Unknown samples were also 
separated by HPLC and the traces are shown in Figure 5.11.   
 
Figure 5.8 – HPLC fluorescence scans for MDA-TBA adduct for 
concentrations of 10µmol/ml – 0.635µmol/ml TEP standard 
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Figure 5.9 – HPLC fluorescence scans for MDA-TBA adduct for 
concentrations of 200nmol/ml – 20nmol/ml TEP standard 
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Figure 5.10 – HPLC fluorescence scans for MDA-TBA adduct for 
concentrations of 10nmol/ml – 0.5nmol/ml TEP standard 
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Figure 5.11 – HPLC fluorescence scans for MDA-TBA adduct for unknown 
samples 
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Although this method was not sensitive enough to detect MDA in the 
samples tested, it was used for the measurement of MDA uptake and 
release from lenses.  This technique was chosen as it was a more cost 
effective method compared to the commercial assays and was a sensitive 
method and more accurate technique than the TBARS assay alone.   
5.8.1 HPLC with fluorescence detection results: summary 
- A linear calibration curve was prepared, with a lower limit of detection 
of 1nmol/ml 
- TBA buffer had an absorbance at a similar retention time to the MDA-
TBA buffer, it was therefore difficult to distinguish between the TBA 
buffer and MDA-TBA at low concentrations of MDA 
- The samples analysed did show an absorbance at ~2.4mins (Figure 
5.11), however the TBA buffer had an absorbance at the same 
retention time and a similar peak intensity 
- This method therefore lacked the sensitivity required to analyse MDA 
in the ocular environment 
- Unknown samples were therefore not analysed using HPLC, but 
HPLC was used to determine the levels of MDA uptake and release 
from various lenses because a linear calibration curve was 
established 
5.8.2 The use of HPLC to determine the uptake and release of 
MDA from contact lenses 
The principle of in vitro uptake and release of active species with particular 
contact lenses is well established.  However, the behaviour of MDA with 
any lens material has not been studied.   
MDA is a small molecule; it can therefore be absorbed into the lens matrix.  
The chemical structure of MDA suggests it is water soluble.  The in vitro 
uptake and release of MDA from various lenses was therefore 
investigated.   
The lenses chosen for investigation were PureVision (PV) and Acuvue 
Oasys (Oasys) as these lenses are known to adsorb high levels of lipid.  
177 
 
They are both silicone hydrogel materials but PureVision lenses have 
been surface treated whereas Acuvue Oasys lenses have not (as 
described in section 1.7.2).   
5.8.2.1 Preparation of solutions and reagents for the measurement of 
uptake and release of 1,1,3,3- tetraethoxypropane (TEP) from lenses: 
A stock solution of 10µmol/ml TEP (MDA substitute) solution was prepared 
by adding 24µl TEP to 10ml ethanol.  From the stock solution, 5μmol/ml 
and 100nmol/ml standard solutions were prepared by serial dilution in 
water.  Single lenses (either PV or Oasys) were soaked in 2ml of a 
5µmol/ml or a 100nmol/ml TEP solution.   
All lenses were blotted with filter paper to prevent packaging solution 
contamination prior to soaking in the TEP solutions. 
The lenses were added to 2ml of the two concentrations of TEP (5µmol/ml 
or a 100nmol/ml) in centrifuge tubes.  These were placed on a flat-bed 
shaker at 172rpm for 2hrs, 4hrs and 24hrs.  After 2hrs, 4hrs and 24hrs; 5µl 
of the TEP solution was transferred to a 1.5ml eppendorf.  1ml 0.2% TBA 
buffer was added to the eppendorfs and they were incubated for 60mins at 
95°C.  After the incubation, the eppendorfs were cooled in a water bath for 
approximately 5mins, vortexed and centrifuged at 12.5rpm for 15 minutes.  
The upper 750µl was transferred to amber vials and analysed by HPLC 
with fluorescence detection.   
The lenses that had been soaked in MDA solutions for different periods of 
time were transferred to new centrifuge tubes containing 1ml HPLC grade 
water to allow the release of MDA.  The tubes were left on a flat-bed 
shaker for 24 hours to release any MDA in the lens.  5µl aliquots of the 
release solution was taken from each tube and transferred to 1.5ml 
eppendorfs.  1ml 0.2% TBA buffer was added and the solution was heated 
for 60mins at 95°C.  The eppendorfs were cooled under cold water, 
vortexed and centrifuged at 12.5rpm for 15mins.  The upper 750µl was 
transferred to amber vials for HPLC with fluorescence detection analysis. 
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The HPLC traces for standard MDA-TBA over a range of concentrations 
are shown in Figure 5.8, Figure 5.9 and Figure 5.10.    
5.8.2.2 Results of the uptake and release of TEP from PureVision lenses 
measured by HPLC 
The data in Table 5.8 shows values for the area under the peak at 
2.4mins, corresponding to MDA-TBA complex.  PureVision lenses were 
soaked in individual 5μmol/ml MDA solutions.  The solutions were 
separated by HPLC with fluorescence detection after 0, 2, 4 and 24hours 
soaking and the area under the peak at 2.4mins (which represents MDA-
TBA complex) was measured for each solution.  The area under the peak 
for the release solutions were also measured.   
Table 5.8 – Absorbance values for MDA uptake and release for 
PureVision lenses from a 2ml solution of 5μmol/ml MDA over time 
Time 
(Hours) 
PureVision uptake from 5µmol/ml 
MDA solution (LU) (area under 
peak at 2.44mins) 
Repeat of 
‘uptake’ 
solutions 
Release 
after 24 
hours 
0 184.99 - - 
2 205.45 230.75 16.99 
4 228.52 281.66 14.09 
24 145.25 366.02 14.17 
 
The results shown in Table 5.8 demonstrated many things.  Firstly, the 
absorbance value for the uptake solution after 0hours soaking was higher 
than the absorbance value after 24hours soaking (Table 5.8). These 
results suggested MDA was not absorbed by the lenses, even after 24 
hours of soaking in a 5μmol/ml MDA solution.  The HPLC separation of the 
uptake solutions was repeated and these solutions produced significantly 
different results for the same samples.  The absorbance values for the 
repeated uptake solutions were much higher than the values of the original 
solutions.  For example, the absorbance for the 24hour uptake solution 
was measured and it was 145.25LU.  However, when this same solution 
was re-analysed, the absorbance value was 366.02LU.  This was more 
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than double the absorbance for the same solution.  The uptake results 
varied considerably.  The repeated absorbance values for the uptake 
solutions were all considerably higher than the original measurements.  
Therefore, the concentration of MDA up-taken by PV lenses could not be 
accurately calculated.   
The absorbance values of the release solutions were also measured for 
PV lenses and they all showed positive results.  The absorbance values 
for the release solution after 2hours soaking in MDA solutions was 
16.99LU.  This is the equivalent of approximately 295nmol/ml MDA.   
Although the concentration of MDA absorbed by the lens could not be 
accurately determined, the release results proved that MDA was absorbed 
by PV lenses and subsequently released.   
Both, the results obtained by HPLC separation and visual observation of 
the solutions after they were reacted with TBA showed that MDA was 
released from PV lenses after a 2hour soak.  When the release solutions 
were reacted with the TBA buffer at 90°C for 60mins, all of the solutions 
were slightly pink in colour.  The solution will only turn pink if MDA is 
present.  Therefore, MDA was either absorbed into the lens matrix or 
adsorbed on the surface after 2hours soaking because there was definitely 
MDA in the release solutions.   
As well as soaking the lenses in 5μmol/ml MDA solutions, fresh PV lenses 
were also soaked in 100nmol/ml solutions.  This was to establish whether 
PV lenses still absorbed MDA even when soaked in lower concentrations 
of MDA.  The solutions were separated by HPLC and the absorbance 
values were again obtained by measuring the area under the peak at 
2.4mins and the absorbance values are shown in Table 5.9.     
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Table 5.9 – Absorbance values for MDA uptake and release for 
PureVision lenses from a 2ml solution of 100nmol/ml MDA over time 
Time 
(Hours) 
PureVision uptake from 
100nmol/ml MDA solution (LU) 
(area under peak at 2.44mins) 
Repeat of 
‘uptake’ 
solutions 
Release 
after 24 
hours 
0 4.34 - - 
2 4.40 5.10 1.42 
4 4.87 6.50 1.44 
24 12.4 6.12 1.34 
 
Again, the absorbance values for the uptake solutions varied (shown in 
Table 5.9).  The absorbance value for the 24hours uptake solution was 
significantly higher than the 0hour uptake solution (4.34 compared to 
12.4).  This suggested there was more MDA present in the solution after 
24 hours than at 0hours, which is not possible.  This showed that the 
results were not reproducible.  Therefore, the concentration of MDA 
absorbed by PV lenses from a 100nmol/ml MDA solution could not be 
accurately calculated.   
The absorbance values for the release solutions show MDA was released 
after a 2hour soak in a 100nmol/ml MDA solution (the absorbance value 
was 1.42LU, equivalent to 10nmol/ml MDA).   All of the release solutions 
were pink once they had been reacted with TBA, which meant MDA was 
present.  Therefore, MDA was absorbed by the lens even from a lower 
concentration solution.   
5.8.2.3 PureVision uptake and release: Summary 
- MDA was absorbed by PV lenses from both a 5μmol/ml MDA 
solution and a 100nmol/ml solution 
- subsequently, MDA was released from PV lenses, although the 
uptake results did not show that MDA had been absorbed by PV 
lenses, the release values suggest that MDA was absorbed and then 
released 
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- This research is unique in showing that MDA can be absorbed by PV 
lenses and then released 
5.8.2.4 Results for the uptake and release of TEP from Acuvue Oasys 
lenses measured by HPLC 
The uptake and release of MDA from Acuvue Oasys lenses was 
investigated to determine whether a material change would affect the 
results.   
The results shown in Table 5.10 and Table 5.11 represent the uptake and 
release absorbance values for Oasys lenses.   The lenses were soaked in 
5μmol/ml and 100nmol/ml MDA solutions for various amounts of time.  
After 0, 2, 4 and 24hours 5μl aliquots were taken, reacted with TBA and 
separated by HPLC.  The area under the peak at 2.4mins was measured 
for each sample.  The absorbance values for the uptake and release 
solutions are given in Table 5.10 and Table 5.11.  
Table 5.10 – Acuvue Oasys uptake and release results in a 5µmol/ml 
solution 
Time 
(Hours) 
Acuvue Oasys uptake from 
5µmol/ml MDA solution (LU) (area 
under peak at 2.44mins) 
Repeat of 
‘uptake’  
solutions 
Release 
after 24 
hours 
0 185.00 - - 
2 209.32 339.84 11.97 
4 259.15 459.88 12.37 
24 227.48 574.62 18.93 
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Table 5.11 – Acuvue Oasys uptake and release results in a 100nmol/ml 
solution 
Time 
(Hours) 
Acuvue Oasys uptake from 
100nmol/ml MDA solution (LU) 
(area under peak at 2.44mins) 
Repeat of 
‘uptake’ 
solutions 
Release 
after 24 
hours 
0 4.34 - - 
2 4.37 6.04 1.34 
4 5.57 7.27 1.33 
24 4.43 11.15 1.20 
 
The results shown in Table 5.10 and Table 5.11 suggest that TEP is being 
released by Acuvue Oasys lenses but not up-taken by the lens.   
TEP was released by the lens as the solution was slightly pink after the 
MDA-TBA reaction.  The solution will turn pink only if MDA is present as it 
binds to TBA and forms a coloured complex.  The results also show that 
TEP is released, but the amount up taken could not be accurately 
determined.   
There were no observable differences between the two lens materials in 
their affinity for MDA.  The absorbance values for all of the solutions tested 
were not very accurate.   
The results in Table 5.8 to Table 5.11 indicated that this method of the 
measurement of MDA uptake and release from lenses was not very 
accurate.  Therefore, repeat experiments were carried out on fresh 
solutions.  The reproducibility was also checked without the added 
complication of having the contact lens in the solution.   
5.8.2.5 Acuvue Oasys uptake and release: Summary 
- The absorbance values suggest that MDA is released by Acuvue 
Oasys lenses but not up-taken  
- MDA has to be absorbed by the lens to be released, therefore MDA 
is absorbed by Acuvue Oasys lenses, however the concentration up-
taken cannot be accurately determined 
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- MDA is up-taken from both 5μmol/ml and 100nmol/ml MDA solutions 
- There were no differences observed in the amount of uptake and 
release of MDA between PV and Oasys lenses 
5.8.2.5.1 Reproducibility of the HPLC uptake and release technique 
Further reproducibility tests were carried out to determine how useful the 
HPLC technique would be for the measurement of uptake and release of 
MDA from various lens materials.   
Fresh 100nmol/ml standard was prepared by firstly preparing a 10µmol/ml 
tetraethoxypropane (TEP) in ethanol (24µl TEP in 10ml ethanol) in a 15ml 
centrifuge tube and diluting it with HPLC grade water.  6x100nmol/ml TEP 
solutions were prepared in 6 x 15ml centrifuge tubes.  5µl of each 
100nmol/ml solution was transferred to 1.5ml eppendorfs containing 1ml 
TBA reagent.  These were placed in an oven at 95°C for 1hr.  They were 
then cooled for 5mins in cold water bath and then centrifuged.  The upper 
750µl from each sample was used for HPLC analysis.  5µl aliquots were 
taken from each 100nmol/ml standard and analysed at time intervals.  The 
results are shown Table 5.12.  
Table 5.12 – Reproducibility results of 100nmol/ml solutions 
100nmol/ml 
Sample 
Area under 2.4 peak  (LU) after: 
0hrs 2hrs 4hrs 24hrs 
1 6.02 5.75 6.05 6.07 
2 6.71 6.52 6.50 6.17 
3 6.70 6.69 7.38 6.74 
4 7.39 6.50 9.01 6.23 
5 6.80 6.91 9.08 6.43 
6 6.94 6.43 9.36 5.84 
 
The absorbance values in the highlighted boxes represent samples that 
were not injected by the HPLC immediately after being centrifuged.  They 
were analysed after 24hrs and this may have affected results, causing 
them to have a higher absorption value.   
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The average area under the peak for a 100nmol/ml solution was 6.51 LU 
(excluding shaded results) 6.84LU (including shaded results).  The 
absorbance value for each sample was quite reproducible; therefore 
further uptake and release experiments were conducted.  PureVision and 
Acuvue Oasys lenses were only soaked in 100nmol/ml TEP solutions and 
not 5μmol/ml solutions.  The absorbance values for lower concentrations 
of TEP were more reproducible.    
Uptake and release experiments were repeated to determine whether the 
results generated by HPLC separation were reproducible.  A stock solution 
of 10µmol/ml (24µl TEP in 10ml ethanol) was prepared. 9900µl HPLC 
grade water was added to six 15ml centrifuge tubes.  100µl of the stock 
solution was added to each centrifuge tube making 6 x 100nmol/ml TEP 
solutions.  2ml of each solution was transferred to fresh centrifuge tubes 
ready for the lenses to be added.   
The lenses used for these experiments were PV and Oasys because they 
are both known for high levels of lipid deposition.  The lenses were 
removed from the blister packaging, blotted on filter paper and placed in 
HPLC grade water.  The lenses were then removed from the water and 
blotted on filter paper.  The lenses were then placed in the centrifuge 
tubes that contained 2ml 100nmol/ml TEP solutions. Individual PV lenses 
were added to 3 centrifuge tubes and Acuvue Oasys lenses were added to 
the other 3 centrifuge tubes.    
5µl was taken from the tubes at 0hrs, 2hrs, 4hrs and 24hrs.  This was 
reacted with TBA as described in Chapter 2, section 2.11.5.1.3.   
The lenses from the 24hrs uptake solutions were removed and placed in 
separate centrifuge tubes each contained 1ml HPLC grade water for 
release.   
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Table 5.13 – PureVision uptake and release results in a 100nmol/ml 
solution  
Time 
(Hours) 
PureVision uptake from 100nmol/ml 
MDA solution (LU) (area under peak 
at 2.44mins 
Release after 24 hours 
0 5.38 - 
2 5.31 - 
4 4.87 - 
24 5.23 1.58 
 
Table 5.14 – Acuvue Oasys uptake and release results in a 100nmol/ml 
solution 
Time 
(Hours) 
Acuvue Oasys uptake from 
100nmol/ml MDA solution (LU) (area 
under peak at 2.44mins) 
Release after 24 hours 
0 5.62 - 
2 5.87 - 
4 4.87 - 
24 5.30 1.27 
 
The absorbance values in Table 5.13 and Table 5.14 represent the uptake 
and release values for PV and Oasys lenses respectively.  The 
absorbance values for both lenses (shown in Table 5.13 and Table 5.14) 
show that MDA is being absorbed by the lens and then released.   
The release of MDA was only measured after 24hours uptake.  The 
absorbance values suggest MDA was released after 24 hours uptake, for 
both lens materials.  The absorbance values for uptake and release for 
both lens materials were similar.  The results suggested that both lens 
materials (PV and Oasys) had a similar affinity for MDA.   
Overall, the results obtained from HPLC separation were not very 
reproducible.  In particular, the absorbance values corresponding to 
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uptake, for both lenses were not reproducible.  Although the results were 
not very reproducible, it was clear that MDA was absorbed by the both 
lens materials and subsequently released.   
As the results for the uptake and release of MDA obtained by HPLC 
separation were not very reproducible, this method was not used for 
further analysis.  However, the results did reveal that MDA is absorbed by 
both lens materials and then released.  Therefore, uptake and release of 
MDA was now measured directly by UV absorbance rather than HPLC 
separation and then fluorescence detection.  The methodology and results 
are shown in section 5.9.   
5.8.3 Uptake and release of MDA using HPLC: Summary 
- The HPLC method for the measurement of MDA uptake and release 
was not very accurate 
- However, it was still determined that MDA was up-taken and 
released by both lens materials 
- MDA was absorbed by both lens materials from both a 5μmol/ml 
MDA solution and a 100nmol/ml MDA solution 
- There were no significant differences in uptake and release results 
between PureVision and Acuvue Oasys lenses.  Both lenses seem to 
have a similar affinity for MDA 
5.9 UV and fluorescence absorbance of MDA 
The HPLC methodology for the separation the MDA-TBA adduct was not a 
very reproducible method and was not sensitive enough to detect MDA in 
tear samples or contact lens extracts.  Therefore, the same method was 
used but without the chromatographic separation (i.e. direct UV 
absorbance).  
0.2% (w/v) TBA buffer in 0.1M sodium acetate buffer was prepared as 
described in Chapter 2 (section 2.11.5.1.1).   
MDA standards were prepared at the same concentrations as shown in 
Chapter 2, Table 2.7.  10μl of each standard was added to 1ml TBA buffer 
and placed in an oven for 60mins at 90°C.  The solutions were allowed to 
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cool in a water bath for 5mins.  The UV absorbance of each standard was 
measured.  As the maximum absorbance was not known, a full 
wavelength scan was taken.  The maximum UV absorbance was found to 
be at between 530-535nm.  A wavelength scan of the TBA buffer was 
taken to ensure its absorbance did not interfere with the MDA peak 
(shown in Figure 5.12).   
 
Figure 5.12 – Wavelength scan between 200nm and 800nm of 0.2% TBA 
(w/v) in 0.1M sodium acetate buffer 
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Figure 5.13 – Wavelength scan of 20nmol/ml TEP reacted with 0.2% TBA 
(w/v) in 0.1M sodium acetate buffer between 200nm and 800nm 
The maximum absorbance for TEP-TBA adduct was found to be between 
530 and 535nm.  Therefore, the UV absorbance for all standards and 
unknowns were measured at this wavelength.  The calibration curve 
shown in Figure 5.14 represents the UV absorbance for TEP-TBA over a 
range of concentrations.   
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Table 5.15 – 10μl TEP standards reacted with 1ml TBA buffer absorbance 
data at 532nm 
TEP concentration (nmol/ml) Absorbance 
200 0.179 
100 0.092 
50 0.059 
40 0.033 
30 0.026 
20 0.019 
1 0.006 
0.5 0 
0.1 0 
0.01 -0.001 
 
Figure 5.14 – 10μl TEP standard calibration curve measured at 532nm 
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The concentration of MDA in unknown samples was determined from the 
calibration curve shown in Figure 5.14.  The samples tested were ex vivo 
daily wear and continuous wear PureVision (PV) and Focus Night and Day 
(F.N&D) lens extracts.  These particular lens materials were used because 
the work discussed in Chapter 4 had shown that there were clear 
differences in fatty acid profile between wear schedules. GCMS results 
showed that unsaturated fatty acids had degraded on lenses that were 
worn on a continuous wear schedule.  Therefore, it was important to 
investigate these lenses for the presence of MDA or lipid oxidative 
products.      
5.9.1 UV absorbance technique for measurement of MDA 
Daily wear and continuous wear PureVision and Focus Night & Day lenses 
were analysed for MDA using the UV absorbance.  The three extraction 
protocols described in Chapter 2, sections 2.8.1 to section 2.8.3 were 
used to extract both daily wear and continuous wear PV and F.N&D 
lenses.   
None of the ex vivo PV or F.N&D lens extracts analysed (daily wear or 
continuous wear) produced positive results for the presence of MDA.  The 
UV absorbance method was not sensitive enough for the measurement of 
MDA in these particular extracts.   
5.10 Induced lipid oxidation 
To test the reproducibility of the UV absorbance technique, linolenic acid 
(18:3 9,12,15) standard was left exposed to oxygen.  This induced the 
oxidation of linolenic acid which would produce MDA.  This oxidised 
linolenic acid was analysed by the UV absorbance technique for the 
presence of MDA.  The method used for inducing oxidation is described in 
Chapter 2, section 2.12.   
The oxidised linolenic acid solution had turned a dark pink colour 
indicating MDA had been produced.  The un-oxidised linolenic acid was a 
clear solution.  200μl of each sample was transferred to a 96 well plate 
and the absorbance read at 532nm.  The un-oxidised lipid had an 
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absorbance value of 0.173 which corresponded to approximately 
75nmol/ml MDA.  The oxidised linolenic acid samples had an absorbance 
value of 2.981 which would correspond to more than 200nmol/ml MDA 
(the most concentrated standard analysed).  The results showed that the 
so called ‘un-oxidised’ linolenic acid sample produced MDA, which meant 
it had also oxidised.  But not to the extent of the linolenic sample which 
was left exposed to oxygen for 24 hours.  Although attempts were made to 
try and prevent the oxidation of the linolenic acid sample, the slightest 
exposure to oxygen caused oxidation to occur.   
This experiment proved that the concentration of MDA could be measured 
by the UV absorbance technique.  This technique combined elements of 
the TBARS assay and the HPLC method.  The UV absorbance method 
was therefore useful for measurement of MDA at higher concentrations.  
However, it was not sensitive enough to detect MDA in the samples 
analysed.   
5.11 Discussion 
The aims of the work discussed in this chapter were to find a single or 
multiple methods for the measurement of lipid peroxidation products in the 
ocular environment (either tears or from contact lens extracts).   
Many commercial available assays that are used for the measurement of 
MDA in various blood, urine and plasma samples were used in this work to 
measure MDA in the ocular environment.  These assay kits were not 
designed to measure lipid peroxidation products in tears.  They included 
the TBARS, NMPI, ELISA assays kits.  
Analytical techniques such as HPLC and capillary electrophoresis were 
also used to enable the measurement of MDA.  Both, HPLC and capillary 
electrophoresis have been used by other researchers for the 
measurement of MDA (134, 151).  Although HPLC was not used for MDA 
measurement in tears in the literature, the small sample volume 
requirement (5μl) made this method ideal for the analysis of tears.  
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Capillary electrophoresis was used for the separation of MDA from tear 
samples in the literature.   
Many of the assays used required at least 100μl of sample.  Therefore all 
of the samples collected; tear samples, tear envelope and lens extracts 
had to be either pooled or made up to the required volume with either 
water or PBS.   
From the initial results, both the TBARS and ELISA assays provided 
positive results for certain samples (Table 5.3 and Table 5.5 respectively).  
The initial ELISA assay provided positive results for contact lens extracts 
which indicated that MDA was in the contact lens matrix.  Further MDA-
ELISA results showed that ex vivo stored lenses showed a higher 
concentration of MDA compared with freshly worn ex vivo contact lens 
extracts (21pmol/ml – stored Air Optix lens compared to 4pmol/ml freshly 
worn Air Optix lens extract).  This was a significant finding as it showed 
that the concentration of MDA was lower in lenses which had just been 
worn and extracted immediately.  This was compared to lenses which had 
been worn and then stored and these lenses showed a significantly higher 
concentration of MDA (21pmol/ml).  This work was novel, as this assay 
had not previously been used to assess the levels of MDA in the ocular 
environment.  It was also novel as the concentration of MDA had not been 
measured from contact lens extracts. 
TBARS results in Table 5.2 and Table 5.3 show that there were detectable 
levels of MDA from particular subjects tear samples and tear envelope 
samples.  The initial results (shown in Table 5.2) showed levels of MDA 
between 1.0-2.5μM for tear samples.    
The follow-up results (shown in Table 5.3) showed positive and negative 
results for tear samples and tear envelope samples.  The results for the 
tear sample collected from Subject 1 showed positive levels of MDA from 
one eye and negative from the other.  Many of the tear samples analysed 
by TBARS showed negative results, however some showed positive 
results.   
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The TBARS assay recommended preparing a new calibration curve each 
time the assay was used.  However, the absorbencies for known 
concentrations of MDA varied each time the calibration curve was 
prepared.  Therefore, the absorbance results for unknown samples were 
compared to one calibration curve, shown in Figure 5.1.  Therefore, the 
true concentration of MDA in unknown samples was not very reproducible 
and this assay was not very accurate.  Although the TBARS assay was 
not very sensitive, it did provide a measure of general lipid oxidation, even 
though it may not have been specific for MDA levels.  
The NMPI technique produced negative results for tear samples, tear 
envelope samples and contact lens extracts.  This assay used third 
derivative spectroscopy which was to increase specificity and sensitivity of 
the data.  As this assay provided negative results for all unknown samples, 
it was not used for any further experiments.   However, a similar assay 
was used by Glasson et al. (121).  They analysed the tears of contact lens 
tolerant and intolerant subjects using a similar assay to the one used in 
our research.  Glasson et al. discovered that the levels of MDA were 
higher in the tears of contact lens intolerance subjects.   
All of the tear samples analysed using the NMPI assay in this work did not 
produce any positive results.   
Both of the analytical techniques; capillary electrophoresis and HPLC did 
not produce any positive results for test samples.  Capillary 
electrophoresis was chosen for MDA analysis as had been previously 
used for the measurement of MDA and antioxidant levels in tears and 
therefore a similar protocol was followed (151).  The MDA standard, from 
the TBARS assay, was used to establish a standard peak on the capillary 
electrophoresis.  There was a small peak that corresponded to MDA at 
20mins with an absorbance of ~2.5mAU.  However, the concentration of 
MDA standard used was very high and it produced a peak with a small 
absorbance, therefore capillary electrophoresis was not considered a 
sensitive enough technique.  Georgakopoulos et al. (151) used capillary 
electrophoresis for the separation and identification of MDA in tears.  The 
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MDA peak was detected at ~22mins.  MDA was detected in the tears of 7 
out of 11 tear samples analysed, however the levels were below the lower 
limit of quantification for all subjects.  Also, the intensity of the peak that 
corresponded to MDA was very low (approximately 1mAU).    
The capillary electrophoresis method that was used in this research was 
similar to the method used by Georgakopoulos et al. (151).  However this 
method did not prove to be very sensitive for the analysis of MDA.     
The other analytical technique used for the separation and identification of 
MDA was HPLC with fluorescence detection.  This method was used 
because a small sample volume of 5μl could be used for analysis.  This 
method provides a more accurate measure of the levels of MDA in 
unknown samples than TBARS assay alone.  The HPLC method is based 
on a reaction between MDA and TBA.  TBA can bind to other molecules 
such as aldehydes.  Therefore, the TBARS assay can over-estimate the 
levels of MDA.   However, only MDA bound to TBA will produce a peak at 
a characteristic retention time by HPLC separation.  Therefore, the HPLC 
method provides a more accurate measure for the actual concentration of 
MDA.   
HPLC separation of MDA showed a lower limit of detection of 
approximately 10nmol/ml.  However, the TBA buffer used in this method 
had an absorbance at approximately the same retention time as the MDA-
TBA adduct.  It was therefore difficult to establish the between the TBA 
buffer and MDA-TBA at low concentrations.  Tear samples and contact 
lens extracts were analysed using the HPLC method, but they did not 
produce any positive results.  This method was therefore not further used 
for the analysis of worn contact lens extracts.  
HPLC was used to enable the measurement of the in vitro uptake and 
release of MDA of various lens materials.  The area under the peak was 
used to determine the concentration of MDA up-taken and released by 
various lenses.  The lenses chosen were PV and Oasys.  The HPLC 
method was not very accurate and therefore a difference was not 
observed in the levels of uptake and release between the two lens 
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materials.  There were low levels of MDA absorbed by both lens types as 
there was a low amount released.  This was evident from the absorbance 
values of the release solutions shown in Table 5.13 and Table 5.14.  
Visual observation of the solutions after they had been reacted with the 
TBA buffer showed that MDA was released by both lenses as the 
solutions had turned pink (indicating the presence of MDA).     
However, this method was not sensitive enough to determine an accurate 
measure of the concentration absorbed by the lens and subsequently 
released by the lens.  This was the case for both lens materials.  The 
HPLC method was therefore not used for further work.   
As the HPLC separation technique was not very accurate, a similar 
procedure was followed, but the samples were not separated by HPLC.  
Instead, the unknown samples and MDA standards were reacted with the 
TBA buffer and the UV absorbance measured directly.  This method had a 
lower limit of detection of 1-10nmol/ml.  Worn PV and F.N&D lens extracts 
that were either worn on a continuous wear or daily wear schedule did not 
produce any positive results by the UV absorbance technique.  This meant 
that either there was no MDA present or that it was below the detection 
limit.  These samples were kept at -20°C for analysis using the MDA-
ELISA assay as it was proved to be the most sensitive.  The same 
samples did not produce any positive results when analysed by the MDA-
ELISA assay.   
5.12 Conclusions 
MDA is one of the most studied biomarkers of lipid oxidation. It is 
produced from the oxidation of polyunsaturated fatty acids (PUFAs) and 
the pathway of MDA production is shown in Figure 1.29.  High levels of 
PUFAs have not been previously detected in meibomian gland secretions, 
however, as already shown, lipids build-up within the contact lens matrix 
and are exposed to oxidative attack.   
The presence of MDA in tears has been previously linked to contact lens 
intolerance in the literature.  Therefore, the aims of the work discussed in 
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this chapter were to find a single or multiple methods for the analysis of 
MDA in the ocular environment.  The most significant findings from the 
work discussed in this chapter are listed below: 
- several commercially available assays and analytical techniques 
were used for the analysis of MDA, overall, the MDA-ELISA 
technique was the most sensitive technique 
- although capillary electrophoresis has been used to detect MDA in 
tears in the literature, this technique was not sensitive enough for the 
detection of MDA in any sample tested in this research 
- the TBARS assay is widely used for MDA detection in various 
samples (blood, urine, plasma); however it was not as sensitive as 
the MDA-ELISA technique 
- the NMPI method did not detect MDA in any sample tested in this 
research,  although it had previously been used for MDA detection in 
tears by Glasson et al. (121) 
- a major finding of the research discussed in this chapter was that 
MDA was found to build-up in the contact lens matrix.  This had 
never previously been shown 
- the most effective extraction protocol for MDA from lenses was 
extraction protocol 1 (1:1 chloroform: methanol extraction).  The 
structure of MDA suggested it would be water soluble; however MDA 
was not extracted by water or saline.  Because MDA was only 
extracted using solvents, this accounted for MDA build-up within the 
lens matrix 
Further work is required to determine whether increased levels of MDA for 
particular subjects correlate with contact lens intolerance and/or contact 
lens comfort.  However, the work discussed in this chapter has shown that 
MDA and can build-up in the lens matrix and this has not been previously 
studied.   
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6. Chapter 6 – Phospholipid-containing 
contact lenses: in vitro and in vivo studies 
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6.1 Introduction 
A large proportion of contact lens wearers report symptoms of discomfort, 
which are similar to those symptoms experienced by dry eye patients.  
This type of dry eye is often called contact lens induced dry eye (1, 152).  
Dry eye can be a pre-existing condition or can be caused by the contact 
lens and this is discussed in detail in Chapter 1 section 1.6.  Contact lens 
induced dry eye is often associated with the disruption of the tear film and 
in particular, the disruption of the tear lipid layer (127).  Correlations have 
also been made between a lack of phospholipids and irregular function of 
the lipid layer, ultimately leading to signs of dryness (95, 121, 127, 153, 
154).  There are many therapies used for the treatment of dry eye such as 
dietary intake of omega-3 fatty acids (86), physical stimulation of the 
meibomian glands, drug therapy,  topical treatments (84, 86) and the use 
of eye drops (discussed in detail in section 1.6),   
A new type of contact lens has been developed for the treatment of dry 
eye.  Dailies Total 1 (delafilcon A) lenses, produced by CIBA vision are a 
new daily disposable silicone hydrogel contact lens material.  They contain 
a phospholipid, dimyristoyl phosphatidylcholine (DMPC) which is said to 
be released into the tear film lipid layer and enhance comfort throughout 
the day.   
There has been a recent publication by Pitt et al. (95) which investigates 
the release of phospholipid from a phospholipid-containing contact lens 
into an artificial tear fluid.  The work by Pitt et al. used radiolabelled DMPC 
to monitor the release of DMPC from the lenses into an artificial tear fluid.  
However, these in vitro conditions did not necessarily mimic in vivo 
conditions.   
The work discussed in this chapter was therefore based on trying to 
establish whether DMPC would be released to the tear film during wear.  
In order to do this, the work involved trying to find a suitable extraction 
procedure that would mimic in vivo conditions.   
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GCMS was used for analysis of worn and unworn phospholipid containing 
lenses because it was able to separate the C14:0 (the fatty acid moiety) of 
the DMPC.   
6.2 Batches of lenses 
All three batches of lenses were supplied by the manufacturer.   
Batch 1 lenses: Clinical lenses with and without DMPC. 
Batch 2 lenses: Non-clinical lenses with and without DMPC.  With the 
addition of two different additives: Processing aid 1 and 2 (IPC-3C and 
IPC-4A lenses).   
Batch 3 lenses: Non-clinical lenses with and without DMPC and 
processing aid 3 (LPEG – a polyethylene glycol like molecule) 
Dailies Total 1 clinical lenses: CIBA vision daily wear silicone hydrogel 
lens, Dailies Total 1 (delafilcon A) that contain DMPC 
This work involved the development of an extraction procedure which 
would mimic the extraction of DMPC into the tear film.  GCMS was used 
for the analysis of lens extracts as it could monitor the presence of the 
C14:0 peak at the retention time of approximately 10.3mins.   
Several extraction protocols were tested in order to try to mimic the 
extraction of DMPC which may occur in the eye, however this proved very 
difficult to do for several reasons.  If an artificial tear like fluid was used for 
the extraction of the lens, the entire extract solution would have to be 
transmethylated and analysed by the GC.  As the GC is a very sensitive 
technique, this had the possibility of over-loading the column.  This was 
the case for many solvents or chemicals used for the extraction of DMPC 
from the lens.  Therefore, the solvents chosen for extraction had to be 
volatile so they could be evaporated to dryness and the extract could be 
transmethylated, rather than the transmethylation of the entire solution.  
However, these solvents are considered to be harsh and they do not 
mimic the in vivo extraction conditions of DMPC.   
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The main analytical technique used for this work was GCMS.  GCMS 
enabled the separation and identification of the peak that corresponded to 
C14:0 (from DMPC) from lens extracts.  The area under the C14:0 peak 
was quantified to determine the concentration of C14:0 from unworn and 
worn lens extracts.  A calibration curve of DMPC standard at different 
concentrations against C14:0 peak area was prepared which allowed the 
concentration of DMPC extracted from the lenses to be calculated.  After 
this, non-clinical lenses were extracted by various extraction protocols and 
they were analysed by GCMS.  Ex vivo clinical lenses were extracted and 
analysed as well as tear samples taken after the wear of DMPC-containing 
lenses to establish whether DMPC had been released into the tear film.   
6.3 Results 
6.3.1 Calibration curve of DMPC separated by GCMS  
The gas chromatograms shown in Figure 6.1 represent different 
concentrations of standard DMPC. The predominant peak at 
approximately 10.3mins corresponds to C14:0.  When DMPC is 
transmethylated, the C14:0 fatty acid is converted to a C14:0 fatty acid 
methyl ester and this is separated by GCMS.  The area under each peak 
was measured and a calibration curve was prepared (shown in Figure 
6.2). 
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Figure 6.1 – Gas chromatograms of standard DMPC at various 
concentrations 
Table 6.1 – Calibration curve data for standard DMPC measured by area 
under peak at 10.3mins measured by GC 
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Figure 6.2 – Calibration curve for DMPC measured by area under peak at 
10.3mins on gas chromatogram 
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6.3.2 Batch 1 results: 
The chromatograms shown in Figure 6.3 represent batch 1 DMPC-
containing lens extracts (unworn and worn for 2hrs). The circled peaks 
correspond to C14:0.   
 
Figure 6.3 – Gas chromatograms of batch 1 lens extracts extracted in 1:1 
chloroform: methanol where: chromatograms 1 and 2 are unworn control 
lenses without and with DMPC respectively and chromatograms 3 and 4 
are worn control lenses without and with DMPC respectively 
The circled peak on chromatograms 2 and 4 corresponds to C14:0 from 
the DMPC.  There was a slight difference in the area under the peak 
between worn and unworn lens extracts.  The concentration of DMPC in 
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unworn lenses was 0.025x10-4g/ml.  The concentration of DMPC 
remaining in an ex vivo lens was 0.020x10-4g/ml.  This suggested that a 
small amount of DMPC was delivered to the tear film; however the 
majority of DMPC remained in the lens after wear.   
The other two peaks observed on the chromatograms in Figure 6.3 
correspond to C16:0 and C18:0.  These are common peaks observed for 
unworn silicone hydrogel contact lens extracts (see Figure 3.6).  
Table 6.2 – Analysis of the GC traces shown in Figure 6.3 
Chromatogram Concentration of C14:0 
Unworn lens extract (chromatogram 2) 0.025x10-4g/ml 
Worn lens extract (chromatogram 4) 0.020x10-4g/ml 
 
6.3.3  Batch 2 (non-clinical) results:  
Batch 2 lenses were non-clinical lenses (not approved to be worn). Batch 
2 lenses were extracted using several extraction protocols to find a 
suitable procedure to mimic in vivo conditions.   
The chromatograms in Figure 6.4 represent lens extracts of batch 2-
with/without DMPC lenses.  Extraction protocol 1 (1:1 chloroform: 
methanol) was used for the extraction.  The circled peaks in 
chromatograms 2, 4 and 6 correspond to C14:0.  
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Figure 6.4 – Gas chromatograms of batch 2 lens extracts extracted in 1:1 
chloroform: methanol.  Where: chromatograms 1 and 2 are control lens 
extracts without and with DMPC respectively, chromatograms 3 and 4 are 
IPC-3C lens extracts without and with DMPC respectively and 
chromatograms 5 and 6 are IPC-3C lens extracts with and without DMPC 
respectively 
The circled peaks in chromatograms 2, 4 and 6 represent C14:0.  There is 
considerably more DMPC in these lenses compared with batch 1 lenses.  
This can be seen from the intensity of the C14:0 peak.  The concentration 
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of DMPC in this particular control lens was approximately 0.90x10-4g/ml 
(chromatogram 2).  The concentration of DMPC in the IPC-3C lens was 
determined to be 0.97x10-4g/ml (chromatogram 4).  The concentration of 
DMPC in this IPC-4A lens was worked out to be 1.08x10-4g/ml 
(chromatogram 6).  The concentration of DMPC in batch 2 lenses was 
considerably more than in batch 1 lenses (0.025x10-4g/ml).   
Batch 2 lenses were extracted using different extraction protocols.  The 
IPC-3C lenses, with and without DMPC were used to investigate the 
efficacy of various extraction procedures because there were several of 
these lenses available for analysis.   
Although the chromatograms for different extraction protocols are not 
shown, the peak areas representing the C14:0 peak were analysed and 
the results are shown in Table 6.3.  Butanol was successful for the 
extraction of some of the DMPC, however the results show that further 
DMPC was extracted from the lenses that had already been extracted in 
butanol.   
Octanol was used for extraction, however it is not volatile, therefore part of 
the extract was transmethylated and analysed by GCMS.  The 
chromatograms did not show the peak corresponding to C14:0, therefore 
octanol was not effective for DMPC extraction.  These lenses were then 
extracted in chloroform: methanol and the chromatograms showed that the 
majority of DMPC was extracted in this extraction and not in the octanol 
extraction (1.77x10-4g/ml).   
 
 
 
 
 
 
207 
 
Table 6.3 – Analysis of batch 2 GC traces  
Lens 
description  
Extraction solvent 
Concentration of C14:0 
extracted from batch 2 lenses 
Control Chloroform: methanol  0.90x10-4g/ml 
IPC-3C Chloroform: methanol 0.97x10-4g/ml 
IPC-4A Chloroform: methanol 1.08x10-4g/ml 
IPC-3C Butanol 0.20x10-4g/ml 
IPC-3C glycerol Below limit of detection 
IPC-3C methanol 0.5x10-4g/ml 
IPC-3C hexane Below limit of detection 
 
6.3.3.1 Batch 2 results: Summary 
The main aim of the work in section 6.3.3 involved trying to find a suitable 
extraction procedure to mimic in vivo conditions.  This was difficult to 
achieve because the extraction solvent needed to be volatile so that it 
would evaporate under nitrogen in order for the extract to be 
transmethylated for GC analysis.  However, if a tear-like fluid was used for 
extraction, the entire extract would have to be transmethylated for GC 
analysis as it would not be volatile.  The fatty acids, in the tear-like fluid 
used for extraction would be converted to methyl esters and would be 
separated by GC.  It would be difficult to detect C14:0 corresponding to 
the DMPC because the intensity of the peaks from the tear-like fluid would 
suppress any extracted material from the lens.  This is why a tear-like fluid 
was not used because it had the potential to over-load the column.   
- Butanol was used because it has a slightly longer hydrocarbon chain 
length than methanol but is still volatile.  It was effective for the 
extraction of DMPC from DMPC-containing lenses; however it did not 
extract all of the DMPC from the lens.   
- Octanol was used for the extraction of DMPC because it has a long 
hydrocarbon chain (trying to mimic in vitro extraction), but it was not 
volatile enough.  The whole extraction was transmethylated and 
analysed, but octanol was not effective for DMPC extraction 
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- Ethyl acetate and glycerol were not effective for the extraction of 
DMPC 
- The concentration of DMPC in batch 2 lenses was much higher than 
in batch 1 lenses (Figure 6.3).   
6.3.4 Batch 3 results: 
The next set of DMPC-containing lenses were extracted and analysed by 
GCMS.  These lenses were not clinical lenses, and were not approved for 
wear.   
The chromatograms in Figure 6.5 represent batch 3 with/without DMPC 
lens extracts with/without additive 3.  The lenses were extracted in 1:1 
chloroform: methanol (extraction protocol 1) or 100% methanol.   
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Figure 6.5 – Gas chromatograms of batch 3 lenses extracted in either 1:1 
chloroform: methanol or 100% methanol 
 
The chromatograms in Figure 6.5 show that 1:1 chloroform: methanol and 
100% methanol extraction procedures were effective at extracting DMPC 
from batch 3 lenses.  The C14:0 peak was present on all chromatograms 
representing DMPC-containing lens extracts.  The concentration of DMPC 
in batch 3 lenses was between 0.038x10-4g/ml and 0.10x10-4g/ml.  This 
was less than the batch 2 lenses.  Peaks corresponding to C16:0 and 
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C18:0 (at 12.8 and 15.0mins) were present for all extracts.  These peaks 
are common for unworn silicone hydrogel lenses (see Figure 3.6).   
6.3.5 Dailies Total 1and Acuvue TruEye extraction results 
The chromatograms in Figure 6.6 represent unworn Dailies Total 1 and 
Acuvue TruEye lens extracts.  Acuvue TruEye (narafilcon A) lens extracts 
were analysed because they are also daily disposable silicone hydrogels 
lenses, however they do not contain DMPC.   
 
Figure 6.6 – Gas chromatograms of lenses extracted using protocol 1 
where: Chromatogram 1 is an unworn Acuvue TruEye lens extract and 
Chromatogram 2 is an unworn Dailies Total 1 lens extract 
The two chromatograms in Figure 6.6 represent an Acuvue TruEye lens 
extract and Dailies Total 1 lens extract.  The two traces are very different 
from each other.  There are many peaks on the gas chromatogram for an 
Acuvue TruEye lens extract (chromatogram 1).  The peak at 7.9mins 
corresponded to C10:0 and it was identified by its retention time and mass 
spectra.  This lens is known to contain low levels of decanoic acid (C10:0).  
The peaks at 10.0 and 10.3mins were not identified as their mass spectra 
did not correspond to known structures.  The peaks at 12.8mins and 
15.0mins correspond to C16:0 and C18:0 respectively.  These are 
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common fatty acids seen observed on the chromatograms of many 
unworn contact lens extracts (see Figure 3.6 for gas chromatograms 
representing unworn contact lens extracts).   
Figure 6.6, chromatogram 2 represents an unworn Dailies Total 1 lens 
extract.  The predominant peak observed at approximately 10.3mins 
corresponds to C14:0, which is the fatty acid moiety of DMPC.  There are 
also peaks at 12.8mins and 15.0mins which correspond to C16:0 and 
C18:0 respectively.  These peaks were observed for many unworn lens 
extracts (see Figure 3.6 for gas chromatograms of unworn contact lenses).  
The concentration of DMPC extracted from this particular unworn Dailies 
Total 1 lens was 0.38x10-4g/ml.   
6.3.5.1 Gas chromatograms of ex vivo Dailies Total 1 lens extracts and 
tear samples 
Both and Dailies Total 1 and Acuvue TruEye lenses were worn by a group 
of subjects for 16hours.  Their lenses were collected and ex vivo Dailies 
Total 1 lens extracts were analysed by GCMS to establish the levels of 
DMPC remaining in the lens.  Ex vivo Acuvue TruEye lens extracts were 
analysed to determine differences in fatty acid profiles between worn and 
unworn extracts.   
The chromatograms in Figure 6.7 represent ex vivo Dailies Total 1 lens 
extracts that have been worn by various subjects.  Ex vivo lenses were 
extracted and analysed to determine whether DMPC had been released 
into the tear film.   
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Figure 6.7 – Gas chromatograms of worn Dailies Total 1 lens extracts 
where: chromatograms 1-4 are subjects A-D respectively 
The chromatograms in Figure 6.7 represent subjects A-D Dailies Total 1 
lens extracts.  The predominant peak, at approximately 10.3mins 
corresponds to C14:0.  Chromatograms 1-4 look identical to the 
chromatogram of an unworn Dailies Total 1 lens extract (shown in Figure 
6.6).   These results suggested that little to no levels of DMPC were 
actually released into the tear film throughout wear.  The intensities of the 
peaks corresponding to C14:0 were similar to the intensity of the C14:0 
peak of an unworn Dailies Total 1 lens.   
The concentration of DMPC extracted from ex vivo Dailies Total 1 lenses 
was measured to determine the level of DMPC extracted by the tear film 
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during wear.  The concentration of DMPC extracted from subject A ex vivo 
lens was 0.231x10-4g/ml, from subject B was 0.33x10-4g/ml, subject C was 
0.35x10-4g/ml and from subject D was 0.52x10-4g/ml.  The concentration 
extracted from an unworn Dailies Total 1 lens was 0.38x10-4g/ml, however 
this value changed from lens to lens.  Therefore, it was difficult to 
determine whether DMPC had been extracted by the tear film during wear.  
However, it was clear that the majority of the DMPC had not been 
released into the tear film and remained in the lens.   
Table 6.4 – Analysis of GC traces shown in Figure 6.7 
Subject 
Concentration of C14:0 extracted from 
subject-worn Dailies Total 1 lenses 
A 0.23x10-4g/ml 
B 0.33x10-4g/ml 
C 0.35x10-4g/ml 
D 0.52x10-4g/ml 
Unworn Dailies Total 1 0.38x10-4g/ml 
 
To determine whether DMPC was released into the tear film throughout 
wear, tear samples were taken from subjects immediately after they wore 
Dailies Total 1 lenses.  This was to observe if there was an increase in the 
C14:0 peak. Tear samples were collected using the Visispear ophthalmic 
sponge collection method (as described in section 2.9).  The gas 
chromatograms in Figure 6.8 represent tear samples taken from subjects 
A-D.   
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Figure 6.8 – Gas chromatograms of Visispear ophthalmic sponge extracts 
(after 12hours wear of Dailies Total 1 lenses) where: Chromatograms 1-4 
are sponge extracts of subjects A-D respectively 
The peaks observed for subjects A-D tear samples represent common 
tear fatty acids such as C14:0, C16:0, C18:1 and C18:0 (at 10.3, 12.9, 
14.8 and 15mins respectively).  There did not appear to be high levels of 
C14:0 observed on the gas chromatograms representing tear samples 
from each subject.  This suggested that DMPC was not being released 
into the tear film from the contact lens.     
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The next set of subjects Dailies Total 1 lens extracts were extracted and 
analysed by GCMS.  The gas chromatograms representing subject 4, 5, 
12, 13 and 14 are shown in Figure 6.9.   
 
Figure 6.9 – Gas chromatograms of Worn Dailies total 1 lens extracts, 
where: Chromatogram 1=Px4, Chromatogram 2=Px5, Chromatogram 
3=Px12, Chromatogram 4=Px13, Chromatogram 5=Px14 
Each of the chromatograms in Figure 6.9 showed a predominant peak at 
10.3mins which corresponds with C14:0.  These chromatograms were 
similar to an unworn lens extract.  However, the peaks corresponding to 
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C16:0 and C18:0 were less intense compared with the unworn lens 
extracts shown in Figure 6.6, chromatogram 2.  This suggested that these 
components may have been extracted from the lens into the tear film. 
Chromatogram 3, subject 12 lens extract was incorrectly labelled and is an 
Acuvue TruEye lens extract.  It is clearly different to the other 
chromatograms because the predominant C14:0 peak is not present and 
the peak at 10.3mins is characteristic of a Dailies Total 1 lens extract.   
Subjects 4-5, 12-14 lenses were removed and a Visispear sponge was 
wiped over the anterior surface of the lens prior to extraction.  The 
sponges were extracted and analysed by GCMS.  The GC traces are 
shown in Figure 6.10.   
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Figure 6.10 – Gas chromatograms representing Subjects 4-5, 12-14 
Visispear Ophalmic sponge lens wipe samples.  Lenses were removed 
and an ophthalmic sponge was wiped over the anterior surface of the lens. 
Low levels of lipid were extracted from Visispear ophthalmic sponges that 
had been wiped over ex vivo Dailies Total 1 lenses (very low peak 
intensities were observed).  The C14:0 peak was not observed on any 
chromatogram representing lens wipe samples.  The predominant peaks 
observed at 12.8, 14.8 and 15.0mins correspond to C16:0, C18:1 and 
C18:0 respectively. 
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Tear samples, from the lens-wearing eye wear were also taken using 
Visispear ophthalmic sponges.  The tear samples were extracted and 
analysed by GCMS.  The gas chromatograms are shown in Figure 6.11.     
 
Figure 6.11 – Gas chromatograms representing Subjects 4-5, 12-14 tear 
samples taken using the Visispear ophthalmic sponges.  Tear samples 
were collected whilst subjects wore Dailies Total 1 lenses and the sponge 
was gently wiped over the lens. 
The chromatograms in Figure 6.11 represent  tear samples that were 
taken whilst the subjects were wearing Dailies Total 1 lenses.  The 
predominant peaks observed corresponded to C16:1 (12.6mins), C16:0 
(12.8mins), C18:1 (14.8mins) and C18:0 (15.0mins).  The sample volumes 
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collected were very small, therefore the peak intensities were low.   The 
C14:0 peak was not present in all of the chromatograms in Figure 6.11.   
More ex vivo Dailies Total 1 lenses were analysed by GCMS and the gas 
chromatograms are shown in Figure 6.12.   
 
 
Figure 6.12 – Gas chromatograms subject worn Dailies Total 1 lens 
extracts.  Where: Chromatogram 1=subject 15, Chromatogram 2=subject 
20, chromatogram 3=subject 22, Chromatogram 4=subject 26, 
Chromatogram 5=subject 37 
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The chromatograms in Figure 6.12 represent Dailies Total 1 lens extracts 
for various subjects.  The most predominant peak observed was at 
10.3mins and corresponded to C14:0 from the lens.  There were low levels 
of C18:1 and C18:0 at 14.8mins and 15.0mins respectively.  Both C18:1 
and C18:0 are common tear fatty acids.   
The concentration of DMPC that was extracted from subject 15, 20, 22, 26 
and 37 ex vivo lenses were: Subject 15 = 0.21x10-4g/ml, Subject 20 = 
0.31x10-4g/ml, Subject 22 = 0.13x10-4g/ml, Subject 26 = 0.24x10-4g/ml and 
Subject 37 = 0.17x10-4g/ml.  There were lower concentrations of DMPC 
remaining in these particular subjects lenses compared with an unworn 
Dailies Total 1 lens (0.37x10-4g/ml).  This would suggest that some DMPC 
was released into the tear film during wear.  However, the concentration of 
DMPC in unworn Dailies Total 1 lenses varied from lens to lens.  It was 
therefore difficult to conclusively state that DMPC was released into the 
tear film or not.  
Table 6.5 – Analysis of the GC traces shown in Figure 6.12 
Subject  Concentration of C14:0 extracted from 
subject-worn Dailies Total 1 lenses 
15 0.21x10-4g/ml 
20 0.31x10-4g/ml 
22 0.13x10-4g/ml 
26 0.24x10-4g/ml 
37 0.17x10-4g/ml 
Unworn Dailies Total 1 0.38x10-4g/ml 
 
6.3.5.1.1 Dailies Total 1 GCMS results: Summary 
It was difficult to mimic the way in which the tear film would extract DMPC 
from the lens using in vitro conditions.    
- Many extraction solvents were used, however these were ‘harsh’ and 
did not mimic the way tears would extract DMPC from the lens 
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- If a tear-like fluid was used for extraction, the whole extract would 
have to be analysed by GCMS, this had the problem of  over-loading 
the column 
- It was therefore decided to analyse ex vivo lenses to determine 
whether there was any decrease in the levels of C14:0 compared 
with unworn lenses 
- Tears were collected after wearing Dailies Total 1 lenses and 
analysed to investigate the presence of C14:0 
- The analysis of ex vivo lenses showed similar levels of C14:0 as the 
unworn lens extracts, this suggested DMPC was not being released 
into the tear film.  Also, tear samples did not show any increases in 
the levels of C14:0, suggesting that DMPC was not released into 
tears 
- It was difficult to assess the exact concentration of DMPC released 
into the tear film by analysing ex vivo lenses because the 
concentration in unworn Dailies Total 1 lenses varied from lens to 
lens. 
6.3.6 Ex vivo Acuvue TruEye (narafilcon A) lens extracts 
Acuvue TruEye lenses were used as a comparator lens to Dailies Total 1 
becasue they are both daily disposable silicone hydrogel lenses.   
The gas chromatograms in Figure 6.13 represent subject worn Acuvue 
TruEye lens extracts.  The gas chromatograms in Figure 6.13 represent 
subjects A-D ex vivo Acuvue TruEye lens extracts.   
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Figure 6.13 – Gas chromatograms of worn Acuvue TruEye lens extracts 
where: Chromatogram 1-4 are subjects A-D respectively 
The chromatograms in Figure 6.13 represent subjects A-D Acuvue TruEye 
lens extracts.  The predominant peaks observed for subjects A and B lens 
extracts (chromatograms 1 and 2) corresponded to C16:0, C18:1 and 
C18:0 (at 12.8mins, 14.8mins and 15.1mins respectively).  The peak 
corresponding to C18:1 (at 14.8mins) was not observed for unworn 
Acuvue TruEye lens extracts, it therefore corresponds to lipids from the 
tear film.  However, both C16:0 and C18:0 have been identified in 
meibomian gland secretions and are therefore considered to be from the 
tear film and not extractable components of the lens.   
The most predominant peaks observed for subjects C and D lens extracts 
(chromatograms 3 and 4) correspond to C16:1, C16:0, C18:1, C18:1 (at 
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12.4mins, 12.8mins, 14.8mins and 15.1mins respectively).  These are all 
common fatty acids known to be secreted by the meibomian glands.    
The chromatograms representing subjects A-D Acuvue TruEye lens 
extracts were different to the chromatogram of an unworn Acuvue TruEye 
extract (Figure 6.6, Chromatogram A).  For example, the peaks at 
10.03mins and 7.9mins on the chromatogram representing an unworn 
Acuvue TruEye lens extract (Figure 6.6, Chromatogram A) are not present 
at all or at the same intensity on subject A-D Acuvue TruEye lens extracts.  
These two species were most likely extracted by the tear film during wear.   
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The gas chromatograms in Figure 6.14 represent unworn narafilcon A, 
narafilcon B and worn narafilcon B lens extracts.  Narafilcon A is available 
to the European market and narafilcon B is only available from the USA 
market.  Narafilcon B lenses differ from narafilcon A because they have a 
higher proportion of hydrogel to silicone.   
 
Figure 6.14 – Gas chromatograms of an unworn narafilcon A lens extract, 
unworn and worn narafilcon B lens extracts 
The GC trace for an unworn narafilcon A lens extract was very different to 
an unworn narafilcon B lens extract.  The C10:0 peak at 7mins was not 
present on the chromatogram representing the unworn narafilcon B extract 
(chromatogram 2) but was a characteristic peak on the narafilcon A extract 
chromatogram.  The peak at ~10mins on chromatogram 1 (unworn 
narafilcon A extract) was not present on chromatogram 2 (unworn 
narafilcon B extract).  Peaks representing C16:0 and C18:0 (at 12.8mins 
and 15.0mins) were present on chromatograms 1 and 2 (unworn 
narafilcon A and unworn narafilcon B respectively).   
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The GC trace for the worn narafilcon B lens extract (chromatogram 3) was 
not very different to the GC trace of an unworn extract.  A major difference 
was the presence of the peak corresponding to C18:1 at 14.8mins on 
chromatogram 3 (worn narafilcon B extract).  The GC trace for the unworn 
narafilcon B extract did not show this peak.  C18:1 is a common tear fatty 
acid and is therefore not present on the trace of an unworn extract. 
Also, the GC trace of the unworn narafilcon B lens extract (Figure 6.14, 
chromatogram 2) showed peaks at 9.5 and 10.3mins.  These peaks 
corresponded to extractable species from the lens.  These peaks were not 
observed on the gas chromatogram representing the worn narafilcon B 
lens extract (chromatogram 3).  These species had most likely been 
extracted from the lens by the tear film.   
6.3.6.1 Acuvue TruEye lens extraction: Summary 
- There were clear differences in the GC traces between worn and 
unworn narafilcon A lens extract (Figure 6.6 chromatogram A and 
Figure 6.14) 
- Certain peaks observed for unworn narafilcon A extracts were not 
observed for worn lens extracts, therefore the tear film had extracted 
them 
- There were differences in GC traces between unworn narafilcon A 
and narafilcon B lens extracts 
- There was no peak corresponding to C10:0 observed for unworn 
narafilcon B lens extracts, the peak at 10.5mins on GC traces 
representing narafilcon A lens extract (Figure 6.14, chromatogram 1) 
was not present for the narafilcon B extract (Figure 6.14, 
chromatogram 2) 
- There were differences in GC traces between worn and unworn 
narafilcon B lens extracts 
- Certain peaks present on the GC trace of an unworn narafilcon B 
extracts were not present on the GC trace of the worn extract, which 
suggested these components had been extracted by the tear film 
during wear 
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6.4 Conclusions 
The aim of this work was to establish whether DMPC would be delivered 
to the tear film during wear.  Initially, non-clinical contact lenses were 
extracted using various extraction protocols.  The results showed DMPC 
was extractible from these lenses using in vitro conditions (Figure 6.3).  
However, many of the extraction protocols did not mimic in vivo conditions.  
Once clinical lenses were obtained, they were extracted (post wear) and 
analysed using GCMS.  The concentration of DMPC that remained in ex 
vivo lenses in the lens was determined.  In addition to the analysis of ex 
vivo lens extracts, tear samples were taken to establish whether DMPC 
had been released into the tear film.    The results show that unworn and 
worn lenses had similar levels of DMPC after the lenses had been worn 
for one day, which indicated low levels or no DMPC had been extracted by 
the tear film.  There was no C14:0 peak present on the gas 
chromatograms representing tear samples taken directly after wearing 
DMPC-containing lenses (see Figure 6.8, Figure 6.10 and Figure 6.11).   It 
was difficult to ascertain the exact concentration of DMPC released into 
the tear film (if any) because the amount of DMPC in unworn lenses varied 
from lens-to-lens.  However, the results suggested that if any DMPC was 
released, it was a very small amount.   
- In summary, it is unclear how much DMPC is released into the tear 
film by using the techniques discussed in this chapter.   
- The concentration of DMPC extracted from several unworn DMPC-
containing lenses varied from lens to lens, which made it difficult to 
monitor whether DMPC was released into the tear film.   
- It could not be conclusively stated whether DMPC was released into 
the tear film or not, however from the work conducted in this chapter, 
it was observed that the majority of the DMPC could still be extracted 
from ex vivo lenses.   
Pitt et al. showed DMPC was being released after 20hrs using an in vitro 
model (95).   They loaded lenses with radio-labelled DMPC and then 
measured its release, however the DMPC standards were prepared in n-
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propanol and lenses were soaked in this solution and this may have 
swollen the lenses which allowed DMPC to be released.     
The work undertaken in this chapter was to ultimately establish whether 
DMPC was released into the tear film from phospholipid-containing 
contact lenses.  The aim was also to try and find a suitable in vitro 
extraction protocol which would mimic the tear film extraction of DMPC 
from the lens.  The research discussed in this chapter successfully 
established that little to no DMPC was actually released into the tear film 
from the phospholipid-containing contact lenses.  After additional research 
of Acuvue TruEye lens extracts, it was shown that components of this lens 
were extracted by the tear film.   
The consequences on the tear film as a result of tear film lipid layer 
extraction of species from lenses are yet to be investigated.  The research 
in this chapter shows that tear film is capable of extracting components 
from certain lens materials.  However, it is unknown whether the extraction 
of components of the lens into the tear film will be beneficial or detrimental 
to tear film dynamics. 
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7. Chapter 7 – Summary, conclusions and 
future work 
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7.1 Concluding discussions 
Contact lenses are worn by millions of individuals all over the world.  
Consequently, the contact lens industry is worth an estimated $6.1 billion 
dollars (155).  The development of contact lens materials is on-going to 
ultimately produce more comfortable lens materials.  Contact lens comfort 
is a very important aspect for wearers, clinicians and manufacturers.     
Many contact lens wearers suffer from a phenomenon known as ‘end of 
day discomfort’.   Trying to understand certain areas of lens comfort were 
therefore the major aim of this research.   
The evolution of silicone hydrogel lenses has been discussed in section 
1.7.  Some of the major problems with silicone hydrogel lenses are related 
to high levels of lipid deposition.  It is well established that lipids deposit on 
contact lenses throughout wear and this has been shown throughout this 
thesis, particularly in section 3.6.1.1, however the nature and fate of lipids 
on contact lenses has not previously been studied in great detail.  The 
correlations between the tear film lipid layer and contact lens comfort are 
only now starting to be examined.  The work in this thesis was based on 
investigating the changes in lipid structure as a consequence of contact 
lens wear.   
7.1.1 Major developments achieved in this work 
- Analytical techniques, extraction techniques and tear sampling 
techniques were developed for the examination of lipids. 
- The Visispear ophthalmic sponge was used to successfully sample 
tear lipids (shown in Chapter 3). 
- Development of an effective contact lens extraction protocol was 
achieved and single lens extracts were examined.  Therefore, 
variations in lipid structure for individual subjects were investigated.  
- The development of HPLC and GCMS to examine both lipid 
classes and fatty acid profiles from lens extracts and tear samples.   
A major part of the work discussed in this thesis was the development of 
analytical techniques, HPLC and GCMS.  HPLC had been used by some 
researchers for the analysis of tear lipids and lens extracts but it had never 
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been used in conjunction with GCMS.  Both HPLC and GCMS proved to 
be powerful techniques which provided individual lipid class and fatty acid 
profiles from single lens extracts and tear samples.  HPLC was useful for 
determining polar to non-polar ratios for individual subjects tears.  The 
properties, including spreading and wetting of individual lipid classes vary 
and this is discussed in the next section.   
7.1.1.1 Spreading and wetting of lipids on contact lenses 
Combined aqueous and lipoidal lubrication is common to several biological 
interfaces (e.g. lung, articulating joint and anterior eye) and there are both 
commonalities and differences between them.  It is clear, for example, that 
the lipid layer associated with the tear film is unique in its composition.  
Whereas the lipoidal content of pulmonary surfactant and synovial fluid are 
primarily phospholipids, the tear film lipid layer consists of mainly non-
polar lipids such as cholesterol, cholesteryl esters and glyceryl esters.  
Although the level of phospholipids is now generally agreed to be much 
lower in the tear film than was previously thought (31, 32) it remains likely 
that they have an active role at the aqueous-lipid interface.  Saville et al. 
suggest the concentration of phosphatidyl cholines in meibum is 
18±5ng/mg (33).   
The properties of non-polar lipids are significantly different from those of 
polar lipids. Phospholipids tend to form bilayers and this is a particular 
feature of lung surfactant, whereas the tear film lipid layer is necessarily 
much thicker because of its function in reducing tear film evaporation.  In 
order to fulfil this function it is essential that the lipid layer should maintain 
a so-called duplex film rather than forming lenses or a monolayer. 
Additionally, because of the rapidity and regularity of eyelid movement it is 
essential that the lipid film spreads rapidly over the tear aqueous. 
The equilibrium stability of the lipid layer on tear aqueous can be 
estimated by calculation of the Harkins spreading coefficient.  In order to 
calculate this it is necessary to know the surface tension parameters of the 
lipid components, the surface tension parameters of the tear aqueous and 
the interfacial tension between the two layers.  The underlying 
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thermodynamic principle is that the lowest energy configuration (fully 
spread lipid film or separate droplets or lenses of lipid) will be favoured.  
The same principles apply to the spreading of tear aqueous on a lipid-
coated lens and the same data set can be used to calculate the spreading 
coefficients for this configuration.  
The phenomenon of surface tension arises from the excess molecular 
force between molecules at an air interface.  The absence of similar 
molecules in the air phase means that bonding and interactive forces 
between molecules in the surface layer is enhanced.  Where two 
immiscible phases meet, a similar concept can be applied.  The sum of the 
surface tensions of the two individual phases contributes to an interfacial 
tension.  The magnitude of this combined value is reduced by any 
molecular forces that can operate across the interface.   A reasonable 
approximation of this interaction can be obtained by separating the total 
surface tension (into polar (pand non-polar (commonly known as 
dispersive (d components. The interfacial tension is calculated from 
these individual components by use of Equation (1). 
γT= γa + γb – 2(γap γbp)
1/2 – 2(γad γbd)
1/2 Equation (1) 
Information on the surface tension parameters of different lipid classes is 
not readily available.  The effect of hydrocarbon chain length on the 
surface tension parameters of fatty acids, fatty alcohols and 
tracyliglycerides has been collected, as have available data on the surface 
energy parameters of cholesterol.  Phospholipids, because of their greater 
polarity and asymmetry, the tendency to form bilayers is more difficult.  
Useful information on the surface free energy of DPPC multilayers on 
different substrates has been obtained, which emphasises the great 
tendency of this molecule to align its polar head group with polar 
interfaces.  Additionally, useful direct measurements of the interfacial 
tension between tear aqueous and lipid-like components have been 
reported.  Data from these various sources enable the necessary 
calculations to be made (13, 156-160). 
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Table 7.1 – Spreading coefficients for various lipid classes 
Lipid class 
Surface 
tension of 
tears 
(γaq) 
Surface 
tension 
of lipid 
classes 
(γL) 
Interfacial 
tension at 
the lipid, 
tear 
interface 
(γaqL) 
Spreading 
Coefficient 
of lipid on 
tear 
S=γaq-(γL + 
γaqL) 
Spreading 
Coefficient 
of tears on 
lipid 
S=γL-(γaq + 
γaqL) 
Min Max Min Max Min Max Min Max 
Cholesterol* 43.6  46.0 36.0 13.4  16.6 -9.6 -3.4  -
24.2 
-
22.4 
TAG 43.6 46.0 31.0 10.6 13.2 -0.6  +4.0  -
25.8 
-
23.6 
PLs 43.6  46.0 32.0 9.0 11.0 +0.6 +5.0 -
23.0 
-
22.6 
*Cholesteryl esters give similar values (161) 
Since a positive spreading coefficient denotes that the conditions are 
favourable for spreading, the following conclusions can be drawn: 
 The most hydrophobic tear lipids will not form a stable spread layer 
on the tear aqueous  
 As the lipid components become more polar there is a transition to 
favourable spreading conditions 
 The calculations indicate that polar lipids are required at the 
aqueous interface in order to promote formation of a spread lipid 
layer over the tear aqueous 
 Tear aqueous is unable to form a spread layer over a lipid-coated 
substrate (i.e. contact lens) that remains stable as the film thins and 
surface forces dominate regardless of the lipid composition.   
The data also indicate why lipid spreading is not uniform and is subject-
dependent.  The tendency to form colour fringes, striations, meshwork 
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patterns and in some cases homogeneous and amorphous films are quite 
consistent with the variation in spreading coefficient of individual lipid 
components (162). 
It is important to note that there are additional factors that affect lipid 
spreading behaviour that will not be dealt with in detail here.  These 
include temperature-dependant phase transitions which form the basis of 
so-called liquid crystal behaviour.  Since many of these occur around 30°C 
they exert a considerable influence on lipid viscosity and consequently 
flow patterns.  A second important aspect of lipid layer formation is the 
rate at which the lipid layer spreads so far we have considered only the 
equilibrium condition which reflects the tendency, rather than the rate.  
The rate of lipid spreading is affected by a complex inter-relation of various 
factors including surface tension gradients and viscosity, but made more 
complex because spreading is an unstable and dynamic situation (163).  
In experimental studies the spreading coefficient has been found to be a 
useful predictor of relative rates of spreading (163).    
The majority of tear lipids are made up of fatty acids such as cholesteryl 
esters, phospholipids, triglycerides, wax esters as well as free fatty acids 
themselves.  The fatty acid chain length and level of unsaturation affects 
the structure and function of the lipid.   
7.1.2 Use of GCMS to examine fatty acid profiles from single 
lens extracts 
- GCMS analysis of lenses worn on a daily wear schedule compared 
with lenses worn on a continuous wear schedule revealed significant 
differences in fatty acid profiles related to wear schedule. 
- Unsaturated lipids had degraded during overnight wear of contact 
lenses after a 30 day wear period. 
- The degradation was independent of lens material and extraction 
protocol. 
- GCMS had never previously been used to examine fatty acid profiles 
from lens extracts.  The work discussed in Chapter 4 showed that 
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GCMS was an extremely powerful technique for the analysis of fatty 
acids from single lens extracts.   
- The use of GCMS enabled the differences in fatty acid profiles 
between daily wear and continuous wear lens extracts to be 
examined.  This was a significant finding of this work and not been 
previously investigated.   
7.1.2.1 Changes to the tear film protein levels during eye closure 
Publications by Sack et al. (164) revealed that levels of certain proteins 
increased when the tears were collected straight after sleep.  Stapleton et 
al. (165) investigated  the changes in tear protein composition during sleep 
in contact lenses.  They showed that levels of certain proteins such as 
sIgA and complement proteins increased after overnight wear of contact 
lenses.  However, they also stated that similar increases had previously 
been showed without contact lens wear.  They also showed that certain 
proteins have an affinity for depositing on the contact lenses which could 
deplete tears of these proteins.  Stapleton et al. (165) extracted and 
analysed the worn contact lenses as well as analysing tears prior to and 
post sleep in lenses to show that certain proteins deposit on the lens 
which depleted their concentrations in tears.  There have been no studies 
up to this date and to our knowledge which examine changes in lipid 
composition post sleep.  The work carried out in Chapter 4 provides 
evidence that there are significant changes to the structure of lipids during 
sleep.   
The consequences of changes in tear lipid composition as a result of 
overnight contact lens wear are to be fully investigated; however 
degradation of lipids does produce oxidative products.   
7.1.3 Production of lipid oxidative end products in the ocular 
environment 
The unique composition of the tear film lipid layer is such that it is fairly 
oxidatively stable.  There are only low levels of polyunsaturated fatty acids 
in the tear film because they are more prone to oxidation.  However, the 
introduction of a contact lens to the eye, as already discussed causes a 
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huge disturbance to the ocular environment.  Therefore, the stability of the 
tear film is compromised by the presence of a contact lens.   
The work discussed in Chapter 5 was therefore based on investigating the 
presence of lipid oxidative end products in the ocular environment.  MDA, 
a commonly studied biomarker of lipid oxidation was found to be present 
in the tears of contact lens intolerant patients by Glasson et al. (121).  
Other than this publication, there has been no other research investigating 
lipid oxidative end products in contact lens wearers.   
- Therefore, the research in Chapter 5 was mainly based on 
establishing a sensitive and suitable assay for the measure of MDA 
in the ocular environment.   
- The MDA-ELISA assay kit was found to be the most sensitive assay 
for the detection of MDA in the ocular environment.   
- The results using this assay showed that MDA was building up within 
the lens matrix and this had never been shown before.   This work 
demonstrates that lipid oxidation can produce MDA, which has been 
previously linked with contact lens intolerance.   
There is another pathway of lipid degradation causing problems of 
decreased wetting and subsequent discomfort and this is the production of 
discrete deposits on contact lenses.    
There have been previous reports of lipid degradation as a result of 
increased lipid deposition on lenses.  Increased lipid deposition can lead 
to the oligomerisation of lipids (conformational change in structure) and 
can produce white spots.  Several authors have previously identified the 
presence of ‘white spots’ or ‘jelly bumps’ on hydrogel contact lenses (140, 
141).  Both Hart and Bowers and Tighe (141) found the presence of 
calcium within these deposits, all be it at a very small concentration 
compared to the amount of lipid.  Bowers and Tighe  (141) found that not 
only did the lens material have an effect on deposition but also that subject 
variability affected the rate of deposition.  The composition of these ‘white 
spots’ were identified as being predominantly non-polar cholesteryl esters 
with unsaturated fatty acids esterified to the cholesterol (140).  These 
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unsaturated fatty acids had oligomerised and therefore produced ‘white 
spots’ or ‘jelly bumps’ on the lens.  Due to the non-polar nature of these 
lipids, they become very difficult to remove using cleaning surfactants.  
The wettability of the lens surface also becomes very difficult because of 
the build-up predominantly non-polar lipids.  The degradation of lipids can 
therefore have two effects:  it can either lead to the production of lipid 
oxidation products such as MDA (as discussed in Chapter 5) which can 
bind to proteins and/or cause deposits on the lens which can lead to 
decreased visual acuity and decreased wetting of the lens.  Both, the 
production of deposits on lenses and/or the production of lipid oxidative 
end products have a major effect on contact lens comfort.  As already 
discussed, contact lens comfort is important for the contact lens industry.   
The spreading and wetting of lipids is vital for the lubrication of the ocular 
surface over the contact lens.  The role and function of the lipid layer is to 
aid lubrication of the eyelid over the ocular surface.  Its function is even 
more important in contact lens wear as it has additional interfaces to cope 
with.  The comparison of the tear film with other biological interfaces helps 
understand the function of the tear film.  Chapter 1, section 1.5.3 is a 
review of literature regarding the comparison in lipid compositions of 
pulmonary surfactant and synovial fluid to the composition of the tear film.  
The key piece of information is that whilst the function at each interface is 
very much similar, the composition of the tear film is unique.  The tear film 
lipid layer is composed of mainly non-polar lipids whereas both synovial 
fluid and pulmonary surfactant are made up of predominately polar 
phospholipids.  Different lipid classes have different properties, not only in 
their interaction with other lipid species, but their spreading properties are 
also different.   
 
7.2 Conclusions 
The major developments of the work carried out in this thesis are 
discussed below.   
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- Single lenses were and analysed by various analytical techniques. 
- Visispear ophthalmic sponges were successfully used to collect tear 
lipids from individual subjects. 
- HPLC and GCMS were both used for lipid class and fatty acid 
profiles for individual lens extracts and tear samples, the build-up of 
lipids on contact lenses was observed (Chapter 3). 
- A range of unworn lenses were extracted and analysed by HPLC and 
GCMS.  Many extractable components were observed.  These 
extractable components from unworn lenses can be extracted by the 
tear film; however their effect on the tear film is unknown. 
- GCMS analysis of phospholipid-containing lenses (Dailies Total 1) 
showed little to no DMPC was extracted into the tear film 
- GCMS showed that even monounsaturated unsaturated fatty acids 
degrade with overnight wear of contact lenses (Chapter 4).  
- Although the tear film lipid layer is known to have low levels of 
polyunsaturated fatty acids (PUFAs), and MDA is only produced by 
PUFAs oxidation, contact lens wear changes tear film dynamics and 
lipids from other sources enter the tear film.  Therefore, MDA can be 
produced in the ocular environment.  MDA has been linked with 
contact lens intolerance in the literature. 
- MDA was assayed by various commercial assays and MDA-ELISA 
was the most sensitive technique.  For the first time, it was shown 
that MDA builds up within the contact lens.  A chloroform: methanol 
extraction was the most effective method of MDA extraction.   
The work carried out in this project was to try to understand and possibly 
monitor the effects on the lipid layer as a result of contact lens wear.  
Although there is still some future work to be carried out, the research 
undertaken provided evidence that lipid composition and structure is 
affected by lens wear and that these changes could be a cause of contact 
lens discomfort.  
The possible implications of the research discussed in this thesis are 
listed: 
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- understanding individual subjects tear chemistry is important to help 
chose suitable lenses for those individuals 
- the interaction and consequences of contact lens wear on the tear 
film are important to understand in order to for the development of 
newer, better contact lens materials.   
7.3 Future directions 
- The future directions of this work involve further investigations into 
the presence of lipid oxidation and MDA, in particular linked with 
length of wear, wear schedule and use of solutions.   
- Investigating the levels of MDA in correlation with tear proteins 
derived from plasma leakage (such as tear albumin).  Albumin can 
be found in tears, it passes into the tear film from plasma leakage.  
One of the functions of albumin in serum is the transport of free fatty 
acids (166).  Therefore, increased levels of albumin could correlate to 
increased levels of MDA.   
- Other future work would involve linking HPLC with other detectors 
such as mass spectroscopy to provide structural identification for 
separated species.   
- The link between analytical and surface techniques (such as the 
measurement of coefficient of friction and Langmuir) is also another 
future aspect of the work discussed in this thesis.   
- It was shown in Chapter 3 and Chapter 6 that non-polar solvents 
extract material from unworn silicone hydrogel materials.  
Investigating the effects that these extractable components have on 
the tear film lipid layer will be of interest in the future.   
- The recruitment of subjects to wear lenses for 7days on a daily wear 
and continuous wear basis to elaborate on the initial findings in 
Chapter 4.   
- As well as the analysis of lipid oxidative end products, the analysis of 
the levels of antioxidants in contact lens wear would be of interest in 
the future.   
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Appendix 1: Calibration curve data for lipid classes measured by normal 
phase HPLC 
Calibration curve data for cholesterol standard 
 
 
Calibration curve for cholesterol standard measured by HPLC 
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Primary peak for cholesterol standard measured by normal phase HPLC 
Calibration curve data for triolein 
Concentration of triolein (moldm-3) Area under peak at 1.962 minutes 
0 0 
0.00041875 495.807 
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Primary peak for triolein (a TAG) 
Calibration curve data for oleic acid 
Concentration of oleic acid (moldm-3) Area under peak at 6.504 minutes 
0 0 
0.0008375 709.35547 
0.001675 1342.91541 
0.00335 2251.34546 
0.0067 4366.9842 
 
 
Calibration curve for oleic acid measured by normal phase HPLC 
separation 
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Primary peak for oleic acid standard separated by normal phase HPLC 
 
Calibration curve data for behenyl oleate (a wax ester) 
Concentration of behenyl oleate 
(moldm-3) 
Area under peak at 1.545 
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0 0 
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Primary peak for behenyl oleate standard separated by normal phase 
HPLC 
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Appendix 2: Mass spectra of various fatty acid standards 
 
Mass spectra for C14:0 (myristic acid methyl ester) 
 
Mass spectra for C16:0 (palmitic acid methyl ester) 
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Mass spectra for C16:1 (palmitoleic acid methyl ester) 
 
Mass spectra of cholesta-3,5-diene 
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Appendix 3: Gas chromatograms of empty vial extracts used for unworn 
lens extraction 
 
Gas chromatograms of empty vial extractions where: Chromatogram 1: 
empty vial extraction, vial used for unworn PV extraction, Chromatogram 
2: empty vial extraction, vial used for unworn F.N&D extraction, 
Chromatogram 3: empty vial extraction, vial used for unworn AO 
extraction, Chromatogram 4: empty vial extraction used for AOA 
extraction, Chromatogram 5: empty vial extraction used for Soflens 66 
extraction 
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Appendix 4: Study details for clinical trial (lenses used in Chapter 4)  
 
 
 
 
 
 
 
 
 
M/F = male: female ratio 
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Appendix 5: Gas chromatograms of daily wear and continuous wear 
PureVision (PV) lens extracts for individual subjects   
 
Chromatogram 1 – Continuous wear PV lens extract (extraction protocol 
1) 
Chromatogram 2 – Continuous wear PV lens extract (extraction protocol 
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Chromatogram 1 – Continuous wear PV lens extract (extraction protocol 
3) 
Chromatogram 2 – Continuous wear PV lens extract (extraction protocol 
1) 
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Chromatogram 1 – Continuous wear PV lens extract (extraction protocol 
1) 
Chromatogram 2 – Continuous wear PV lens extract (extraction protocol 
3) 
Chromatogram 3 – Daily wear PV lens extract (extraction protocol 1) 
Chromatogram 4 – Daily wear PV lens extract (extraction protocol 3) 
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Chromatogram 1 – Continuous wear PV lens extract (extraction protocol 
1) 
Chromatogram 2 – Continuous wear PV lens extract (extraction protocol 
3) 
Chromatogram 3 – Daily wear PV lens extract (extraction protocol 1) 
Chromatogram 4 – Daily wear PV lens extract (extraction protocol 3) 
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Chromatogram 1 – Continuous wear PV lens extract (extraction protocol 
1) 
Chromatogram 2 – Continuous wear PV lens extract (extraction protocol 
3) 
Chromatogram 3 – Daily wear PV lens extract (extraction protocol 1) 
Chromatogram 4 – Daily wear PV lens extract (extraction protocol 3) 
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Chromatogram 1 – Continuous wear PV lens extract (extraction protocol 
1) 
Chromatogram 2 – Daily wear PV lens extract (extraction protocol 1) 
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Appendix 6: Gas chromatograms of daily wear and continuous wear 
Focus Night and Day lens (F.N&D) extracts 
 
Chromatogram 1 – Daily wear F.N&D lens extract 
Chromatogram 2 – Daily wear F.N&D lens extract 
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Chromatogram 1 – Continuous wear F.N&D lens extraction (extraction 
protocol 3) 
Chromatogram 2 – Continuous wear F.N&D lens extraction (extraction 
protocol 1)  
Chromatogram 3 – Daily wear F.N&D lens extraction (extraction protocol 
1) 
Chromatogram 4 – Daily wear F.N&D lens extraction (extraction protocol 
3) 
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Chromatogram 1 – Continuous wear F.N&D lens extract 
Chromatogram 2 – Daily wear F.N&D lens extract 
 
Chromatogram 1 – Continuous wear F.N&D lens extract 
Chromatogram 2 – Daily wear F.N&D lens extract 
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Appendix 7: HPLC traces of daily wear and continuous wear PV lens 
extracts worn by different subjects (post column change) 
 
HPLC trace of a daily wear PV lens extract (extraction protocol 1) (subject 
53) 
 
HPLC trace of a daily wear PV lens extract (extraction protocol 1) (subject 
54) 
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HPLC trace of a continuous wear PV lens extract (extraction protocol 1) 
(subject 29) 
 
 
HPLC trace of a continuous wear PV lens extract (extraction protocol 1) 
(subject 59) 
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Appendix 8: HPLC traces of daily wear and continuous wear Focus Night 
and Day lens extracts worn by various subjects 
 
HPLC traces of a daily wear F.N&D lens extract (extraction protocol 1) 
subject 27) 
 
HPLC traces of a daily wear F.N&D lens extract (extraction protocol 1) 
(subject 11) 
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HPLC traces of a daily wear F.N&D lens extract (extraction protocol 1) 
(subject 61) 
 
 
HPLC traces of a continuous wear F.N&D lens extract (extraction protocol 
1) (subject 56) 
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